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Summary 
 
Introduction 
 
Economic evaluations of health intervention programs can provide decision makers with 
quantitative information on how to allocate the scare resources available for health 
investment.  Malaria is the single most important parasitic infection in humans and accounts 
for a large proportion of the disease burden of sub-Saharan Africa.  Currently many 
strategies are being employed for malaria prevention, and there is a need for evaluation of 
the various strategies being used.  Additionally, routine malaria diagnosis in Africa often 
leads to mis-use of anti-malarial drugs and there is an urgent need to assess the cost 
implications of strategies for diagnostic improvement.   
 
Costs and cost-effectiveness of vector control 
Economic evaluations of ITNs (insecticide treated bednets) and IRS (indoor residual 
spraying) have been conducted in several settings but few of these evaluations relate to the 
scope and scale of interventions currently underway. Furthermore, few of these evaluations 
used comparable methodologies.  We developed a standardized methodology for the 
economic evaluation of malaria vector control programs by reviewing and refining existing 
guidelines. Utilizing this methodology we collected new data from several settings (Eritrea, 
Malawi, Senegal, and Tanzania) and reanalyzed existing datasets from others (Togo, South 
Africa, and Mozambique).  These sites were chosen to represent geographic variability as 
well as a diversity of implementation models for ITN delivery.   
 
The goals of this thesis were threefold: (1) to evaluate the relative cost and cost-
effectiveness of ITNs and IRS for vector control in sub-Saharan Africa, (2) to evaluate the 
relative cost and cost-effectiveness of different implementation strategies for ITN delivery, 
and (3) to estimate the costs of introducing RDTs and their effect on the cost of case 
management of febrile patients.  The ITN programs which we evaluated were chosen to 
represent five different delivery strategies:  (1) free delivery through integrated vaccination 
campaigns (Togo), (2) free delivery through routine services and community mechanisms 
(Eritrea), (3) highly subsidized delivery through routine services (Malawi), (4) subsidized 
delivery through the commercial sector utilizing vouchers aimed at pregnant women and 
infants (Tanzania), and (5) pure commercial sector subsidization (Senegal). 
 
ITN/IRS Results 
The results of the studies generally showed that both interventions remained attractive uses 
of health resources in a low income country context under almost any scenario.  More 
 Summary xiv
specifically, for conventional ITNs (targeted to children) the cost per treated net year of 
protection (TNY) and child death averted ranged from USD 1.21 to USD 6.05 and USD 438 
to USD 2,199, respectively.   Long-Lasting Insecticidal Net (LLIN) scenarios (also targeted to 
children) resulted generally in improved cost-effectiveness (USD 1.38 to USD 1.90 per TNY 
and USD 502 to USD 692 per death averted).   IRS was more expensive in base scenarios, 
with a total cost per person year of protection of USD 3.27 in KwaZulu-Natal and USD 3.90 in 
Mozambique, this resulted in costs per death averted of USD 3,933 and USD 4,357.  
 
ITN programs appeared to be a more efficient strategy for the prevention of child mortality in 
highly endemic sub-Saharan African settings. However, this was dependant on both effective 
use of nets and a preferential usage of nets by children.    Generally, the cost effectiveness 
of either strategy was heavily dependant on the cost of the commodities and their effective 
lifetime (nets for ITN programs and insecticide for IRS programs).  ITN programs benefited 
clearly from a shift to LLINs.   
 
Under most scenarios free net delivery utilizing integrated campaigns appeared the most 
attractive method for short term “catch-up” in coverage levels for ITNs.  The other strategies 
that were reviewed appeared to be better suited to the long term maintenance of coverage 
(“keep-up”).       
 
The data presented here provide a significant amount of new information collected and 
analyzed in a comparable manner to aid in decision making regarding vector control for 
malaria in sub-Saharan Africa.                    
 
Costs of introducing rapid diagnostic tests in Tanzania 
We also conducted a study on the costs of implementation of Rapid Diagnostic Tests (RDTs) 
for malaria in Dar Es Salaam, Tanzania.  Data were collected both at the level of individual 
patients and for entire health facilities.   
 
RDTs significantly lowered patient expenditure on drugs (by USD 0.37; p=0.001) and 
provider drug costs (by USD 0.44; p=0.014), but did not significantly reduce patients’ overall 
expenditures (USD 1.08 vs. USD 1.36) and have increased total provider costs (USD 3.62 
vs. USD 2.31).  Clinician’s compliance with tests was higher in clinics with RDTs than in 
those with routine microscopy.   
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Use of the economic data in this thesis will hopefully help to provide a better evidence base 
for program managers to make more rational and efficient decisions about malaria control 
options and case management of febrile patients. 
 Zusamennfassung xvi
Zusamennfassung 
 
Einleitung 
 
Wirtschaftliche Evaluierungen von Interventionsprogrammen im Gesundheitswesen bieten 
Entscheidungesträgern quantitativ gestützte Informationen darüber, wie knappe Mittel 
sinnvoll für Investitionen im Gesundheitswesen eingesetzt werden können. Malaria ist die 
bedeutendste parasitäre Erkrankung des Menschen, und sie macht einen grossen Teil der 
Krankheitslast im subsaharischen Afrika aus. Derzeit werden viele Strategien zur 
Malariaprävention verfolgt. Diese müssen dringend evaluiert werden, um eine bestmögliche 
Ausschöpfung vorhandener Mittel zu erreichen. Ausserdem kommt es durch die 
routinemässige Diagnose von Malaria in Afrika häufig zu einem Missbrauch von 
Malariamedikamenten. Strategien zur Verbesserung der Diagnostik und die damit 
verbundenen Kosten müssen dringend beurteilt werden. 
 
Kosten und Kostenwirksamkeit der Vektorkontrolle 
Wirtschaftliche Evaluierungen des Einsatzes von ITNs (mit Insektizid behandeleten 
Mückennetzen) und IRS (das Besprühen von Hausinnenwänden mit Insektizid) wurden 
bereits durchgeführt. Nur wenige dieser Evaluierungen werden jedoch der Bandbreite und 
der Grössenordnung derzeit laufender Interventionen gerecht. Ausserdem stützen sich nur 
wenige dieser Evaluierungen auf eine vergleichbare Methodik. Wir haben eine 
standardisierte Methodik für die wirtschaftliche Evaluierung von Vektorkontrollprogrammen 
für Malaria entwickelt, indem wir bestehende Richtlinien weiterentwickelt haben. Diese 
Methodik wurde dann zum einen verwendet, um neue Daten an verschiedenen Standorten 
(Eritrea, Malawi, Senegal und Tansania) zu erheben, und andererseits um bereits 
vorliegende Daten aus dem Togo, Südafrika und Mosambik erneut zu analysieren. Die 
Standorte wurden so ausgewählt, dass die geographische Vielfalt der verschiedenen 
Modelle zur ITN- Abgabe abgedeckt wurde. 
 
Die vorliegende Dissertation hat drei Ziele: (1) die Kosten und die Kostenwirksamkeit von 
ITNs und IRS zur Vektorkontrolle im Afrika zu vergleichen, (2) die Kosten und 
Kostenwirksamkeit von verschiedenen Implentierungsstrategien der Abgabe von ITNs zu 
evaluieren, und (3) die Kosten von Malariadiagnostik darzustellen. Die evaluierten ITN 
Programme wurden so ausgewählt, dass fünf verschiedene Strategien der ITN-Abgabe 
berücksichtigt wurden: (1) Gratisabgabe im Rahmen integrierter Impfkampagnien (Togo), (2) 
Gratisabgabe über Gesundheitsdienste und durch die Gemeinden gesteuert (Eritrea), (3) 
stark subventionierte Abgabe über Gesundheitsdienste (Malawi), (4) stark subventionierte 
Abgabe über den kommerziellen Sektor zussamen mit einem Gutscheinsystem für 
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schwangere Frauen und Kleinkinder (Tansania), sowie (5) eine ausschliessliche 
Subventionierung des kommerziellen Sektors (Senegal). 
 
ITN/IRS Resultate 
Die Studien ergaben im Allgemeinen, dass beide Interventionen unter fast allen Szenarios 
attraktive Investitionen im Gesundheitswesen in einkommenschwachen Ländern sind. Für 
herkömmliche ITNs, die an Kinder gingen, waren die Kosten pro behandeltes Netz und Jahr 
(TNY) zwischen 1.21 und 6.05 US Dollar und die Kosten für einen verhüteteten Tod eines 
Kindes von 428 bis 2199 US Dollar. Szenarios unter Verwendung von dauerhaft 
imprägnierten Mückennetzen (LLIN), verbesserten im Allgemeinen die Kostenwirksamkeit 
(1.38 bis 1.90 US Dollar pro TNY, und 502 bis 692 US-Dollar für einen verhüteten Todesfall). 
IRS erwies sich in Basisszenarien als teurer. Die Gesamtkosten pro Person und Jahr der 
Schutzwirkung beliefen sich auf 3.27 US Dollar in KwaZulu-Natal und auf 3.90 US Dollar in 
Mosambik und ergaben Kosten pro verhüteten Todesfall in der Höhe von 2,933 und 4357 US 
Dollar. ITN Programme stellten sich als wirksamere Strategie heraus, um der 
Kindersterblichkeit in hochendemischen Gebieten im subsaharischen Afrika vorzubeugen. 
Dies hing jedoch einerseits davon ab, ob die Netze tatsächlich benutzt wurden, und 
andererseits ob sie bevorzugt Kindern zu Gute kamen. Allgemein hing die 
Kostenwirksamkeit der jeweiligen Strategie stark von den Materialkosten ab und von der 
Wirksamkeitsdauer der Netze bei ITN Programmen und des Insektizids bei IRS 
Programmen. ITN Programme würden von einer Umstellung auf LLINs generell profitieren. 
Den meisten Szenarien gemäss erwiesen sich die integrierten Kampagnien, bei denen Netze 
gratis abgegeben werden als attraktivster Weg, einen höheren Deckungsgrad von ITNs 
innerhalb kurzer Zeit zu erreichen („Catch-up“). Die anderen Strategien, die untersucht 
wurden, schienen besser geeignet zu sein für ein „Keep-up“ des Deckungsgrades über 
längere Zeit. Mit den hier vorgestellten Daten, die auf vergleichende Weise erhoben und 
ausgewertet wurden, sind nun neue Informationen in beträchtlichem Umfang verfügbar, um 
Entscheidungen in der Malaria-Vektorkontrolle im subsaharischen Afrika zu treffen. 
 
Kosten für die Einführung von Diagnostik-Schnelltests in Tansania 
Wir führten weitherhin eine Studie durch, in der die Kosten der Einführung von Diagnostik-
Schnelltests (RDTs) für Malaria in Dar Es Salaam, Tansania, untersucht wurden. Hierzu 
wurden mittels Umfragen Daten auf der Ebene der einzelnen Patienten und auf der Ebene 
von Gesundheitszentren erhoben. Es zeigte sich, dass RDTs die Ausgaben der Patienten für 
Medikamente signifikant verringerten (0.37 US Dollar, p=0.001), und ebenso die Ausgaben 
des Gesundheitssystems für Medikamente (0.44 US Dollar, p=0.014). Die für die Patienten 
entstehenden Gesamtausgaben wurden jedoch nicht deutlich gesenkt (USD 1.08 vs. USD 
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1.36) und die für die Verkäufer entstehenden Gesamtausgaben dürften sogar angestiegen 
sein (USD 3.62 vs. USD 2.31). Die Compliance des klinischen Personals mit Tests war in 
Kliniken, in denen RDTs eingesetzt wurden höher, als dort, wo Mikroskopie routinemässig 
eingesetzt wird. 
 
Die Verwendung wirtschaftlicher Daten in der vorliegenden Dissertation kann als Grundlage 
dienen, auf der Manager von Malariakontrollprogrammen begründete und wirksame 
Entscheidungen in der Malariakontroll- und Behandlungsstratgie treffen können. 
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1.  Introduction 
 
1.1 Economics and Health 
 
Economics has been defined as the study of “human behavior as a relationship 
between ends and scarce means which have alternative uses (Robbins, 1935).”  Its 
techniques have been used in both their micro and macro formations to examine both 
the individual choices which help to understand the prices and quantities of goods 
consumed and produced in a market and the aggregate results of this activity in the 
formation and behavior of national or regional economies.  Only more recently have 
the techniques developed in these fields been implemented or adapted to the specific 
features and nuances of human health and health care markets.   
 
Much work has been carried out examining the relationships between 
macroeconomics and health. In total it shows that health and economic development 
are intertwined with causal relationships between the two often flowing in both 
directions (Rivera & Currais, 1999; CMH, 2001).  Low socio-economic status 
populations are likely to bear the highest burden of disease, as well as to be the least 
likely to access medical care and preventive interventions. Consequently, their share 
of the disease burden is disproportionate (Marmot, et al.1987; Wagstaff, 2000; 
Schellenberg et al., 2003; Victora et al., 2003; Barat et al., 2004).  Furthermore, 
individuals and households with low socio-economic status are also most likely to 
have their economic prospects damaged by the costs of the health care or losses to 
productivity associated with disease states (Ettling et al., 1994; Russell, 2004).  It is 
clear that economic development and growth will be required for poor-countries to 
financially sustain improvements in health, but also that economic growth alone is not 
enough to ensure good health outcomes.  The poor in middle and high income 
countries still have substantially worse health outcomes than those higher on the 
economic ladder within their own societies (CMH, 2001; Lynch et al., 2000; Yusuf et 
al., 2007).  At the same time, it is clear that with outside support and resources 
substantial gains in health outcomes can be made for the poorest of the poor with 
interventions which can be delivered even in the absence of an ideal health system 
(Bryce et al., 2003).  Several diseases, including HIV/AIDS and malaria, have been 
shown to clearly slow the overall economic growth of countries with high burdens 
(Cuddington, 1993; Cuddington & Hancock, 1994; Gallup & Sachs, 2001; Sachs & 
Malaney, 2002; Jefferis et al., 2008).  The relationship has also been shown to run 
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from economic growth or stagnation to health impact (Gurfinkel et al., 1996; Pritchett 
& Summers, 1996; Yusuf et al., 2007; Preston, 2007). 
 
While macro-economic relationships between health and economic growth are 
important.  Investments in health can provide benefits not only in the realm of saved 
lives or averted episodes of disease, but also in terms of relieving drags on economic 
growth in the aggregate or perhaps stimulating economic growth themselves.  Micro-
economics also has tools which are highly relevant for decision makers in the health 
care sector both in developed and developing countries. 
 
1.2 Disease Control Priority Setting and Welfare Analysis 
 
Health policy makers are forced to allocate scarce resources to only a subset of the 
possible investments which might provide health benefits.  In order to rationalize 
these choices and to improve the economic efficiency of the mix of health 
investments made, several types of economic analysis were developed or adapted to 
the health care sector. 
 
Classically, an economic analysis might use cost-benefit analysis to evaluate an 
investment or policy decision.  In such an analysis the potential costs of an approach 
are calculated and the potential monetarized gains which could be generated from 
this investment or policy change are summed.  An analysis which indicated that there 
were net benefits from making the investment would indicate that the investment 
should be made.  In a more complicated decision environment of several investment 
choices, the choice with the highest net benefits would be favored.  There are 
substantial methodological problems with such analysis, including estimating levels of 
uncertainty in cost and benefit measurements or estimates, and insuring that the 
appropriate costs as well as benefits are included.  When applied to the health arena 
these problems become even more substantial.   
 
The foremost issue has to do with the fact that in many cases the benefits are not 
financial in nature but rather lives saved, or healthy lives extended.  Unsurprisingly, 
the estimation of a monetary value for a year of human life raises issues both 
methodologically and ethically.  For this reason welfare analysis in the health context 
typically uses specialized adaptations.  Though estimates and benchmarks are 
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available for desirable levels of spending to gain a healthy year of human life in 
different settings, other types of analysis are more common.  Among these the main 
groups are cost minimization and cost effectiveness analysis.  Cost minimization 
analysis seeks to estimate the least costly way to achieve a fixed health outcome. 
For example: given that 1,000 new HIV infections occur in our district each year, what 
is the least costly way to reduce the number of new infections by 500?  Cost-
effectiveness analysis on the other hand asks what the unit cost of achieving a given 
health outcome is with a specific methodology.  For example: what is the cost of 
saving a life by preventing malaria through the use of insecticide treated bed-nets or 
by immunizing children against measles?  The results would indicate that the 
intervention which has a lower unit cost per health outcome measure would be the 
more cost-effective intervention, and would thus be a more efficient investment when 
allocating scarce health care resources. 
 
In order to make comparisons across different interventions, specific measurements 
of disease burden which incorporate and quantify both morbidity and mortality due to 
disease have been developed.  Measures such as the disability adjusted life year 
(DALY) or the quality adjusted life year (QALY) allow better comparisons between 
interventions which target very different diseases (e.g. childhood acute respiratory 
infections and traffic accidents) in different populations (e.g. elderly mortality vs. 
neonatal mortality).                  
 
These techniques and measures offer powerful methods for evaluating health care 
investment decisions.  This thesis examines the use of economic welfare analysis 
applied to the problem of prevention and treatment of malaria in sub-Saharan Africa. 
 
1.3 Malaria 
 
Malaria is a parasitic disease caused by one of four members of the genus 
Plasmodium. In addition, one species which has been typically held to be primate 
malaria (P. knowlesi) has recently been shown to be a source of zoonotic malaria 
(Gilles & Warrell, 1993; Singh et al., 2004; Cox-Singh & Singh, 2008).  Of the four 
human malaria species, (P. malariae, P. ovale, P. vivax, and P. falciparum) P. 
falciparum is both the most common in Africa and causes the most severe forms of 
disease.  These protozoan parasites are transmitted exclusively by female Anopheles 
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mosquitoes. During the blood meal an infected mosquito injects sporozoites under 
the skin, which then pass to the bloodstream of its human host.  These sporozoites 
travel through the bloodstream until they reach the liver where they infect liver cells, 
multiply and mature.  The cells then rupture releasing merozoites back into the hosts’ 
bloodstream.  P. vivax and P. ovale also produce hypnozoites, dormant liver stages 
which can result in relapse of infection months or years later. The blood stage 
parasites go on to infect erythrocytes (human red blood cells) and continue to 
multiply and mature, eventually rupturing the erythrocytes and releasing more 
parasites (also called merozoites) to infect other cells. This part of the cycle is largely 
responsible for the clinical manifestations of human disease. Some blood stage 
parasites differentiate into male or female gametocytes, which can be ingested by a 
mosquito taking a blood meal on the host.  When a mosquito ingests male and 
female gametocytes, the parasites undergo sexual reproduction in the mosquito mid-
gut and differentiate into ookinetes, which then invade the mosquito’s mid-gut wall 
and form oocysts.  When these oocysts rupture, releasing sporozoites which 
subsequently migrate to the mosquito’s salivary glands the mosquito is then 
competent to transmit the infection to further human hosts.  The cycle of transmission 
and disease lasts for varying periods depending on the parasite species, as well as 
temperature conditions and the acquired immunity of the human host among other 
factors. Generally it requires from 10 to 18 days from the mosquito’s ingestion of 
gametocytes to its ability to transfer the infection, and the human cycle typically 
requires at least seven days before clinical symptoms appear. Relapses may appear 
months or even years later, especially in the case of P. vivax or P. ovale which both 
produce dormant liver stages (Gilles & Warrell, 1993).  Figure 1 illustrates the life 
cycle of P. falciparum.  
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Figure 1: Life cycle of Plasmodium falciparum malaria  
 
 
© Kaitlin Baudier 2009 
 
 
1.4 Clinical Features of Malaria 
 
Generally P. falciparum malaria is clinically classified in one of two categories, 
uncomplicated or severe, though there is a continuum of symptoms over this range.  
Uncomplicated disease is characterized by a myriad of symptoms, including but not 
limited to fever, malaise, fatigue and pain in the back and limbs, nausea and chills.  
Symptoms onset at least seven days after infection, though the incubation period can 
vary depending on both host and parasite factors.  Disease can proceed very rapidly 
from uncomplicated to severe disease, especially among the non-immune.  While 
severe disease may fall into an array of varied pathologies including cerebral malaria, 
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it is generally characterized by convulsions, malarial anemia, hyperpyrexia, 
hypoglycemia, renal failure, and other signs and symptoms.  Cerebral malaria is a 
complication of malaria characterized by a loss of consciousness, generalized 
convulsions and persistent coma. It has a high case fatality rate, 10-15% if good 
hospital care is available, but much higher if treatment is unavailable or poor.  Malaria 
anemia is also associated with a high potential for fatality in young children and in 
parts of Africa may be responsible for as many deaths in children as cerebral malaria. 
Severe and cerebral malaria also can leave lasting sequelae including mental and 
cognitive impairments (Gilles & Warrell, 1993). 
 
In highly endemic areas in sub-Saharan Africa the vast majority of mortality occurs in 
children under five years of age.  An individual who survives this high risk period is 
likely to have developed some level of clinical immunity and tolerance to the parasite. 
This dramatically reduces the probability of dying from a P. falciparum infection.  
While neonates and infants typically have reduced malaria specific mortality due to 
conferred maternal immunity, this quickly fades and between six months and three 
years of age children in highly endemic areas are at a high risk of mortality (Gilles & 
Warrell, 1993).   
 
In highly endemic areas pregnant women also form a special high risk group; this is 
especially true of primagravidae.  In areas with unstable or low transmission there is 
a high risk of maternal mortality, abortion or still birth as a result of malaria, while in 
higher transmission areas the complications of malaria in pregnancy are largely 
characterized by increased likelihood of low birth weight and the concomitant risks to 
child survival (Gilles & Warrell, 1993).  
 
            
1.5 Mosquito Ecology and Malaria in Africa 
 
Malaria is always transmitted by a mosquito from the Anopheles genus.  However, 
despite there being several hundred Anopheline species recognized worldwide, only 
approximately 50 species are recognized as important vectors of malaria 
transmission in nature (Gilles & Warrell, 1993).  Of these, the most important in sub-
Saharan Africa are An. gambiae sensu lato and An. funestus (Gilles & Warrell, 1993).  
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Both the gambiae complex and the funestus species have slightly different behavior 
and ecological patters, but also have highly important similarities. 
 
Both species are highly efficient vectors for malaria transmission and both tend to be 
anthropophilic and endophilic, and they preferentially feed between 10 pm and dawn 
on sleeping hosts. Both have similar geographic distributions, though typically choose 
different larval habitats and often are responsible for malaria transmission with 
different seasonal patterns (Gilles & Warrell, 1993).   
 
1.6 Breaking the transmission cycle 
 
Malaria transmission can be interrupted at various stages in both the mosquito and 
human cycles.  Several interventions are available to do this, including insecticide 
treated bednets (ITNs), indoor residual spraying (IRS), mass drug administration 
(MDA), larviciding, integrated vector management (IVM) and the possible 
development of effective vaccines.  Here we will focus only on the two most common 
prevention strategies, insecticide treated bed nets and indoor residual spraying. 
 
1.7 Insecticide Treated Bednets (ITNs) 
 
Insecticide treated bed nets are a modern adaptation of an age old technique for the 
prevention of biting by nuisance mosquitoes.  In many areas of the world, including 
parts of sub-Saharan Africa, people have used netting over beds or sleeping areas to 
prevent nuisance mosquitoes from interfering with sleep, perhaps inadvertently or 
knowingly preventing malaria to some extent as well (Ross, 1910; Lindsay & Gibson, 
1988).  Though examples of their use in the USSR in the 1930s and by US and 
German militaries was available in the 1940’s and 50s, it was not until the late 1980s 
and early 1990s that techniques were revived, developed and properly tested in 
many African settings.  The trials indicated that the consistent use of polyester nets 
soaked in an emulsion of a synthetic pyrethroid insecticide could significantly reduce 
the incidence of clinical malaria as well as both malaria specific and all-cause 
mortality in under five children (Lindsay & Gibson, 1988; Lengeler, 2004).  
Concurrent and subsequent research indicated that this effect occurred for a 
combination of reasons.  The primary being that malaria infected mosquitoes are 
prevented from biting human hosts using ITNs (direct protection), due simultaneously 
to the excito-repellency of the insecticide, the killing properties of the insecticide 
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impregnated into the net, and the physical barrier to the mosquito which an intact net 
presents (Curtis et al., 1990).  The second way in which ITNs prevent malaria 
infections happens is by massive mosquito mortality as the coverage and use of nets 
locally increases leading to reductions in parity of the local female Anopheline 
population and thereby to reductions in transmission of malaria even to those who 
are not directly protected. This effect has been termed variously the mass-, mass-
killing- or community effect (Magesa et al., 1991; Binka et al., 1998; Howard et al., 
2000; Hawley et al., 2003; Killeen et al., 2007).    
 
1.8 Indoor Residual Spraying (IRS) 
 
Indoor residual spraying involves coating the inside walls and ceilings of homes or 
other structures with an insecticide which clings to walls for an extended period.  
Because both An. gambiae and An. funestus tend to rest on vertical surfaces after 
taking a blood meal and tend to feed indoors (endophagy) they are thus exposed to 
the insecticide and killed after feeding.  IRS breaks the malaria transmission cycle by 
preventing a mosquito from further transmitting its infection. This occurs by killing 
(hence reducing the longevity of) adult female Anophelines and thus reduces 
transmission intensity over time (Lengeler & Sharp, 2003).  However, unlike in the 
case of ITNs, IRS does not typically directly protect individuals whose home has 
been sprayed from being bitten by an infected mosquito, except in the case where 
the insecticide used for spraying has a strong excito-repellent effect (Lengeler & 
Sharp, 2003).  
 
IRS is a relatively old intervention, the first experiments with the technique in Africa 
date back to the 1930s. By the 1950s large scale operations were under way using 
DDT in a number of settings (De Meillon, 1936; Park Ross, 1936; Kouznetsov, 1977; 
Mabaso et al., 2004).  By the mid-1950s a global effort to eradicate malaria using IRS 
with DDT and mass drug administration was under way, though little of the programs 
efforts were focused in Africa (Kouznetsov, 1977).  The ultimate failure of this 
program to eradicate malaria globally, despite many local successes, led to the 
subsequent neglect of malaria control (Scholten et al., 1972).  Subsequently IRS has 
continued to be used, albeit infrequently, in Africa until recent increases in funding for 
malaria control have led to large expansions (Lengeler et al., 2003; Sadasivaiah et 
al., 2007).    
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1.9 P. falciparum and the distribution of malaria globally and locally 
 
Sub-Saharan Africa, by any measure bears the largest burden of malaria of any 
region on the globe (Hay et al., 2004).  While large numbers of people are at risk in 
both South East Asia and South Asia, those at risk are often from specific sub-
groups, as with forest malaria in South East Asia. In many areas individuals are 
mainly exposed to P. vivax malaria, which carries a far lower mortality risk than does 
falciparum malaria, the dominant species in sub-Saharan Africa (SSA) (Gilles & 
Warrell, 1993; Mendis et al., 2001).  Best estimates are that around one million 
deaths occur due to malaria globally and that, of these, 80% occur in children in SSA 
(WHO 2008). While vast areas of Asia, the Indian sub-Continent, Latin America, and 
Central Asia appear in global risk maps for malaria, nowhere but in sub-Saharan 
Africa is the combination of falciparum malaria, highly competent vectors and ideal 
climactic conditions for malaria transmission so pervasive.  Figure 2 shows the global 
distribution of malaria risk according to the WHO. 
 
Figure 2: Worldwide risk of malaria transmission. (http://www.who.int/globalatlas) 
 
 
 
Even within Africa there is a large heterogeneity of malaria transmission patterns, 
seasonality, specific dominant vector species and both at the country level and lower 
(Gilles & Warrell, 1993).  Evidence also indicates that within cities heterogeneity of 
 1. Introduction 10 
transmission occurs on very small scales (Robert et al., 2003; Keiser et al., 2004).  
All of this indicates that while some vector control strategies may be appropriate in 
very large areas, significant consideration of the national, regional or local situation 
should be incorporated into the decision making process for malaria control. Some 
strategies may be inappropriate for certain climatic conditions, local living conditions 
or vector species. 
 
1.10 Distribution strategies for Insecticide Treated Nets 
 
Given that ITNs are now a proven technology African Heads of State and 
international organizations have made several declarations of the intent to provide 
protection for populations with ITNs and other suitable vector control measures.  
These include the Abuja declarations and Roll Back Malaria strategic goals among 
others (African Heads of State and Government, 2000; RBM Partnership, 2005).  
However, a diversity of implementation methods for the delivery of ITNs have been 
proposed or implemented and relatively little evidence has been generated on which 
to base decisions as to the most appropriate delivery methods. The main proposed 
and implemented strategic delivery options are: support and development of a 
commercial sector for the retail sale of ITNs -- pure social marketing (in which an 
organization develops and sells a branded, usually subsidized, product) -- delivery, 
either free or subsidized, through existing health care services (including especially 
ante-natal care clinics or other health facilities) -- community interventions 
(Community based organizations (CBOs)) -- free delivery through campaigns (often 
integrated with vaccination campaigns) -- and the use of vouchers to subsidize sales 
through the commercial sector (Webster et al., 2007).   
 
Each of these strategies have unique features which may help or hinder their ability 
to provide ITNs and have them used. For example, commercial strategies risk failing 
to supply ITNs to areas where markets are limited or excluding those on the bottom 
end of the socio-economic ladder (Curtis et al., 2003).  Social marketing faces some 
of the same risks, though by subsidizing the price of ITNs price exclusion of low 
income groups might be reduced (Guyatt et al., 2002).  Delivering nets through 
existing health services can potentially add burden to those services which in many 
African settings are already under-staffed, under-trained and under-funded, and is 
further dependant on access and equity of access to services in order to deliver nets 
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(Hongoro & McPake, 2004).  CBOs are unlikely to have the funding to finance large 
capital purchases on their own, and though they may be far reaching, they also have 
a potential to be highly uncoordinated resulting in a myriad of different 
implementation strategies and varying levels of access (Wacira et al., 2007).  Free 
net delivery campaigns can be far reaching in scope but are temporally very limited 
and may leave gaps in access to ITNs during the long time periods between 
campaigns (Lengeler et al., 2007). Finally, voucher systems potentially help with the 
price based exclusion which can occur in pure commercial systems while reducing 
the logistic burden on health facilities and systems, but they typically also rely on 
individuals having access to both health services and private ITN markets and the 
expansion of both (Lengeler et al., 2007). 
 
ITNs can be classified in economic terms as a “mixed good,” meaning that they 
possess attributes of both private and public goods.  Given their public good aspects 
the socially desirable level of ITN usage is unlikely to be achieved without subsides 
(Hanson, 2004; Stevens, 2005).  How, where, when and whom should receive these 
subsidies are essentially the main elements of the debate around ITN implementation 
in Africa.  
 
1.11 Cost and cost-effectiveness studies of ITNs 
 
When compared to most other malaria control interventions, ITNs have been more 
thoroughly investigated from a cost and cost-effectiveness perspective - though most 
studies were associated with trials or small scale projects and programs.   Extensive 
trials were conducted in the Gambia (Picard et al., 1993; Aikins et al., 1993; Aikins et 
al., 1998).   
 
While these two studies both used rigorous methodology to establish effectiveness 
and cost data they are illustrative of the problems associated with comparing CE 
ratios, even from within the same country. Picard et al. (1993) established cost and 
included the cost to households but reported gross costs as opposed to Aikins et al. 
(1998), who reported net costs (which include savings from reduced treatment).  
Furthermore, the study populations covered different age ranges.  Their comparability 
suffers further when one considers the differences in the methodology of 
establishment of effect measures.  Finally, the Gambia already had a high level of 
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bednet usage, meaning that in both of these interventions, only insecticide for 
treating the nets needed to be supplied.  This significantly reduced the cost of 
implementation, improved the CE ratio and possibly, due to already prevalent usage, 
improved adherence compared to an area with little experience with ITNs.     
 
Another important ITN study, carried out in Ghana by Binka et al. (1997), reported 
gross CE ratios of $2,003 per death averted and $74 per DHLY (Discounted Healthy 
Life Year) gained (1993/1994 USD).  This controlled trial was carried out in an area 
with low net usage pre-intervention thus the costs of purchasing and distributing nets 
were included, significantly increasing the costs and shifting CE ratios.  Further, 
sensitivity analysis from this study suggested that program implementation and 
delivery mechanism may have significant effects on the cost-effectiveness ratio for 
ITN programs (Binka et al., 1997).  
 
Other cost and cost effectiveness studies of ITNs have been conducted in the 
Gambia, Kenya, Ghana, Benin, Tanzania, Malawi, the Solomon Islands, Thailand, 
Vietnam, India, Afghanistan, Colombia and South Africa (Maccormack et al., 1989; 
Kere & Kere, 1992; Rashed et al., 1997; Curtis et al., 1998; Rowland et al., 1999; 
Verle et al., 1999; Goodman et al., 2001; Kamolratanakul et al., 2001; Guyatt et al., 
2002b; Guyatt & Snow, 2002; Kroeger et al., 2002; Hanson et al., 2003; Wiseman et 
al., 2003; Bhatia et al., 2004; Ngugi et al., 2004; Grabowsky et al., 2005; Stevens et 
al., 2005; Mulligan et al., 2008).  A 2002 study conducted by Guyatt et al performed a 
cost analysis of programs for Residual House Spraying (RHS) and ITNs during a 
1999 malaria epidemic.  The study used the output indicator of cost per person 
protected as its outcome measure and therefore was not directly comparable to other 
studies of ITNs which used impact indicators such as cost per death averted. They 
found a cost per person protected with ITNs of $2.34 per year and $0.88 with IRS per 
year (one round of spraying) (2000 USD)(Guyatt et al., 2002a).  Wiseman et al’s 
2003 report on permethrin impregnated ITNs in western Kenya is interesting because 
it attempts to incorporate positive externalities of ITN usage i.e. the possibility of a 
“mass-killing” or neighborhood effect on vector densities.  This would indicate the 
extension of protection to households in a community or near to areas with high ITN 
usage.  While there is incomplete quantitative evidence of phenomenon’s size and 
importance in varied settings (Binka et al., 1998; Hawley et al., 2003; Killeen et al., 
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2007; Gosoniu et al., 2008) its existence may be an important factor in determining 
the CE of ITNs in operational settings and furthermore, justification for considering 
them partially as public goods thereby providing impetus for including them in publicly 
funded malaria control programs (Wiseman et al., 2003; Hanson, 2004; Stevens, 
2005).  Wiseman et al. (2003) found significant decreases in both the CE ratios for 
DALY saved and all cause sick child clinic visits when the community effect was 
included in their study, from $65 to $49, and $49 to $38 respectively (1996 USD).  
 
Several issues are of importance to expanding the scope of the ITN CE literature, 
one is the relative effect on CE ratios of extending the interventions to areas of low 
malaria mortality.  A community randomized control trial conducted in India by Misra 
et al. compared IRS to ITNs in the Surat district of Gujarat State, India, a highly 
malarious area for India, but one where malaria mortality is low (Misra et al., 1999; 
Bhatia et al., 2004).  The authors of the subsequent costing study reported net costs 
as $50 and gross costs $52 both per case averted (1997 USD), mortality being too 
low in the district to measure (Bhatia et al., 2004).   
 
One other area of importance which has been little explored is the delivery method 
for ITNs.  One study from Tanzania conducted by Hanson et al. described a social 
marketing program for ITNs.  They found CE ratios of $1560 per death averted and 
$57 per DALY saved which consequently fell to $1018 and $37 when the costs and 
effects of untreated nets were included (2000 USD) (Hanson et al., 2003).   
 
Recently a review of existing cost and cost effectiveness literature on ITNs was 
conducted by Kolaczinski and Hanson. The authors found that there were major 
difficulties in comparing cost assessments due to large variations in the 
methodologies used (Kolaczinski & Hanson, 2006).  More recently information on the 
costs of large scale implementation of ITNs has become available, Mueller et al. 
reported on the costs of a national scale ITN campaign in Togo, Stevens et al. 
produced cost estimates for large scale ITN distribution in Malawi, and several other 
studies of ITN delivery at large scales are included in this thesis (Stevens et al., 
2005; Mueller et al., 2008; Mulligan et al., 2008; Yukich et al., 2008; Yukich et al., 
2009).    
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1.12 Cost and cost-effectiveness studies of IRS 
 
Most studies identified which performed cost-effectiveness analyises of IRS 
programs were done in comparison with ITN programs.  This may be a consequence 
of the perceived need to make a policy decision between the two interventions, as 
well as the relatively sparse application of IRS in Africa in recent years (Pluess et al. 
in press; Sadasivaiah et al., 2007).  Currently the effect of combining ITNs and IRS is 
poorly understood and considerable debate remains as to how much additional 
benefit can be gained by adding one intervention to the other; some evidence of an 
additive (non-interactive) effect does exist (Kleinschmidt et al., 2006).  No studies of 
the cost or cost effectiveness of combining the two interventions have been identified 
in the present work.   
 
The first identified report of CE analysis of IRS was done in 1979 by Walsh & Warren 
(Walsh & Warren, 1979).  Many reports from the era of malaria eradication also 
included cost measurements but given the large gap in time between those studies 
and more current data, refinements in costing methodology, as well as the 
development of new insecticides we decided not to include such information here.  
Their paper estimated effectiveness and cost for IRS with DDT twice per year using 
data from trials in the 1950s and 60s showing 40-50% reductions in crude death rate 
and infant mortality to estimate a cost of $584 per adult death averted and $1,402 per 
infant death averted (1995 USD) (Walsh & Warren, 1979; Goodman & Mills, 1999b).   
 
By 1986 Barlow & Grobar had estimated the cost per case averted by residual house 
spraying at $342 (1995 USD).  But their study, based on data from the Garki project 
in Nigeria, included substantial research costs (Molineaux & Gramiccia, 1980; Barlow 
& Grobar, 1986; Goodman & Mills, 1999b).  
 
Anne Mills’ Nepal study analyzed a program containing both passive case detection, 
active case detection and indoor spraying with DDT, Malathion or Bendiocarb but 
was unable to determine outcome level effectiveness and therefore used the process 
indicator of spraying cycle cost per capita which varied from $0.61 when DDT was 
used to over $1.05 when Ficam was used (USD 1984) (Mills, 1992).     
 
Bhatia et al. (Bhatia et al., 2004) found that IRS in a randomized control trial in India 
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had a gross CE ratio of $87 per case averted (1997 USD). Goodman et al. 
(Goodman et al., 2001), examined the provision of ITNs and IRS in KwaZulu-Natal, 
South Africa where a significant IRS program, already running, was the base-case or 
control scenario.  Because IRS was already in place they could not calculate average 
cost-effectiveness versus do-nothing approach but they did show that the cost of IRS 
per capita using pyrethroids was approximately $2.30 to $2.40 (1999 USD) 
(Goodman et al., 2001).   
 
Guyatt et al.(Guyatt et al., 2002b) studied an IRS campaign in the highlands of Kenya 
found an economic cost of $0.88 per capita when a pyrethroid insecticide was 
sprayed, the research did not measure effectiveness of the two intervention and thus 
could not estimate a cost-effectiveness measure (Guyatt et al., 2002b). 
 
A detailed study of a large IRS program in Southern Africa conducted as part of the 
Lubombo Spatial Development Initiative was conducted by Conteh et al. (Conteh et 
al., 2004).  The program was an internationally supported attempt to reduce malaria 
burden and transmission in southern Mozambique and thereby also reduce the 
number of introduced cases of malaria into South Africa.  Where two rounds of 
spraying with carbamate insecticides were conducted, they found that the economic 
cost of spraying per capita was $3.48 and $2.16 for the rural (LSDI) and peri-urban 
areas respectively when both project management costs and monitoring and 
surveillance costs were excluded. When these costs were included the cost per 
capita for the two rounds of spraying increased to $4.82 and $2.83 per capita (2000 
USD).  Conteh et al. (Conteh et al., 2004) also estimated a cost per infection averted 
based on the monitoring data generated by an associated intervention assessment of 
$20-$30 per infection/case averted assuming that all the averted infections in a 
before and after assessment were due to the spraying program; the raw data 
produced by this study were reanalyzed as part of this thesis (Conteh et al., 2004).    
 
Several other studies conducted in assorted settings examined various aspects of 
IRS implementation with respect to costs.  Walker (Walker, 2000) examined the 
relationship between the various aspects of insecticide choice and the insecticide 
costs of IRS programs based on a simple model of house size, duration and 
application rates.  The model confirmed the commonly held tenet that DDT is the 
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lowest cost insecticide when residual lifetime is considered and that the carbamate 
insecticides group is at the higher end of the cost scale due to their shorter residual 
lifetimes and high prices (Walker, 2000). 
 
Kroeger et al. (2002) examined the relative unit costs of malaria vector control in 
Colombia and found a mean cost per house sprayed and person protected per year 
with two spraying rounds of $37-$48 and $7-$10; the ranges varied depending on 
how far the communities to be sprayed were from district centers (2001 USD).  
 
Curtis et al. (1998) used the framework of a comparative trial between ITN and IRS in 
Tanzania to estimate a cost of $2.3 per person protected per year using one round of 
pyrethroid insecticides, not including spray pumps and protective clothing which 
could continue to be used for multiple years. 
   
In western Thailand Kamolratanakul et al. (2001) examined the relative cost and cost 
effectiveness of ITNs and IRS in the frame of a trial.  They estimated a cost per 
person protected by one round of spraying with DDT of $1.87 (1994 USD). 
 
Rowland (1999) published the results of an economic analysis of an IRS campaign in 
the North West Frontier Province of Pakistan, which showed a cost per person 
protected per year of $0.63 using one round per annum of malathion or lambda-
cyhalothrin, and a cost per infection averted of $20.  It was not clear if or to what year 
costs were standardized, though the program analysis covered the years 1990-1995 
(Rowland, 1999). 
   
Verlé et al. (1999) estimated the costs per person protected with one round of 
spraying of a pyrethroid insecticide (lambda-cyhalothrin) in Hoa Binh Province of 
Vietnam and found a cost of $0.47 USD per year (1996 USD).  This cost did not 
include program management costs.  They also compared insecticide usage based 
on national guidelines and observed usage rates based on activity reports and found 
that usage rates based on activity reports was much lower per capita than national 
guidelines indicated.     
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Cost and cost-effectiveness for IRS appears to be sensitive primarily to the price of 
insecticide and the number of rounds of spraying per year (Guyatt et al., 2002b; 
Conteh et al., 2004). Additionally, compliance in operational settings and perhaps 
resistance to insecticides may also play a role in cost and cost-effectiveness of the 
intervention either directly or by driving insecticide choice towards more expensive 
alternatives (Mnzava et al., 1998; Goodman et al., 2001; Conteh et al., 2004; 
N'Guessan, et al., 2007). 
 
Indoor residual spraying remains an important component of the prevention 
strategies of some African countries especially in southern Africa, including South 
Africa where it has remained the primary preventative measure since its large-scale 
inception in the 1940s (Mabaso et al., 2004).  Currently IRS has received 
dramatically increased interest with the large expansion of malaria control funding 
available due the Global Fund for AIDS Tuberculosis and Malaria, and the U.S. 
President’s Malaria Initiative (Sadasivaiah et al., 2007).   
 
Ultimately, the studies discussed here together range in estimates of cost per person 
protected annually range from USD 0.47 to USD 10, greater than an order of 
magnitude.  These estimates reflect differences in choices as to which costs to 
include, choices of different insecticides, different timing of studies and many other 
sources of methodological variation. Overall the costing literature on IRS programs 
shows the same type of heterogeneity of methods, assumptions, quality and clarity 
as is shown by Kolaczinski and Hanson (2006) for the economic analysis of ITN 
programs.  Because of this large variation in time, type of data collection, clarity, 
completeness of reporting of data and conclusions it is difficult to asses either the 
comparability of the various studies or their potential for portability or predictive value 
in other settings. 
 
1.13 Comparing ITNs and IRS: which strategy is more cost-effective? 
 
Understanding the tradeoffs between ITNs and IRS in terms of both cost and 
effectiveness is currently of the utmost importance. For ITNs and IRS there is an 
existing, but limited body of literature on the relative effectiveness of the two 
interventions, which was reviewed by (Lengeler & Sharp, 2003) and by a recent 
Cochrane Review on IRS (Pluess et al. submitted).  Both reviews found that there 
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was not a consistent and significant difference in the two interventions in settings 
where they were applied effectively. The Lengeler and Sharp review covered several 
studies with locations in Africa, Asia, the Solomon Islands and India (Kere et al., 
1996; Curtis et al., 1998; Misra et al., 1999; Mnzava et al., 1999; Rowland, 1999; 
Kamolratanakul et al., 2001; Guyatt et al., 2002a). 
 
Curtis and Mnzava (2000) compared historical IRS trials and modern ITN trials as 
well as modern IRS trials and found that in modern trials the effectiveness of the two 
intervention systems was comparable on all outcome measures.  In the historical 
comparisons IRS performed better, however, the settings of the trials were, due to 
the large gap in time, undertaken in very different populations, with differing 
availability of effective drugs and vastly altered socio-economic status making such 
comparisons difficult at best and of questionable validity (Lengeler, 2001). 
 
Mnzava et al. (1999) conducted a cluster randomized trial comparing ITNs and IRS in 
South Africa.  The trial showed that ITNs were significantly more effective in 
preventing malaria cases than an established IRS program, though subsequent 
economic analysis showed that ITNs were also significantly more expensive 
(Goodman et al., 2001).   
 
In Tanzania a comparative trial using lambda-cyhalothrin for either IRS or bednet 
impregnation was conducted by Curtis et al. (1998).  They demonstrated significant 
effects on the vector population with both interventions and strongly reduced the 
probability of re-infection after a parasite clearing treatment among children, but were 
not able to detect meaningful differences between the effectiveness of the two 
interventions.   
 
A comparison of ITNs and IRS in highland area of Kenya where there was 
operational targeting of communities to receive either intervention was conducted by 
Guyatt et al. (2002a).  Their study found that among randomly selected households, 
the presence or use of the intervention at the household level was protective against 
infection, however IRS appeared significantly more protective, and a subsequent cost 
analysis showed an economic cost per infection averted of $9 with IRS as compared 
to $29 with ITNs (Guyatt et al., 2002b).     
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Outside of Africa, trials or other investigations into the comparative effects and cost-
effectiveness of the two interventions were conducted in several settings including 
India, Pakistan, Thailand and the Solomon Islands (Kere et al., 1996; Misra et al., 
1999; Rowland, 1999; Kamolratanakul et al., 2001; Over et al., 2004) Implications for 
cost and cost-effectiveness where built upon these studies or examined separately in 
other areas (Kere et al., 1992; Rowland, 1999; Verlé et al., 1999; Kamolratanakul et 
al., 2001; Kroeger et al., 2002; Bhatia et al., 2004). Generally the studies found 
differences in both costs and effectiveness of the two interventions but the results did 
not show consistency in either direction or size of the effect.  Nor were the 
differences easily attributable to the vastly different malaria epidemiology present in 
the various study areas. 
 
Additionally, comparisons between ITNs and IRS have been conducted through and 
extensive modeling study, the results of which were reported by Goodman et al. 
(1999a).  Using data from published studies as well as cost data collected from 
program managers, they estimated that in a very low income country with high 
malaria transmission ITNs and IRS would be likely to overlap in cost effectiveness, 
while ITNs would be likely to be more cost effective if only insecticide treatment was 
required (e.g. the nets already exist in the community) but that these estimates were 
sensitive to factors which include the length of the transmission season (which has 
an effect by increasing cost due to need for extra spray rounds), cost of commodities 
(Nets, ITNs, LLINs and insecticide) as well as usage and compliance factors. 
 
Based on the existing evidence it seems clear that no universal conclusion regarding 
the relative cost or cost-effectiveness of these two interventions is possible at 
present.  While this thesis does not attempt to provide new comparative data for 
effectiveness, it will attempt to produce standardized cost estimates for the two 
interventions.  
 
1.14 Improving Malaria Diagnosis 
  
The expansion of artemisinin combination therapy (ACT) in Africa has driven an 
increased need for the improvement and evaluation of malaria diagnostic methods 
(Guerin et al., 2002).  Typically in African public health facilities malaria has been 
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diagnosed either clinically or microscopically.  However, due to the high costs of 
ACTs as compared to past first line treatments, as well as concerns about the 
development of drug resistance due to drug overuse, many donors and health 
system managers are searching for ways to improve the rational use of drugs for 
malaria treatment.   Additionally, mistreatment of other febrile disease in the context 
of falling incidences of clinical malaria, both due to urbanization and vast expansion 
of vector control, has further enhanced the need for new diagnostic strategies (Bell et 
al., 2006; d’Acremont et al., 2009).  The modern generation of HRP2 antigen based 
rapid diagnostic tests (RDTs) have been shown in trials to have high sensitivity and 
specificity for the diagnosis of P. falciparum infection among clinical patients in Africa 
(Bell et al., 2006; Abeku et al., 2008; D’Acremont et al., 2008).  When the standard 
use of microscopy in many health facilities is poor, RDTs may produce more accurate 
diagnostic results in many settings despite expert microscopy being regarded as the 
gold standard for research purposes (Mundy et al., 2000; Reyburn et al., 2007; 
Abeku et al., 2008).   
     
More accurate parasitological diagnosis may help to rationalize anti-malarial drug use 
at health facilities in Africa and might be expected to significantly reduce the usage of 
anti-malarial drugs in some situations (Reyburn et al., 2007; Hume et al., 2008).  
However, any cost-savings made from the reduction of anti-malarial prescriptions 
may be outweighed by increases in prescription of antibiotics or other drugs to treat 
the non-malarious patients.  Additionally, RDTs add cost to diagnosis which is not 
inversely proportional to throughput, as is likely to be the case is for microscopy 
(Lubell et al., 2007).  Furthermore, the effects of diagnostic changes will depend not 
only on the sensitivity and specificity of the RDT as compared to routine microscopy 
but also on the adherence of clinicians to the diagnostic result, the frequency with 
which they request a test, and the prevalence of parasitaemia among the clinical 
population (Zurovac et al., 2006; Lubell et al., 2008b). 
 
There is a sizable body of literature which has examined the implications of improving 
and changing malaria diagnostic methods, including both empirical and modeling 
studies.  The results of the empirical studies have shown that there is a possibility to 
reduce average cost per patient and household costs through improving malaria 
diagnosis and that such interventions could be highly cost-effective (Jonkman et al., 
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1995; Hume et al., 2008; Lubell et al., 2008b). However, whether there would be cost 
saving or improvement in  treatment outcomes depended on the prices of the RDTs 
and the first line drug regimen, but also on situational factors such as prevalence of 
malaria among patients and the effectiveness of the alternative diagnostic method 
(Lubell et al., 2008a; Zikusooka et al., 2008).   
 
Modeling studies have helped to confirm and highlight the myriad factors which could 
influence both the cost-effectiveness of improving diagnosis as well as the overall 
cost-saving potential of implementing parasitological diagnostic improvements 
including RDTs.  The main factors which influence the desirability of one testing 
mechanism over another relate to the proportion of febrile cases which are parasite 
positive, the sensitivity and specificity of the new methods and their alternatives, and 
the costs of both the tests themselves and the drug regimens prescribed to parasite 
positive patients vs. parasite negative patients (Jonkman et al., 1995; Lubell et al., 
2007; Hume et al., 2008; Lubell et al., 2008a; Lubell et al., 2008b; Shillcutt et al., 
2008; Zikusooka et al., 2008).  
 
Because the potential for improvement in outcomes and cost savings appear to be 
highly situation dependant it is necessary to evaluate the decision to shift to rapid 
diagnostic test locally and at specific levels of the health care system. Useful models 
have been developed to aid in decision making (Lubell et al., 2008a).  However, it is 
still necessary to evaluate the decision empirically in representative settings, 
especially before embarking on large national programs.  The final section of this 
thesis examines the economic implications of implementing parasitological diagnosis 
with RDTs in an urban African setting, Dar Es Salaam, Tanzania. 
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1.15 Goals and Objectives 
 
 
The goal of this thesis is generally to improve the knowledge of allocatively effeicient 
strategies in malaria control for Africa.  More specifically it aims to do so by improving 
the current evidence base on the costs and cost-effectiveness of vector control for 
malaria using ITNs and IRS, and examining the cost implications of the introduction 
of antigen based diagnosis for malaria in primary health care facilities in Tanzania.     
 
Specific Objectives: 
 
1. To measure the costs and estimate the cost-effectiveness of large scale vector 
control programs utilizing ITNs or IRS in sub-Saharan Africa. 
 
2. To compare different delivery strategies for ITNs on the basis of cost and cost-
effectiveness. 
 
3. To develop operational descriptions of each vector control intervention 
strategy for the comparison of the operational feasibility and the prospects for 
financial and operational sustainability of each intervention.   
 
4. To measure the cost implications of the introduction of rapid diagnostic test 
based malaria diagnosis in six primary health care facilities in Dar es Salaam, 
Tanzania. 
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2.  Methods 
 
As the general aim of this thesis is to produce comparable cost estimates of the 
implementation of ITN and IRS programs on large scales in sub-Saharan Africa, and 
to analyze this data in a comparable manner, the following chapter outlines the 
general methodology which is used to measure and value costs and activities as well 
as to estimate health effects.  Sections 2.1 and 2.2 cover the methods used in the 
vector control studies, while section 2.3 covers the methods used in the malaria 
diagnostic study. 
 
2.1 Costing Methodology 
 
2.1.1 Time frame 
The time frames of the costing studies in this thesis vary due to constraints both in 
data collection and due to the varied timing of implementation of the programs.  In 
general it was intended to collect data over a time period which encompassed both 
the start-up of the program until it had been running at scale for a reasonable period, 
however, because either some programs were implemented over relatively short 
periods, e.g. Togo, and others were begun long before data collection was possible, 
e.g. Eritrea and KwaZulu-Natal, this was not always possible. 
 
Attempts have been made to follow existing guidelines for the cost evaluation of ITN 
programs, as well as to use methodologies comparable to past studies in order to 
maximize comparability (Phillips et al., 1993; Creese & Parker, 1994; Drummond et 
al., 2005; Stevens et al., 2005; Kolaczinski & Hanson, 2006). 
 
2.1.2 Perspective and types of costs included 
These studies generally use what could be termed a “modified provider perspective,” 
or alternatively a “limited societal perspective.” Travel or time costs to users, or other 
household-level costs or cost savings have not been measured or included. All 
identified direct and shared costs of the ITN or IRS program to the provider, including 
those of the commodities and their delivery, health promotion, social mobilization, 
and international overheads of implementing agencies as listed in Table 1 are 
included. Additionally where it was applicable we have included the direct costs to the 
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user of ITN purchases, this is especially relevant where there is a cost sharing or 
commercial sector approach to ITN delivery. 
 
Costs generally represent the marginal cost of adding an ITN or IRS intervention onto 
an existing malaria control program and health system. These expenses include the 
cost of training health workers, or spraymen, health promotion and social 
mobilization, use of facilities, transportation, payment of personnel, and the 
commodities themselves. Costs that were required to build and train networks of 
community health workers or to develop a network of health facilities have not been 
included.  Additionally these costs represent gross costs, and do not incorporate any 
savings which might arise due to reduced in- or out-patient health care demand. 
 
2.1.3 Cost collection 
Costs were generally collected retrospectively from financial and operational records 
kept by the various implementing agencies. This included examining agencies' 
financial records, including budgets, expenditure records, receipts, and invoices, but 
also included activity reports and conducting semi-structured interviews with key 
stakeholders and managers. Cost and activity information were collected through 
stakeholder interviews and direct observation where costs were not reflected in the 
financial records. Identification of costs was guided by thorough operational 
descriptions which were compiled using Monitoring and Evaluation documentation, 
agencies’ internal and external reports, existing literature and semi-structured 
interviews with stakeholders. 
 
Where possible, the ingredients approach has been used, meaning that unit activities 
were first determined and then a unit cost was determined for these activities, 
allowing for the establishment of a total cost. Where this approach was not possible, 
either because the information was deemed too sensitive or was not available in 
adequate detail, aggregated expenditure was generally used. 
 
Some costs have been estimated using the WHO Choosing Interventions which are 
cost-effective (WHO-CHOICE) unit cost and activity database (WHO-CHOICE 
2006a). WHO-CHOICE database costs are reported in 2000 International Dollars and 
have been converted to their equivalent in 2000 US dollars (USD) for the country of 
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interest, using implied purchasing power parity (PPP) ratios from the International 
Monetary Fund (IMF, 2006). These costs were then been adjusted into prices for the 
appropriate year of the input using the US gross domestic product (GDP) deflator 
index published by the US Bureau for Economic Analysis (US BEA, 2007). Following 
adjustment, these costs were treated identically to all other costs included in the 
study. 
 
Table 1: Costs included in the following studies  
 
  
ITN Programmes IRS Programmes 
Capital cost Buildings Buildings 
  Vehicles Vehicles 
  ITNs (retail cost & subsidies)1 Sprayers 
  Other equipment Other equipment 
  Start-up costs2    
Recurrent cost Insecticide (when separable from 
nets) 
Insecticide 
  Personnel Personnel 
  Fuel/maintenance Fuel/maintenance 
  Management cost/training & 
meetings 
Management cost/training & 
meetings 
  Office/warehouse rental Office/warehouse rental 
  Supplies/overheads Supplies/overheads 
  Recurrent building costs Recurrent building costs 
  Basic evaluation and monitoring 
(excluding specific research costs) 
Basic evaluation and monitoring 
(excluding specific research costs) 
  Advertising and promotion (or 
related) 
  
 
Resource use was generally valued at multiple levels depending on the structure of 
the program: centrally (within the MOH and the NMCP), at regional warehouses or 
coordinating sites and at peripheral health facilities or implementing sites.  Where unit 
activities were available resources were valued according to their financial and 
economic costs as appropriate to the activity, more details for country specific 
instances are available directly in those country specific studies included in this thesis 
or in an unpublished report (Yukich et al., 2007). 
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2.1.4 Cost classification and adjustments 
Costs have been divided into capital and recurrent costs based mainly on the lifetime 
of the goods being purchased. As stated above, it was not possible in all cases to 
collect start-up costs. Capital costs have been discounted in the economic analysis 
using lifetimes and discount rates determined through stakeholder interviews, expert 
information, and past literature. Varying discount rates and lifetimes were generally 
examined in the sensitivity analysis. Both financial and economic analyses were 
conducted, in order to show (1) what the actual expenses of running a program would 
be, as well as (2) the level of all resources used. In the financial analysis, taxes were 
included where they applied though most implementing agencies had tax exempt 
status, while in the economic analysis they have been treated as transfer payments 
and have therefore been excluded. In the financial analysis, capital costs have not 
been discounted and are instead incurred in full at the time of the purchase. 
 
Most costs were collected in either local currencies or USD, though some were 
collected in Swiss Francs (CHF). Costs collected in local currencies or CHF were 
converted to USD based on official yearly average exchange rates for the period 
during which the costs were incurred, and all costs were adjusted for inflation to 2005 
prices using the US GDP deflator produced by the US Bureau for Economic Analysis 
(US BEA, 2007). 
 
2.1.5 Outputs 
Generally, two main output measures were used: (1) number of nets delivered and 
(2) number of re-treatments performed.  Though methods for measuring these 
indicators varied across settings, more details on the specifics of output 
measurements are available in the country specific chapters or in the previously 
mentioned report (Yukich et al., 2007). 
 
The two output indicators above were used to calculate a third combined output 
measure: treated net years (TNY), which blend the results of both outputs by 
assuming that either a re-treatment or a new ITN provides 1 year of full protection for 
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any individual using that net. This combined indicator is useful because it allows the 
inclusion of re-treatments of existing nets as part of the outcome measure, while the 
calculation of the cost per ITN delivered does not. Though in some programs a 
significant portion of all nets delivered (all nets in Togo) were LLINs, all nets have 
been treated as conventional nets for the calculation of outputs in the base scenario 
of this analysis. The number of TNYs delivered through an LLIN would be 
theoretically higher — approximately 3-5 years per net — and the inclusion of the 
extended benefits of using these nets would be expected to significantly lower the 
cost per TNY or the cost per health impact. In the sensitivity analysis, outputs were 
also calculated using the assumption that all nets delivered were LLINs. 
 
2.1.6 Base scenario 
In these studies, a base scenario was used to increase the comparability across 
interventions; generally, this scenario relies on the following set of assumptions. A 
discount rate of 3% has been applied to both DALYs (see below) and to economic 
capital costs. Shared costs have been attributed to the interventions based on the 
actual value of the indicator chosen to allocate them. Nets have been assumed to 
last for 3 years and, as noted above, treated nets and re-treatments to provide 1 year 
of protection each. Fifty percent of the nets delivered were assumed to be used by 
children and only one child was assumed to sleep under each of these nets.  
Additional assumptions specific to each country program were necessary in certain 
cases, these are detailed in the country specific studies or in an unpublished report 
(Yukich et al., 2007). 
 
2.2 Benefit Methodology 
2.2.1 How benefits are calculated 
Many of our methodological choices were guided by the overarching need to ensure 
comparability between the settings. As a result, our estimates differ from previously 
published costing studies for the programs in Malawi (Stevens et al., 2005), Tanzania 
(Mulligan et al., 2008) and Togo (Mueller et al., 2008), but we believe these 
differences are minimal and important to maintain comparability. 
 
DALYs and death averted 
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Generally, DALYs averted are calculated by adding years of life lost due to cause-
specific mortality and years lived with disability (resulting from the specific disease or 
risk factor). In our calculations we have excluded (1) the disability DALYs and (2) 
DALYs lost in persons over five years of age.  The burden of malaria in highly 
endemic areas (i.e., most of sub-Saharan Africa) is highly concentrated in under-five 
children (Breman et al., 2006) and the large majority of lost DALYs are years of life 
lost rather than disability-related (WHO-DALY). Fortunately, the effects of vector 
control by either approach are likely to be similar and hence our approach is unlikely 
to bias our comparisons, as long as the settings are highly endemic for malaria 
(nearly 75% of the population of sub-Saharan Africa) (MARA/ARMA, 2004). 
 
In accordance with the WHO Global Burden of Disease Project, we used a 
standardized life table for DALY calculations (WHO-DALY, 2006b). We made this 
decision in order to apply the same value to each life lost, regardless of the country 
investigated. Choosing country-specific life tables would have made comparisons 
between different vector control approaches in part dependent on different life 
expectancies and this was not desirable in the present study.  As a result we have 
chosen to treat all child deaths as infant deaths and assign a value of 33 DALYs lost 
for each death (WHO-DALY, 2006b). This is conservative, since allowing for deaths 
among older children would have yielded higher numbers of DALYs averted, due to 
both slightly longer life expectancies for older children and age weighting.  
 
We have also ignored the effect of vector control on pregnant women.  Pregnant 
women form a relatively small fraction of the population, typically 4–5%, but their 
share of malaria mortality and morbidity is higher than average. Unfortunately, this 
risk is not properly quantified at present. At least we believe that the important effect 
of reduced infections in pregnant women on low birth weight and anemia in children 
has been taken into account in our estimates of child mortality.  
 
Finally, significant increases in risk of malaria infection and severe disease due to 
HIV have been identified for all age groups (Hewitt et al., 2006). Due to the high HIV 
prevalence levels in southern Africa, as well as the generally lower malaria 
transmission levels, there is likely to be a significant burden of increased malaria 
mortality and morbidity among adults. One modeling study estimated that deaths 
 2. Methods 29 
from malaria in southern Africa could increase by as much as 114% due to the 
interaction of HIV and malaria, largely due to adult mortality (Korenromp et al., 2005).  
Again, we decided not take this into account for lack of sufficient data. 
 
Our decisions with regard to outcome assessment are unlikely to lead to a bias in our 
comparisons as long as the age profile of lost DALYs is similar in all programs. 
Where this is not the case, as perhaps in areas of low malaria transmission or 
epidemic prone areas, the comparisons shown here should be reconsidered in light 
of the differing distribution of burden of disease.   
 
2.2.2 Impact data for ITNs and IRS 
Another problem we were confronted with was the paucity of bias-free estimates of 
IRS efficacy and effectiveness in sub-Saharan Africa. While there are many 
descriptive studies that showed the significant health impact of IRS programs over 
time (Mabaso et al., 2004; Lengeler & Sharp, 2003) there are only two randomized 
controlled trials that provided unbiased quantitative values of this impact (in Tanzania 
and South Africa, see above). A Cochrane review on IRS impact has been conducted 
(Pluess et al. in press) but it did not identify quality quantitative evidence on the effect 
of IRS and showed that past trials cannot be used to quantitatively estimate the 
impact of IRS.  Fortunately, good impact estimates are available for ITNs from an 
existing Cochrane review (Lengeler, 2004):  the regular use of ITNs in a high 
coverage situation averted 5.5 child deaths per 1,000 child-years of ITN use.  In the 
absence of a better data set for IRS, and in the light of the fact that the impact of 
ITNs and IRS seemed to be similar, we decided to apply the same estimate of impact 
for IRS. We believe this is a reasonable assumption on the basis of our current 
knowledge (Lengeler & Sharp, 2003).  
 
2.2.3 Targeting risk groups versus general coverage in the population 
There was one important aspect in our calculations of cost per person protected and 
cost per death/DALY averted that presented a challenge for standardized 
comparisons: ITNs can be targeted at age specific high-risk groups, while IRS can 
not - either a high percentage of houses is sprayed or the effect is lost.  This has 
obvious practical implications which are shown in this thesis (Yukich et al., 2008). 
Protecting everyone in the population (either by ITNs or IRS) has obvious benefits, 
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for users and even more for non-users (Killeen et al., 2007). However, this obviously 
bears a much higher cost (since children and pregnant women represent together 
only around 20% of the population) and it is unclear a priori how cost-effective this 
marginal increase in protection would be.  
 
This point is important because of a recent shift in global targets for malaria vector 
control to increase coverage levels to 80% in the total population on the basis of at 
least two LLINs per household (Roll Back Malaria Partnership, 2005).  With this goal, 
ITNs would be deployed in a way very similar to IRS, with no targeting and a high 
coverage level in all age groups. This approach is meant to maximize the vector 
control effects for the whole population.  Since neither the cost nor the effects of this 
strategy are quantified at present, we will not further discuss this point here.  Our cost 
estimates could provide a basis to estimate the total cost of such strategies on the 
basis of the cost per person-year protection, and the operational experience 
presented in the five ITN case studies might also prove useful. 
 
2.3 Malaria Diagnostics 
2.3.1 Study area 
Twelve public health facilities in Dar Es Salaam, Tanzania were selected for inclusion 
in a trial of RDT rollout at the facility level.  Of these six primary health care facilities 
were included in the costing exercise.  Four primary care facilities were experimental 
facilities in which RDTs replaced routine microscopy for the parasitological diagnosis 
of malaria.  Two primary care health facilities remained as controls.  Dar Es Salaam 
is a large urban area (pop. approx. 3 million) in sub-Saharan Africa composed of 
highly heterogeneous developed areas including commercial districts, industrial 
districts, residential districts, urban slums, and areas with high levels of urban 
agriculture. Consequently there is a high variability in the availability of Anopheline 
breeding sites and mosquito densities.  Generally, however, it is considered a low but 
stable malaria transmission area (EIR ≈ 1.3) with low parasitaemia prevalence (~10% 
in the general population) (Geissbuhler et al., 2009).  All of the health facilities 
included in the costing exercise are located in densely populated low-income urban 
areas, though one facility’s catchment area also includes some peri-urban and higher 
income areas. 
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2.3.2 Collection of patient and facility costs and resource use 
 
Costing was conducted both from the patient and provider perspectives.  A larger 
survey examining the effects of RDT on health workers and patients was used as a 
platform for collecting patient specific and facility costs.  Within the six selected 
facilities patients were selected who fit the inclusion criteria for potential non-severe 
malaria, namely: first consultation for the present complaint (not a follow-up visit), 
absence of severe disease, and main complain not trauma related.  Patients or 
caretakers of young patients who fit the inclusion criteria and gave oral informed 
consent had their consultation passively observed by a survey worker with clinical 
training.  These patients or caretakers were then selected for an exit interview which 
included questions relating to both their perceptions of the clinical and laboratory 
consultation as well as expenditures, and any previous treatment seeking.  All 
patients or caretakers who participated in the exit interview, which included the 
costing questions, were requested to return to the same health facility one week later 
for a follow-up interview and were provided with a small incentive to cover 
transportation costs.  At follow up all patients or caretakers were administered a 
questionnaire which solicited information on their current health status and any 
treatment seeking activity or expenditure which occurred in the intervening week, 
they were also asked about the previous consultation and any associated 
expenditures, mainly as a check on consistency.  All returning patients were tested 
with an HRP2 based RDT in order to check for missed infections as well as to identify 
false negatives or positives in the control facilities given the persistence of the HRP2 
antigen even in treated patients.  For all patients testing positive by RDT during 
follow-up it was ascertained if they had received appropriate first line treatment and if 
their condition had improved, if they had not improved or received appropriate 
treatment it was ensured that they were subsequently treated at the health facility.  In 
order to assess treatment costs to the provider a health facility survey was conducted 
in the six facilities participating in the cost study to identify per patient resource use at 
the facility level.   
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2.3.3 Valuation of Resource use 
 
Costs of resource inputs were determined for the provider costs based on the 
Tanzania pharmaceutical and supply price list for 2007, and interviews with the 
appropriate financial managers of the Dar Es Salaam City Medical Office of Health.  
Information on drug prices was obtained from the International Drug Price Indicator 
Guide database published by Management Sciences for Health (MSH) or from the 
WHO-AFRO drug price indicator database (MSH, 2009; WHO-AFRO, 2008).  Patient 
costs were valued by patients reported expenditure.  
 
Costs for the initial implementation of RDTs, training in their use, and quarterly 
supervisory visits were calculated based on the reported expenditure and or activities 
tracked during the project, excluding specific research related costs.  Costs were 
reported in the local currency (TSH), U.S. Dollars (USD), or Swiss Francs (CHF).  All 
costs were converted to USD using official exchange rates and adjusted into a 
common year (2008) using the U.S. GDP deflator (US BEA, 2009).  Capital costs 
were discounted and annualized using a 3% discount rate and assumed lifetimes for 
equipment based on expert opinion and past literature.  All costs attributable to RDT 
implementation were then divided by the estimated total number of RDT tests 
performed in the nine experimental health facilities (328,000 – 435,000) over the 
duration of the project (approximately two years) to calculate an implementation cost 
per test.   
 
Statistical methods are discussed in more detail in Chapter 7, where the full RDT 
study ispresented.  Data was entered in EpiInfo 3.4.1 (U.S. Centers for Disease 
Control and Prevention, Atlanta, GA), and analyzed in STATA 9.2 (Stata Corporation, 
College Station, TX).   
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3.1 Abstract 
 
Background 
While insecticide-treated nets (ITNs) are a recognized effective method for 
preventing malaria, there has been an extensive debate in recent years about the 
best large-scale implementation strategy.  Implementation costs and cost-
effectiveness are important elements to consider when planning ITN programmes, 
but so far little information on these aspects is available form national programmes. 
Methods 
This study uses a standardized methodology, as part of a larger comparative study, 
to collect cost data and cost-effectiveness estimates from a large programme 
providing ITNs at the community level and ante-natal care facilities in Eritrea.  This is 
a unique model of ITN implementation fully integrated into the public health system.   
Results 
Base case analysis results indicated that the average annual cost of ITN delivery 
(2005 USD 3.98) was very attractive when compared with past ITN delivery studies 
at different scales.  Financing was largely from donor sources though the Eritrean 
government and net users also contributed funding.  The intervention’s cost-
effectiveness was in a highly attractive range for sub-Saharan Africa. The cost per 
DALY averted was USD 13 - 44. The cost per death averted was USD 438-1449.  
Distribution of nets coincided with significant increases in coverage and usage of nets 
nationwide, approaching or exceeding international targets in some areas. 
Conclusions 
ITNs can be cost-effectively delivered at a large scale in sub-Saharan Africa through 
a distribution system that is highly integrated into the health system.  Operating and 
sustaining such a system still requires strong donor funding and support as well as a 
functional and extensive system of health facilities and community health workers 
already in place.    
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3.2 Background 
 
Vector control generally and insecticide-treated nets (ITNs) specifically have been 
identified as effective and cost effective methods for the prevention of malaria related 
mortality and morbidity in sub-Saharan Africa (SSA) (WHO, 2008).  Despite the vast 
expansion of vector control implementation, relatively few studies have examined the 
key economic characteristics of programmes operating on a large scale (Aikins et al., 
1998; Stevens et al., 2005; Mueller et al., 2008; Mulligan et al., 2008).  Considerable 
debate still remains as to the most appropriate strategy for delivering ITNs on a 
national scale (Lengeler et al., 2007).  Further, the relative merits of ITNs versus 
Indoor Residual Spraying (IRS) are also insufficiently documented. This study 
provides data on the operations, costs and estimates of the cost effectiveness of the 
national ITN programme in Eritrea. This analysis is part of larger multi-country 
analysis of the main strategies used by ITN and IRS programmes in SSA (Yukich et 
al., 2008).   
 
Eritrea is divided into three zones of malaria risk based on epidemiology and 
geography. In the western lowlands, where the malaria burden is most severe, 
transmission is highly seasonal and most intense along water bodies or irrigation 
projects. The transmission season lasts from September until November. In the 
highlands there is generally little risk of malaria transmission, but due to the low 
immunity of the population there is a risk of epidemic malaria. Finally, in the coastal 
plains along the Red Sea, highly seasonal malaria transmission occurs which peaks 
between January and March, though transmission in this zone is generally low due to 
low levels of precipitation. A recent study estimated that two-thirds of the Eritrean 
population are considered at risk of malaria, either epidemic or endemic (Sintasath et 
al., 2005), and the Mapping Malaria Risk in Africa (MARA) project estimates that 
approximately 92% of the population is at risk for malaria, with approximately 51% at 
risk of endemic malaria (MARA/ARMA)(Figure 3).  The population of Eritrea in the 
year 2005 was estimated to be 4.3 million (MARA/ARMA). Of this number, 
approximately 760,000 were children under five years of age. Using an assumption 
that 5% of the population is made up of currently pregnant women, there are 
approximately 215,000 such women in the country, while a total population of 2.9 
million lives in malaria-endemic areas. 
 3. Costs and cost-effectiveness of vector control in Eritrea 37 
 
Figure 3: Climatic suitability for malaria transmission in Eritrea (source: Mapping 
Malaria Risk in Africa, www.mara.org.za). 
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The Eritrean ITN programme is part of a broader malaria control programme 
which includes environmental modification, larviciding, IRS and the provision of 
prompt and effective treatment.  The mix of interventions used varies depending 
on the area of the country, with IRS being used more extensively in the highest 
burden areas and environmental management and larviciding used in all 
malarious regions, but most extensively in moderate to low burden areas 
(Nyarango et al., 2006; Ceccato et al., 2007; Graves et al., 2008).  The ITN 
programme currently utilizes free distribution of ITNs to high-risk groups through 
ante-natal care (ANC) clinics, and to the general population in malarious areas 
through community health agents (CHA) and local administrations.  This has 
provided a “catch-up”strategy in Eritrea, increasing ITN coverage rapidly among 
households and vulnerable groups by providing a large number of free and low-
cost nets. Recent coverage data are shown in Table 2. It has also maintained a 
more continuous pipeline and thereby helped to “keep-up” coverage in the longer 
term as well (Nyarango et al., 2006; NSEO & ORC Macro 2003; Eisele et al., 
2006).  Generally the programme has achieved relatively high ITN coverage and 
usage results including reaching household possession over 80%, and meeting 
Abuja Target usage levels in some regions and high coverage and usage overall 
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(Nyarango et al., 2006; Eisele et al., 2006; Macintyre et al., 2006).  Several 
studies have found that ITN distribution has been effective in reducing the 
incidence of clinical malaria in Eritrea (Nyarango et al., 2006; Graves et al., 2008; 
Mufunda et al., 2007).  Malaria specific mortality and case fatality rates also fell 
during the period of dramatic increases in ITN coverage in Eritrea (Nyarango et 
al., 2006; NMCP [Eritrea] 2002; NMCP [Eritrea] 2003; NMCP [Eritrea] 2004; 
NMCP [Eritrea] 2005; NMCP [Eritrea] 2006). As of 2008, the Eritrean programme 
still represents the only national-scale ITN interventions in SSA that relies almost 
entirely on routine public sector implementation.  While overall results of this study 
have been published in a multi-country comparative study (Yukich et al., 2008), 
this paper provides an opportunity (1) to show the unique features of the Eritrea 
programme, (2) present in much more detail the data used for the comparative 
study, and (3) illustrate the ways in which average cost-effectiveness results can 
be confounded by issues of scale and timing of measurement. 
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Table 2: Net coverage and usage in Eritrea according to latest available statistics. 
 
 
NMCP=National Malaria Control Programme;  RBM=Roll Back Malaria. 
*ITN defined as a net treated within the last 6 months. 
**ITN defined as any net treated within the last 12 months, surveys restricted to Gash-Barka and 
Anseba zobas for purposes of comparison. DHS survey is dry season, while the Tulane survey was 
conducted during the rainy season. 
***ITN defined as any net treated within the last 6 months, survey conducted in Gash-Barka, 
Anseba, Debub and the Northern Red Sea zobas, where malaria control measures are active 
(data from (Nyarango et al., 2006)).    
 
 
3.3 Methods 
 
ITN programme: operational description 
ITN distribution began in 1995 as a pilot project in Gash-Barka, in the western 
lowlands. ITNs were delivered through health facilities and local administrations, 
with assistance from CHAs. The programme was gradually scaled up from a few 
villages to cover all malarious areas of the country. Families were charged 
30 Nakfa (USD 2–3) per ITN before the 2003 distribution. Local administrations 
could make exceptions for those families deemed too poor to pay. In 2001, free 
 2002 DHS* 2002 DHS** 2003 NMCP/Tulane** 
2004 
NMCP/RBM*** 
 
Any 
net ITN 
Any 
net ITN 
Any 
net ITN 
Any 
net ITN 
Children under nets last 
night                    All 12.1% 4.2%  7.3%  76.6%  58.6% 
                             Urban 14.3% 4.8%       
                             Rural 11.0% 4.0%       
 
Pregnant women under 
nets last night    All 6.6% 2.9%  4.7%  52.6%  50.4% 
                             Urban 8.7% 4.5%       
                             Rural 5.5% 2.1%       
 Household possession 
                             All 33.8%  47.8%  92.3% 82.9% 79% 62% 
                             Urban 28.3%        
                             Rural 37.3%        
 3. Costs and cost-effectiveness of vector control in Eritrea 40 
distribution to women at ANC and maternal and child health (MCH) clinics began, 
and from 2003, nets were also given freely to the general population living in 
malarious areas. Since 2001, over 900,000 ITNs have been delivered and two 
million re-treatments have been conducted through community campaigns and 
health facilities (NMCP [Eritrea] 2002; NMCP [Eritrea] 2003; NMCP [Eritrea] 2004; 
NMCP [Eritrea] 2005; NMCP [Eritrea] 2006). 
 
Re-impregnation campaigns are conducted once a year, one to two months prior 
to the malaria transmission season, at health facilities and community re-
treatment points. Supervision is ensured by health facility staff with the support of 
CHAs and with the collaboration of community members. 
 
Administratively the country is divided into six regions, called Zobas, and further 
into sub-Zobas (districts) and Kebabis (agglomerations of ~3-10 villages).  Four of 
the Zobas are considered to be at significant malaria risk, with the highest risk 
Zobas being Debub and Gash Barka and the lowest risk in the Northern Red Sea 
Zoba (Macintyre et al., 2006).  Operationally, the ITN programme functions 
similarly in all malarious regions with the caveat that some areas considered at 
higher risk were targeted for earlier distributions of ITNs. A full description of the 
Eritrean ITN programme is available in an unpublished report (Yukich et al., 
2007). The structure of the programme is shown schematically in Figure 4. 
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Figure 4: Structure of the Eritrean national ITN programme. 
 
 
 
The ITN distribution system in Eritrea was highly successful in raising the level of 
coverage to Abuja target levels and survey evidence that the country had met the 
60% coverage targets set under that agreement within specific regions became 
available in 2003 (See Table 2) (Eisele et al., 2006).  Given that success, the 
National Malaria Control Programme (NMCP) set higher targets at its annual 
meeting in Tesseney in 2004 (80% household ownership and pregnant 
women/under five usage by 2006) (NMCP [Eritrea] 2004).  These targets are in 
line with current RBM international policy (WHO 2008). Unfortunately, there is no 
available survey data to provide evidence as to the expansion or maintenance of 
the success of the Eritrea programme after 2004, however, a NMCP/Tulane 
survey undertaken in 2003 showed that when ITNs were defined as nets treated 
within 12 months nearly 80% of households in the most highly malarious areas of 
the country already owned ITNs (Table 2 shows selected results of ITN coverage 
and usage surveys in Eritrea).  Distribution of nets in Eritrea has continued since 
the last survey was conducted. 
  
Donors / Funding 
National Malaria Control 
Programme 
ZMC 
Zoba Malaria Coordinator 
Health Facilities sub-Zoba & 
Kebabi Administration 
Households 
Pregnant Women Community Health Agents 
ESMG 
Eritrea Social Marketing Group 
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Time frame and perspective for costing exercise 
Costs and outputs collected for this study cover a time period which extended from 
2001, when nets were first given freely though ANC facilities, through the end of 
2005, after three full years of community-wide distribution. This time interval covered 
a period of large scale up in ITN coverage, although it did not include the initial 
expansion of the programme to all malarious areas of the country (NSEO & ORC 
Macro 2003; Eisele et al., 2006). Hence, it was not possible to include the start-up 
costs of the programme. 
 
Attempts were made to follow existing guidelines for the cost evaluation of ITN 
programmes, as well as to use methodologies similar to past studies in order to 
maximize comparability (Creese & Parker 1994; Stevens et al., 2005; Kolaczinski & 
Hanson 2006).  On this basis all costing methods were standardized with six other 
national programme assessments that were conducted concurrently (Yukich et al., 
2007; Yukich et al., 2008). 
 
Types of costs included 
The study generally used the provider perspective. Travel or time costs to users, or 
other household-level costs or cost savings have not been measured or included, 
however, user charges from the early years of the program were included when 
calculating sources of financing. All direct and shared costs of the ITN programme to 
the provider were included, including those of the commodities and their delivery, 
health promotion, and social mobilization, as listed in Table 3. Costs represent the 
marginal cost of adding Eritrea’s ITN intervention onto an existing malaria control 
programme and health system. These expenses include the cost of training health 
workers in ITN use and re-treatment, health promotion and social mobilization, use of 
facilities, transportation, payment of personnel, and the commodities themselves. 
Costs required to build and train a network of Community Health Agents (CHAs) or to 
develop a network of health facilities have not been included. 
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Table 3: Types of costs included in the Eritrea analysis 
 
Capital  Buildings 
Vehicles 
Equipment and furniture 
ITNs 
Recurrent Insecticide 
Personnel 
Training and meetings 
Fuel/maintenance of vehicles 
Office/warehouse rental 
Advertising and promotion 
Supplies/overheads 
Patients’ expenditures (excluding cost of ITN) 
Management cost 
Basic evaluation and monitoring (excluding specific research cost) 
 
 
Cost collection 
Costs were collected retrospectively from financial and operational records kept by 
the NMCP, zonal offices in the four main malarious zobas of Eritrea, the Eritrean 
Social Marketing Group (ESMG), the World Bank-funded HAMSET project, and the 
Global Fund to Fight AIDS, TB and Malaria (GFATM). Cost and activity information 
collection occurred during two periods, from May to June 2005 and from May to June 
2006. Costs were collected by examining agencies' financial records, including 
budgets, expenditure records, reports, receipts and invoices. In addition, cost and 
activity information were collected through stakeholder interviews and direct 
observation where costs were not reflected in the financial records. 
 
Where possible, the ingredients approach was used, meaning that unit activities were 
first determined and then a unit cost was determined for these activities, allowing for 
the establishment of a total cost. Where this approach was not possible, either 
because the information was deemed too sensitive or was not available in adequate 
detail, aggregated expenditure was generally used. 
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Resource use was valued at three levels: centrally (within the MOH and the NMCP), 
at the Zoba level, and peripherally including health workers, health facilities, and 
CHAs. Direct costs to Kebabi administrators have not been included since they are 
believed to be small and no reliable information about these activities could be 
acquired within the framework of this study. 
 
Resources were valued based on the reported expenditures or budgets, and in the 
case of shared personnel, on salary plus any fringe benefits. Capital goods were 
valued based on their procurement costs or alternatively, in the case of building 
rents, on an average market value of similar properties as reported by the Eritrean 
government. 
 
Cost classification and adjustments 
Costs have been divided into capital and recurrent costs based mainly on the lifetime 
of the goods being purchased. As stated above, it was not possible to collect start-up 
costs.  Because of the long and gradual build-up to a full national scale programme, 
the start-up costs were likely to be large but also difficult to define as they were 
spread over a long time period and involved pilot programmes which would not be 
replicated if the strategy were used elsewhere.  Due to the long development period, 
these costs would have little effect on the current running costs of the programme, 
but failure to capture them reduces the stated costs. Capital costs have been 
discounted in the economic analysis using lifetimes and discount rates determined 
through stakeholder interviews, expert information, and past literature. Varying 
discount rates and lifetimes were examined in the sensitivity analysis. Both financial 
and economic analyses were conducted, in order to show (1) what the actual 
expenses of running a programme would be, as well as (2) the level of all resources 
used. In the financial analysis, taxes on nets and insecticide have been included, 
while in the economic analysis, they have been treated as transfer payments and 
have therefore been excluded. In the financial analysis, capital costs have not been 
discounted and are instead incurred in full at the time of the purchase. 
 
Costs were collected in either Eritrean Nakfa or United States Dollars (USD). Costs 
collected in Nakfa were converted to USD based on official yearly average exchange 
rates for the period during which the costs were incurred, and all costs were adjusted 
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for inflation to 2005 prices using the US Gross Domestic Product deflator produced 
by the US Bureau for Economic Analysis (US BEA). 
 
Outputs 
Generally, two main output measures were used: (1) number of nets delivered and 
(2) number of re-treatments performed. Both figures were reported by the NMCP 
annually, and reflect nets and re-treatments delivered at the primary health care 
facility level or community level. In the years 2001 and 2002, care was taken to 
disaggregate nets delivered via ANC clinics and community mechanisms, as nets 
delivered through community mechanisms involved a user fee, while nets delivered 
through ANC clinics did not. The number of re-treatments performed during annual 
re-treatment campaigns were reported by the Eritrea NMCP (NMCP [Eritrea] 2002; 
NMCP [Eritrea] 2003; NMCP [Eritrea] 2004; NMCP [Eritrea] 2005; NMCP [Eritrea] 
2006). 
 
The two output indicators above were used to calculate a third combined output 
measure: treated net years (TNY), which blends the results of both outputs by 
assuming that either a re-treatment or a new ITN provides one year of full protection 
for any individual using that net. This combined indicator is useful because it allows 
the inclusion of re-treatments of existing nets as part of the outcome measure, while 
the calculation of the cost per ITN delivered does not. Though some nets in the year 
2005 were LLINs, all nets have been treated as conventional nets for the calculation 
of outputs in the base scenario of this analysis. The number of TNYs delivered 
through an LLIN will be higher — approximately 3-5 years per net. In the sensitivity 
analysis, outputs were also calculated using the assumption that all nets delivered 
were LLINs. 
 
Cost-effectiveness calculations 
Two separate cost-effectiveness ratios were measured: (1) cost per child death 
averted and (1) cost per disability-adjusted life year (DALY) averted. Each of these 
ratios has been calculated using both the cost and effects of ITNs delivered and 
TNYs achieved. Only the effects of ITN use and possession by children were 
included in either calculation, thus ignoring potential benefits to older individuals. 
While this calculation underestimates the morbidity burden averted by ITN use, it 
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would be difficult to include other effects, which are not well quantified at present 
(Breman et al., 2007). It is also consistent with the fact that the DALY burden in 
malaria-endemic countries is largely driven by child deaths (Snow et al., 2004). The 
effects of untreated nets were excluded in the analysis because (1) it would have 
been difficult to obtain information on both numbers of such nets and their effect, and 
(2) the effects of long-lasting insecticidal nets (LLIN) were included in the sensitivity 
analysis, a more relevant scenario for the future. 
 
Cost results were coupled with standard health impact indicators derived from (1) the 
Cochrane review on ITNs (Lengeler 2004), and (2) WHO methodology for the 
calculation of DALYs averted (WHO-DALY). Estimates from the Cochrane review 
show that approximately 5.5 child deaths are prevented for every 1,000 children who 
are protected by a net for one year, or approximately 33 DALYs per death if all 
deaths are treated as infant deaths. This output has been combined with both cost 
outputs (cost per ITN delivered and cost per TNY delivered) to produce the final cost-
effectiveness ratios. 
 
Base scenario 
 
In this analysis, the base case scenario relies on the following set of assumptions. A 
discount rate of 3% has been applied to both DALYs (see below) and to economic 
capital costs. Shared costs have been attributed to the interventions based on the 
actual value of the indicator chosen to allocate them. Nets have been assumed to 
last for 3 years and, as noted above, treated nets and re-treatments are set to 
provide 1 year of protection each. Fifty percent of the nets delivered were assumed to 
be used by children and only one child was assumed to sleep under each of these 
nets.  The cost of nets was based on the commodity, insurance and freight (c.i.f.) 
price of the nets; for the portion of nets delivered with user fees through community 
mechanisms the user fee was included for the purpose of calculating sources of 
funding (the proportion of nets delivered this way was assumed to be 50% in the 
early years of the programme). Clearly, these are conservative estimates, mainly 
chosen in order to make a cross-country comparison easier and more meaningful 
(Yukich et al., 2008). 
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3.4 Results and Discussion 
 
The Eritrean national ITN programme delivered over 900,000 ITNs and over two 
million re-treatments during the period 2001-2005, at a total economic cost of 
USD 3.7 million, or a financial cost of just under USD 4.4 million USD (Table 4). The 
cost composition (Table 4 and Figure 5) of the programme was quite similar to that of 
other programmes which have been examined (Yukich et al., 2008). In economic 
terms, about 50% of the costs of the programme were capital costs, which were 
accounted for almost entirely by the cost of the nets. The commodity costs (nets and 
insecticide) represented 63% of the total economic cost of the programme. Other 
major costs were staff (21%), and vehicle costs (approximately 7%). 
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Table 4: Cost composition of the Eritrean national ITN programme (2005 USD). 
 
Line item Economic 
 
Financial 
 
 Total cost % Total cost % 
Recurrent 
Insecticide 442,213 12% 473,698 11% 
Staff 787,638 21% 787,638 18% 
Overheads 125,309 3% 125,309 3% 
Fuel and maintenance 111,284 3% 111,284 3% 
Health promotion and 
marketing 
73,850 2% 73,850 2% 
Rented-vehicle costs 229,984 6% 229,984 5% 
     
Subtotal recurrent 1,770,278 48%  1,801,764 41% 
     
Capital 
Nets 1,901,729 51% 2,519,343 58% 
Vehicles 18,527 1% 39,294 1% 
Furniture and equipment 7,704 <1% 19,614 <1% 
     
Subtotal capital 1,927,960 52% 2,578,251 59% 
 
    
Grand total 3,698,238 100% 4,380,015 100% 
 
In financial terms, the cost composition of the programme appeared somewhat 
differently. The largest differences were due to the removal of annualization for nets, 
which significantly increased their costs in any given year, as well as their share of 
the total cost of the programme. Secondly, there was a small increase in the costs of 
nets and insecticide due to the inclusion of import taxes. Other capital costs also 
increased significantly, but their overall contribution to the cost of the programme was 
generally low, so these increases had little effect on overall spending patterns. 
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Figure 5: Economic and financial cost composition of the Eritrean ITN programme 
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Table 5 summarizes the results of the costing analysis in terms of cost per ITN and 
TNY delivered. The results indicate an economic cost of approximately USD 3.98 per 
ITN delivered over the period 2001-2005 and a financial cost of USD 4.72. The cost 
per ITN delivered excluding the commodity cost (ITNs and re-treatments) was about 
USD 1.50.  Costs per TNY were significantly lower due to the large numbers of re-
treatments conducted during annual re-treatment campaigns, which increased the 
denominator in the TNY ratio significantly. When the commodity costs were excluded, 
the Eritrean programme delivered a year of protection for an approximate economic 
cost of USD 0.44. 
 
Table 5: Annual costs per ITN and Treated Net-Year (TNY) delivered in Eritrea (2005 
USD). 
 
Year 2001 2002 2003 2004 2005 Average/Total 
Financial cost (per ITN) 4.98 3.56 3.87 4.43 9.39 4.72 
Economic cost (per ITN) 3.15 2.47 4.14 4.07 8.51 3.98 
Economic cost (per ITN) 
less commodities 
2.02 1.03 1.23 1.23 2.68 1.46 
Financial cost (per TNY) 2.55 1.95 1.06 1.25 1.20 1.43 
Economic cost (per TNY) 1.61 1.35 1.14 1.15 1.09 1.21 
Economic cost (per TNY) 
less commodities 
1.03 0.57 0.34 0.35 0.34 0.44 
ITNs delivered 141,766 276,038 187,709 214,752 108,011 928,276 
Re-treatments 135,290 227,750 497,117 544,464 734,154 2,138,775 
 
The Eritrean national ITN programme was largely funded through donor 
contributions. However, in the early stages of the Eritrean national ITN programme 
(before 2003), user charges were collected for nets delivered through community 
mechanisms. Unfortunately, it was not possible to determine the specific number of 
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nets for which user charges were applied. As these charges were used to fund the 
programme, an assumption that 50% of nets delivered before 2003 included user 
fees when estimating the contribution to the program from each sector was used.  In 
this scenario, donors contributed 69% of funding, users contributed 14% and the 
MoH contributed 17%.  As the practice of charging user fees was discontinued after 
2002, the programme relied much more heavily on donor and governmental financing 
from 2003 onward.  Investment from the government of Eritrea was largely in terms 
of salaries, building space, and vehicles. 
 
Returns to scale 
When the costs were disaggregated by year (Table 5), several interesting findings 
emerged. One was that the cost of ITN delivery did not fall over time, partly because 
there was no trend toward an increase in scale over the time period analysed. In fact, 
the number of nets delivered fluctuated over time and the figures were substantially 
lower in 2005 compared to previous years. 
 
Evidence of the increasing returns to scale is more apparent in these results due to 
the large increases in TNYs delivered as compared to the ITNs delivered. However, 
some of this effect was mitigated after 2003 by rising costs for net procurement. If, 
however, the analysis took into account the fact that some of the nets delivered in 
2005 were LLINs and thus provide more than one TNY, the costs per TNY would 
have fallen despite the real increase in the cost per ITN delivered (data not shown). 
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Figure 6: Annual economic costs vs. total output (period 2001–2005). 
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Annual economic cost per ITN or Treated Net-Year (TNY) delivered vs. total annual number of ITNs or 
TNYs delivered in Eritrea (period 2001–2005). 
 
 
Figure 6 and Table 6 illustrate the scale efficiency savings due to increases in the 
number of TNYs of protection and the numbers of ITNs delivered. In Eritrea’s 
programme it is relatively straightforward to segregate procurement costs from 
distribution costs, and the former may be a good proxy for savings due to changes in 
the price of the inputs versus the latter. This can be used to examine changes due to 
efficiencies of delivery (or economies of scale in distribution). Separating these costs 
and analyzing their annual fluctuations shows that the programme achieved a 
savings of over 60% in terms of TNY distribution by its final year. These savings are 
largely attributable to the increasing share of re-treatments in the input mix, which 
significantly reduced the average cost of delivering one TNY of protection. The 
programme also showed approximately a 30% reduction in the total unit cost per 
TNY over the study period, indicating significant returns to scale in the system, 
despite procurement costs which increased. These results argue strongly for 
operating on a larger scale, as well as for the desirability of delivering re-treatments 
for nets when the use of LLINs is not generalized. Evidence that providing re-
treatments to existing nets can be more cost-effective than delivering new nets has 
been developed previously in the literature (Goodman et al., 1999). Figure 3 shows 
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how with increasing scale, the costs of distribution fell significantly in Eritrea both for 
TNYs and ITN delivery. As there is no trend of increasing scale over time in the 
Eritrean programme, the figure shows the cost versus annual delivery of nets and 
helps to better illustrate the scale efficiencies in the system. 
 
Table 6: Scale efficiency savings in the Eritrean national ITN programme 
 
Year 2001 2002 2003 2004 2005 
Total / 
average 
Output growth (actual) 
 113,366 90,519 37,195 311,502 1,665,025 
Output growth (%) 
 82% 36% 11% 82% 53% 
       
Total cost       
   TNY unit cost  1.61 1.35 1.14 1.15 1.09 1.21 
   TNY unit cost savings  
 0.26 0.22 -0.02 0.06 0.52 
   TNY unit cost savings (%) 
 16% 16% -1% 5% 32% 
Procurement only       
   TNY Unit Cost  0.58 0.79 0.80 0.80 0.75 0.76 
   TNY Unit Cost Savings  
 -0.21 -0.01 -0.01 0.05 -0.17 
   TNY Unit Cost Savings (%) 
 -36% -1% -1% 7% -29% 
Distribution only       
   TNY Unit Cost  1.03 0.57 0.34 0.35 0.34 0.44 
   TNY Unit Cost Savings 
 0.47 0.23 -0.01 0.00 0.69 
   TNY Unit Cost Savings (%) 
 45% 40% -3% 1% 67% 
TNY=Treated Net Year 
 
However, it should be pointed out that while there might be a significant amount of 
spare capacity within the Eritrean ITN programme, at least in low net delivery years, 
the integrated nature of the programme means that this spare capacity is likely to 
have been used for other productive activities. 
 
Cost-effectiveness 
Cost-effectiveness calculations began with the base case cost analysis and were 
derived using either cost per ITN or cost per TNY, as shown in Table 5. Table 7 
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shows the predicted health impacts of the intervention in a base scenario analysis. 
Using the total TNY measure of protection, it can be seen that significantly more 
deaths and thus DALYs were predicted to have been averted by the intervention due 
to the addition of protection through re-treatment delivery. By contrast, when only 
conventional ITNs, without re-treatment, were included in the calculation, the 
predicted health impact was much lower.  These data illustrate again the urgent need 
to introduce LLINs instead of conventional nets. 
 
Table 7 also illustrates the overall cost-effectiveness ratios that were derived in the 
base analysis. Overall, cost per death and DALY averted were generally low in terms 
of previously published WHO criteria for assessing interventions and research (Ad 
Hoc Committee 1996), but vary markedly depended on the output measure used.  As 
expected, TNYs yielded significantly lower costs per death averted and DALY 
averted due to the large number of re-treatments provided by the programme. 
 
Table 7: Estimated cost-effectiveness of the Eritrean national ITN programme (2005 
USD). 
 
 Using cost per ITN Using cost per TNY 
Deaths averted (2001–2005) 2,553 8,434 
DALYs averted (2001–2005) 84,241 278,335 
Cost per death averted (USD) 1,449 438 
Cost per DALY averted (USD) 44 13 
TNY=Treated Net-Year  DALY=Disability-Adjusted Life Year 
 
Sensitivity analysis 
Sensitivity analysis was conducted to examine the effects of key assumptions on the 
cost per output and on cost-effectiveness ratios. The parameters examined included: 
lifetime of nets, discount rate, allocation of shared costs, the costs of nets and 
insecticide, and two scenarios corresponding to the use of Long-Lasting Insecticidal 
Nets (LLINs). The parameters have been varied to the extremes of their potential 
ranges, as determined by reviews of the literature or expert opinion. 
 
Sensitivity analysis was also applied to the main assumptions about the connection 
between the cost output ratios and the cost-effectiveness calculations. Parameters 
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examined included the usage rates of the nets delivered, the percentage of nets used 
by children, the length of time during which a net or re-treatment offers protection, 
including the extended protection offered by LLINs, and the cost-to-output 
parameters which affect the overall cost of delivering a net or re-treatment. 
 
The LLIN scenarios were calculated by assuming a nominal price and lifetime for 
types of LLINs: USD 5.00 and 3 years of protection or USD 7.00 and 5 years of 
protection. These scenarios were expected to bracket the cost-effectiveness ratios 
which would have been generated by assuming that some protection was offered by 
untreated conventional nets, an effect which was ignored in our base scenario. Table 
8 shows the results of a sensitivity analysis for the cost per ITN and TNY delivered. 
Table 9 shows the results of the analysis for the other outputs and outcomes: deaths 
averted and DALYs averted. 
 
Table 8: Results of sensitivity analysis: cost per ITN and Treated Net Year (TNY) 
delivered in Eritrea (2005 USD). 
 
Parameter Values assumed 
Range (USD) per 
ITN 
Range (USD) per 
TNY 
Discount rate 1–10% 3.90–4.27 1.18–1.29 
Cost of nets 1.50–5.00–7.00 3.62–6.88–8.75 1.09–2.08–2.65 
Lifetime of nets 1 year–5 years 4.49–3.47 1.36–1.05 
Cost of insecticide/liter 6.00–12.00 3.80–4.10 1.15–1.24 
Shared costs 0–100% 3.29–10.30 1.00–3.12 
LLIN use* 
Base – 3 years, 
USD 5 – 5 years, 
USD 7 
3.98–7.75–10.08 
(NA - 7.28 - 9.60) 
1.43–1.46–1.38 
(NA - 2.43 – 1.92) 
Length of protection 
offered by ITN or re-
treatment 
3 months – 6 
months – 1 year 
N/A  5.73–2.87–1.43  
LLIN=Long-Lasting Insecticidal Net. 
*numbers in brackets represent exclusion of re-treatment commodity costs and benefits 
 
The overall range of results for the cost per ITN delivered is quite wide, ranging from 
USD 3.29 to 10.30, indicating that there are significant uncertainties in the cost 
measurements. However, there are several reasons to believe that the actual 
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variance is less than that suggested by the extremes of the sensitivity analysis. The 
upper values only exceed approximately USD 5.00 in the case of two variables: the 
cost of the nets and the allocation of shared costs. In terms of the cost of nets, USD 7 
per net is an unlikely figure since the Eritrean programme was able to procure LLINs 
in 2005 for an average cost of USD 4.85. The other variable which gives rise to the 
most extreme value in the sensitivity analysis is the allocation of shared costs. In 
most cases, the personnel involved in the Eritrean ITN programme are involved with 
ITN activities for only a portion of the year, and even during that time, they are 
typically not fully dedicated to the programme. Most allocation measures, which were 
based on either the days of per diem paid to employees, or the amount of space 
used in offices and buildings, indicated that less than one-third of a given shared 
resource was being used for ITNs. 
 
Table 9: Results of sensitivity analysis: cost per death and Disability-Adjusted Life 
Year (DALY) averted in Eritrea (2005 USD). 
   
Parameter Values 
assumed 
ITN range 
(USD) per 
death 
averted 
TNY range 
(USD) per 
death 
averted 
ITN range 
(USD) per 
DALY 
averted 
TNY range 
(USD) per 
DALY 
averted 
Discount rate 1–10% 1,420–1,554 430–470 43–47 13–14 
Cost of nets 1.50–5.00–7.00 
1,315–2,503–
3,183 398–758–963 40–76–96 12–23–29 
Lifetime of nets 1 year –  5 years 1,634–1,263 495–382 50–38 15–12 
Cost of 
insecticide/liter 6.00–12.00 1,383–1,490 419–451 42–45 13–14 
Shared costs 0–100% 1,196–3,745 362–1,134 36–113 11–34 
Length of 
protection 
offered by ITN 
or re-treatment 
3 months –  
6 months –  
1 year 
5,795–2,897–
1,449 
1,754–877–
438 176–88–44 53–27–13 
Usage of nets 25–50–100% 2,897–1,449–724 877–438–219 88–44–22 27–13–7 
Children 
protected per 
net 
1–2 1,449–724 438–219 44–22 13–7 
LLIN use (TNY)*  
Base –  
3 years, 
USD 5 –  
5 years, 
USD 7 
438–531–502 
(NA – 882 - 698) 
13–16–15 
(NA – 27 – 21) 
TNY = Treated Net Year; LLIN=Long-Lasting Insecticidal Net. 
*numbers in brackets represent exclusion of re-treatment commodity costs and benefits 
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For the calculation of deaths averted and DALYs averted, the assumptions regarding 
(1) the length of protection provided by an ITN or re-treatment, and (2) assumptions 
concerning the usage of these nets among children had a dramatic impact on the 
results. While published information suggests that usage rates for children in net-
owning households were high (on the order of 80%, meaning that 80% of households 
with nets had at least some children using them), the link between the actual number 
of nets delivered by the programme and usage is less certain (Macintyre et al., 2006). 
As a matter of course, some of the nets will be lost, damaged or misused. Hence, 
even if usage among households owning nets is high, the actual relationship 
between household ownership and nets delivered will yield lower rates of usage per 
net delivered. It was not possible to explicitly quantify this effect. However, usage 
rates were varied to include expected wastage rates in the sensitivity analysis (from 
25% of nets used by children to 100%).  Our assumptions were generally 
conservative, but it is clear that if usage of nets was worse and/or wastage higher, 
the cost effectiveness results presented here would overestimate the values 
presented for Eritrea. Additionally it should be noted that while we calculated health 
impacts in a manner intended to be consistent with the other studies in a large multi-
country comparison, this scenario is reflective of a highly endemic malaria situation 
(Yukich et al., 2008).  In a country with malaria epidemiology as varied as Eritrea’s 
these results may not be reflective of the true epidemiological impact of the 
intervention in all settings.   
 
When the scenarios using different LLIN assumptions were calculated, the cost-
effectiveness ratios in all cases approached the result obtained by delivering 
inexpensive conventional nets and large numbers of re-treatments through 
campaigns. As it was not possible to disaggregate all re-treatment campaign costs 
from the analysis, it would be expected that the true LLIN cost-effectiveness ratios 
would improve slightly compared to those shown here.  
 
3.5 Conclusions 
 
Under the base case scenario the cost per DALY averted was as low as 13 USD.  
Considering that this is a conservative scenario, the result is clearly within the 
acceptable range for interventions in low-income countries as defined in previous 
WHO publications (Ad Hoc Committee 1996). The results of the sensitivity analysis 
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clearly showed that some parameters, such as the usage of the nets, their cost, and 
the length of protection delivered had important effects on cost per output and cost-
effectiveness.  Scenarios which incorporated LLINs showed only small changes in 
cost-effectiveness over the delivery of conventional nets and re-treatments but did so 
despite substantial increases in the upfront cost of ITN procurement.  Since the use 
of LLINs would eliminate the need for re-treatment campaigns it appears that a full 
shift to LLIN technology would be beneficial in Eritrea and this has been adopted as 
the current national policy. 
 
The Eritrean National ITN programme has increased ITN coverage dramatically to 
the point that it has essentially met the Abuja targets for ITN coverage in vulnerable 
groups within at least some areas of the country (Nyarango et al., 2006; Eisele et al., 
2006).  The new target of 80% protection in high-risk groups (WHO 2008; NMCP 
[Eritrea] 2004) should also be within reach of the programme. Two studies used 
regression analysis to demonstrate that ITNs had a measurable effect on clinical 
malaria incidence (Nyarango et al., 2006; Graves et al., 2008).  The cost-
effectiveness results presented here indicate that Eritrea has achieved this goal in an 
efficient manner and that it is possible to distribute ITNs at no charge to users 
through a system fully integrated into the existing health system. This is currently a 
unique model in SSA and worth investigating for other countries.  It must be stressed, 
however, that such a system relies (1) on an adequately functioning health system, 
and (2) on a good outreach system, in the case of Eritrea in the form of CHAs.  If 
these two conditions are not met, such a public sector approach might not be an 
effective way to distribute ITNs. 
 
Similarly to the four other ITN programmes reviewed in a larger comparative study 
(Yukich et al., 2008), the Eritrean ITN programme is largely dependent on external 
financing, underscoring the importance of reliable and predictable funding for vector 
control activities.  Ultimately, the Eritrean programme has been both successful in 
providing wide reaching high ITN coverage and sustaining it over a period of some 
years. Furthermore it has done so in a cost-effective manner, thus providing an 
example for other SSA countries, whether they still need “catch-up” ITN activities or 
need to “keep-up” already high ITN coverage. 
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4.1 Abstract 
Background 
The cost-effectiveness of insecticide-treated nets (ITNs) in reducing morbidity and 
mortality is well established. International focus has now moved on to how best to 
scale up coverage and what financing mechanisms might be used to achieve this. 
The approach in Tanzania has been to deliver a targeted subsidy for those most 
vulnerable to the effects of malaria while at the same time providing support to the 
development of the commercial ITN distribution system. In October 2004, with funds 
from the Global Fund to Fight AIDS Tuberculosis and Malaria, the government 
launched the Tanzania National Voucher Scheme (TNVS), a nationwide discounted 
voucher scheme for ITNs for pregnant women and their infants. This paper analyses 
the costs and effects of the scheme and compares it with other approaches to 
distribution. 
Methods 
Economic costs were estimated using the ingredients approach whereby all 
resources required in the delivery of the intervention (including the user contribution) 
are quantified and valued. Effects were measured in terms of number of vouchers 
used (and therefore nets delivered) and treated nets years. Estimates were also 
made for the cost per malaria case and death averted. 
Results and Conclusion 
The total financial cost of the programme represents around 5% of the Ministry of 
Health's total budget. The average economic cost of delivering an ITN using the 
voucher scheme, including the user contribution, was $7.57. The cost-effectiveness 
results are within the benchmarks set by other malaria prevention studies. The 
Government of Tanzania's approach to scaling up ITNs uses both the public and 
private sectors in order to achieve and sustain the level of coverage required to meet 
the Abuja targets. The results presented here suggest that the TNVS is a cost-
effective strategy for delivering subsidized ITNs to targeted vulnerable groups. 
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4.2 Background 
The cost-effectiveness of insecticide-treated nets (ITNs) in reducing morbidity and 
mortality is now well established (Wiseman et al., 2003; Picard et al., 1993). It is 
considered to be one of the most cost-effective ways of reducing the burden of 
malaria with an estimated cost per Disability Adjusted Life Year (DALY) averted of 
between $19 and $85 (1995 prices) (Goodman et al., 1999). International focus has 
now moved on how best to deliver ITNs to achieve a high level of coverage and what 
financing mechanisms might be used to achieve this. Recent debates have centred 
on the trade-off between the need for immediate impact and the long-term 
sustainability of increased coverage. Proponents of free distribution emphasize the 
urgency for immediate results, whereas those who favour a more pluralistic 
approach, including the development of domestic markets for ITNs, are keen to 
ensure the long term sustainability of delivery of ITNs (Muller & Jahn 2003; Stevens 
2005; Curtis et al., 2003; Lines et al., 2003). 
The WHO Position Statement on ITNs recommends implementation of strategies to 
sustain high levels of long-lasting insecticidal net (LLIN) coverage ("keep up" 
strategies) in parallel with strategies for achieving rapid scale- up ("catch up" 
strategies) with an overall aim of achieving full LLIN coverage (WHO 2007). 
However, the statement also recognizes that commercial markets are a valuable 
source of nets and recommends that where strong commercial markets exist or are 
developing they should be encouraged. The benefits of this are identified as ensuring 
longer-term access to nets and enhancing management of logistics and education 
efforts. The statement argues that separating the delivery of a targeted subsidy and 
the ITNs through distribution of vouchers or coupons to a target population makes it 
possible to stimulate local trade by building and maintaining a countrywide network of 
outlets. In this way "commercial demand and the commercial market are 
strengthened while the burden on the public health system of the logistics and 
distribution of ITNs, including long lasting nets, and of the associated management 
functions, is reduced" (WHO 2007). Importantly, the WHO statement recognizes that 
a decision to use vouchers should be considered in light of local experience. 
The policy in Tanzania has been to combine the approaches of a targeted subsidy for 
those most vulnerable to the effects of malaria while at the same time providing 
support to the development of the commercial ITN distribution system using a social 
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marketing programme (Magesa et al., 2005). Social marketing in this context refers to 
a range of activities including improving the impact of locally manufactured nets by 
bundling them with long lasting insecticide and improving availability at the retail 
level. In 2008, this "keep up" approach will be reinforced by a massive "catch up" 
campaign for children aged between one and five who are not beneficiaries of the 
voucher programme. 
In October 2004, with funds from the Global Fund to fight AIDS, Tuberculosis and 
Malaria (GFATM), the government launched the Tanzania National Voucher Scheme 
(TNVS), a nationwide discounted voucher scheme for ITNs for pregnant women and 
their subsequently new born infants.  Table 10 shows the key events in the 
development of the scheme. Under the scheme, every pregnant woman who attends 
an antenatal clinic (ANC) is eligible to receive a voucher which can be used as part-
payment for an ITN (defined as a conventional net bundled with a package of 
insecticide). The vouchers carry a fixed value: this was set at Tsh 2750 (around US$ 
2) from October 2004 to December 2006, and was raised to Tsh 3250 from January 
2007. Upon production of the voucher and her ANC card a woman can purchase any 
size of net using her voucher. This means that the value of the top-up amount is 
variable but in 2006 was around Tsh 1019 around 20% of the cost of a standard 4 × 
6 net. 
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Table 10: Timeline of key events 
Time Activity 
Mar 2002 Contract signed with GFATM 
Nov 2002 Agreement signed between MoH and GFATM 
Mar 2003 GFATM Funds arrive 
Apr 2003 
ITN cell leader appointed with funds and technical assistance from 
Swiss Development Corporation and Swiss Tropical Institute 
Oct 2003 Programme Assistant and advisor appointed 
May 2004 Tender for contractors issued 
June 2004 Contract issued to logistics and training contractors 
Jul 2004 Roll out planning begins 
Sep 2004 Rollout training begins Regional training begins for voucher redemption 
Oct 2004 Contracts issued to auditors and monitoring and evaluation contractors 
Oct 2004 
TNVS scheme formally launched Voucher distribution begins phased 
roll-out by district 
May 2006 100% nationwide coverage achieved 
  
The TNVS was expanded from October 2006 onwards with funding from the 
President's Malaria Initiative (PMI) to provide a further voucher to the mothers and 
caretakers of infants aged nine months issued at the time of the measles vaccination, 
in order to provide continued protection for the child when it sleeps alone or with 
other siblings. 
Implementation of the TNVS is through a public private partnership between the 
National Malaria Control Programme (NMCP), the district Council Health 
Management Teams (CHMTs), Reproductive and Child Health (RCH) facilities, 
private net manufacturers, over two hundred wholesalers, more than six thousand 
retailers and three non-governmental organisations (NGOs) contracted to the Ministry 
of Health. RCH staff and CHMTs are trained by World Vision Tanzania staff under a 
contract with the Ministry of Health and Social Welfare. Responsibility for voucher 
supply, distribution and redemption lies with the logistics contractor, Mennonite 
Economic Development Associates (MEDA), which procures vouchers and delivers 
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them to district level. District Medical Officers (DMOs) are responsible for delivering 
vouchers to RCH facilities. RCH facilities distribute them to pregnant women who 
then redeem the vouchers for ITNs at local retailers (Figure 7). Redeemed vouchers 
are returned to wholesalers and then to manufacturers in exchange for new stock. 
Cash is provided against vouchers only at the very top of the system, to any of the 
four local manufacturers or a limited number of large wholesalers. This is to minimize 
the misuse of vouchers for products other than ITNs. A parallel system is used to 
supply free insecticide re-treatment kits to children attending vaccination clinics at 
three months and nine months, to encourage regular re-treatment of nets. The 
Medical Stores Department (an autonomous agency of the Ministry of Health) 
supplies insecticide re-treatment kits (IRK) directly to the districts through the 
distribution channels used for drugs and other medical supplies. A phased roll-out of 
the TNVS was launched in the first districts in October 2004, and all districts on the 
mainland were covered by May 2006. 
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Figure 7: Structure of the Tanzanian National Voucher Scheme 
 
 
 
The Ifakara Health Research and Development Centre and the London School of 
Hygiene and Tropical Medicine were contracted to undertake the monitoring and 
evaluation of the TNVS. The aim of this paper is to analyse the costs and effects of 
the scheme and to compare with other approaches to distribution. The perspective of 
the analysis is of both the provider and users whereby all costs and consequences 
attributable to the donors, the MOH and users were estimated. 
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4.3 Methods 
Data collection 
To ensure that this costing is comparable with future evaluations the analysis 
followed standardized guidelines recommended for costing ITN distribution systems 
(Kolaczinski & Hanson 2006). Economic costs were estimated using the ingredients 
approach whereby all resources required in the delivery of an intervention are 
quantified and valued. This involved collecting actual line item expenditure and 
activity data wherever possible. In other instances, budget data were used to 
estimate expenditure. Project cost data were collected retrospectively from 
accounting records held by NMCP and the implementing partners. Data on the costs 
incurred by users were derived from the TNVS household survey and retail audit 
(Hanson et al., 2006; Stephen et al., 2006). Household survey data also provided 
information on the mean number of children protected by a net bought with a 
voucher. Semi-structured interviews were held with key stakeholders and project staff 
to identify activities not recorded in project documentation and information on 
programme outputs. Estimates of ITN effectiveness (in terms of averted deaths and 
malaria cases) were derived from the literature (Lengeler 2004). 
Categorization and analysis of costs 
Economic costs or opportunity costs represent the value of resources in their next 
best alternative use. In this analysis economic costs differ from accounting financial 
costs in two main ways: first an equivalent annual capital cost is calculated for those 
items which are deemed to last more than one year and second any donated or 
subsidized goods and services (e.g. time of users to collect nets) are valued at their 
estimated market cost. 
Cost identification was done by tracking the financial and economic costs associated 
with each activity. The time-frame for identifying costs ran from the first planning 
workshop held in early 2004 through to July 2006. The scheme involved four areas of 
activity: central management, training of key stakeholders, promotion activities and 
the logistics associated with the distribution, redemption and accounting for vouchers 
(see Table 11). Shared costs such as office equipment, office rent and office furniture 
and utilities were grouped as overheads. Budget estimates provided by the 
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implementing partners were used to assign values to these items. Fixed asset 
registers were also used to identify and value capital equipment. 
Table 11: Contributors to the intervention 
 
Contributor Role 
Global Fund to Fight AIDS, Tuberculosis 
and Malaria 
• Funder of TNVS main activities 
Swiss Development Corporation (SDC) 
and Swiss Tropical Institute (STI) • Funder of ITN cell 
Ministry of Health National Malaria 
Control Programme (NMCP) • Project management 
Mennonite Economic Development 
Agency (MEDA) 
• Logistics contractor 
• Voucher distribution and redemption 
World Vision/CARE • Conducting roll out training 
Population Services International (PSI) • Social marketing and technical support 
District Health Management Team 
• Costs of voucher distribution and 
reporting 
Health Facilities • Distribution of vouchers at ANC clinics 
Retailers and wholesalers • Handling vouchers 
Households 
• Top-up charges for ITNs 
• Time costs associated with collection of 
nets 
Since 1999, a large network of stakeholders in Tanzania has promoted and 
supported a coordinated national ITN strategy (NATNETS). Household ownership of 
an ITN has increased substantially (from virtually nil to around 36% by 2007) and a 
strong commercial sector for the production, distribution and retailing of mosquito 
nets has emerged. The NATNETS strategy consists of four components: i) An ITN 
'cell' based at the National Malaria Control Programme (NMCP), ii) SMARTNET a 
strategic social marketing program funded by the UK Department for International 
Development and the Royal Netherlands Embassy (this finished in June 2007), (iii) 
the provision of insecticide treatment and re-treatment kits to net manufacturers and 
retailers, and iv) the TNVS. A key decision in framing the analysis was determining 
the extent to which costs associated with the wider activities of the NATNETS 
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programme should be included. While it is clear that the TNVS could not have taken 
place without the existence of wider social marketing activities, the focus of the 
present analysis are activities that are directly related to the voucher scheme only. 
The ITN cell of NMCP comprises a team leader and two programme staff. Following 
discussions with staff they are estimated to spend between 75 and 80% of their time 
on TNVS activities and this allocation was used in the baseline analysis. The 
activities of the wider NATNETS programme are the subject of a separate evaluation 
(Yukich et al., 2007). 
Recurrent and capital costs 
Expenditure was disaggregated by recurrent and capital expenditure, showing the 
difference between investment costs that are one-off and recurrent costs that are 
ongoing and represent the running costs of any programme implementation (see 
Table 12). Capital costs included formative research, building space, equipment for 
office use (e.g. computers), vehicles and ITNs (includes voucher subsidy and user 
contribution). Formative research refers to the costs of running a pilot voucher 
scheme in two districts but excludes on-going monitoring and evaluation activities. All 
capital items were annualized over assumed life spans using a discount rate of 3%. 
This enables an annual equivalent cost to be estimated that is then added to the 
annual recurrent estimate. This process reflects the value in use of capital items, 
rather than reflecting when the item was purchased. The useful life of vehicles was 
estimated at eight years. Formative research, computers, furniture and equipment 
were all estimated to have a useful life of five years. Nets were assumed to last for 
three years, although the effect of initial treatment and any subsequent re-treatments 
were assumed to provide one year of protection. Recurrent costs included staff 
related costs, consumables and fees (such as banking charges, service fees, and 
communication charges). 
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Table 12: Costs included in the analysis 
 
Capital  
 Formative research 
 Planning costs 
 Consensus building and meetings 
 Initial training 
 Buildings 
 Vehicles 
 Equipment and furniture 
 ITNs (user contribution and subsidy) 
Recurrent  
 Insecticide 
 Personnel 
 Fuel/Maintenance of vehicles 
 Office/warehouse rental 
 Advertising and promotion 
 Supplies/overheads 
 Management cost 
All cost items were valued according to their market value in the year they were 
purchased in either Tanzanian shillings or US dollars, depending on where they were 
purchased. All costs were then translated into US dollars at the Tsh-US$ exchange 
rate for the year in which they were incurred (in July 2006 1340 Tsh = 1 US$). All 
costs are reported in 2006 US dollars. 
An attempt was made to distinguish between start up costs and running costs of the 
programme. Start up costs are classified as one-time activities to get the programme 
up and running and includes formative research undertaken in two districts in 2004, 
planning activities by NMCP in the months leading up to the formal launch and the 
training of health workers by Care and World Vision. The start up costs of NMCP are 
defined as those relating to activities undertaken by the ITN cell staff from the 
appointment of the ITN cell leader to the official launch date in October 2004. In 
contrast to the formative research start up costs were not treated as a capital cost, as 
it is likely that some activities will need to be repeated at some point. 
Estimating user and health facility staff costs 
The voucher scheme works on the basis that part of the price of the net is paid for by 
users. An important part of this analysis is the inclusion of user costs as well as the 
cost incurred by the providers of the voucher scheme. The retail audit and household 
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survey provided information on the average top-up payment by users and typical 
travel costs involved in collecting nets (Hanson et al., 2006; Stephen et al., 2006). 
The household survey reported that it takes women on average 40 minutes to get to 
a shop to redeem the voucher (Hanson et al., 2006). The opportunity cost of the total 
time taken to redeem the vouchers was based on the minimum wage of an 
agricultural worker and estimated to be Tsh 520 ($0.39). The associated average 
travel costs were found to be 68 Tsh ($0.05). Data from the retail audit indicated that 
the mean top-up price charged by retailers was Tsh 1019 ($0.76) (Stephen et al., 
2006). This figure was varied in the sensitivity analysis. 
The distribution of the vouchers at the health facility involves a number of activities by 
clinic staff including communal health education talks, explaining how the scheme 
works to individual women during antenatal clinic sessions, filling in the ledger books, 
collecting new voucher books and delivering used voucher books to the District 
Medical Officer (DMO). Although difficult to quantify it is important that these 
opportunity time costs are reflected in the results. Based on informal discussions with 
clinic staff and those involved in the monitoring and evaluation of the scheme it was 
estimated that these costs would amount to around five minutes per voucher 
distributed. 
Cost – effectiveness 
As the effectiveness of ITNs in reducing infant and child mortality and improving 
maternal health has been amply demonstrated (Lengeler 2004), no health impact 
data were collected as part of this study. The focus instead is on programme outputs 
i.e. the number of nets delivered to users. Only outcomes for children under five 
years of age are considered here. Estimating the number of malaria deaths averted 
by the intervention depends on net coverage, usage and the relationship between 
treated net years and mortality. The review by Lengeler found that in areas with 
stable malaria, ITNs reduced the incidence of uncomplicated malarial episodes by 
50% compared to no nets (Lengeler 2004). They estimated that 5.5 lives could be 
saved each year for every 1,000 children protected with ITNs. In order to translate 
output data into health outcomes, the baseline analysis assumes that all vouchers 
redeemed at shops are used to purchase a net. Survey data from the TNVS 
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household survey shows that on average each voucher net protects 0.88 children. 
This is reduced to 0.5 in the sensitivity analysis to take account of net wastage. 
The outputs of the scheme are measured in terms of number of nets delivered to 
women and number of re-treatments performed. These outputs are combined into 
treated net years (TNY). The combined indicator TNY is useful because it allows the 
inclusion of re-treatments of existing nets as part of the outcome measure. The WHO 
defines a conventionally treated net as any net that has been treated with a WHO 
recommended insecticide at least once a year (WHO 2007). The baseline analysis 
therefore assumes that either a re-treatment or a new ITN provides one year of 
protection for any individual using that net. The sensitivity analysis examines the 
impact of reducing insecticide effectiveness from 12 to 6 months. The following ratios 
are estimated: cost per voucher used (and, therefore, net delivered); cost per treated 
net year (TNY); cost per malaria case averted; cost per malaria death averted. 
4.4 Results 
Financial and economic costs 
Over the first two years (2004–2006), the total provider financial costs of the TNVS 
programme were $10,680,516 (Table 13). Figure 8 provides a graphical breakdown 
of provider costs with staff costs making up the biggest component, followed by 
promotion activities and the costs of the ITNs themselves. Including the user 
contribution takes the total to $11,837,838. Economic costs include the user top up 
plus donated inputs in the form of ANC clinic time and user travel time. Capital costs 
are also annualized to reflect the annual equivalent value in use. The economic costs 
of the programme are $10,599,367 (see Table 14). 
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Table 13: Financial Costs, Provider plus User, 2004-2006 
 
 
US$ % 
Financial 
cost per 
voucher 
used 
(US$) 
 
   
Capital costs 
   
Formative research 68,736 1% 0.05 
Office furniture and equipment 46,944 0% 0.03 
Vehicles 83,110 1% 0.06 
ITN costs (voucher subsidy) 3,123,294 29% 2.24 
Total Capital 3,322,084 31% 
 
    
Recurrent costs 
   
Staff (includes direct and zonal costs) 2,609,508 24% 1.87 
IRK procurement costs 1,200,355 11% 0.86 
Vehicle running costs 522,204 5% 0.37 
Voucher production 255,275 2% 0.18 
Promotion activities 1,645,608 15% 1.18 
Training of health workers 627,224 6% 0.45 
Office running costs 347,077 3% 0.25 
Overheads 151,182 1% 0.11 
Total recurrent 7,358,432 69% 
 
Total provider costs 10,680,516 
  
    
User direct costs 
   
ITN user contribution 1,157,322 11% 0.83 
    
TOTAL FINANCIAL COSTS 11,837,838 
 
8.49 
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Table 14: Economic costs, 2004-2006 
 
 
$US % 
   
Capital 
  
Formative research 27,121 0.3% 
Office furniture and equipment 18,652 0.2% 
Vehicles 21,394 0.2% 
ITN costs (voucher subsidy) 2,153,047 20.4% 
Sub total 2,220,213 21.0% 
   
Recurrent costs 
  
Staff 2,609,508 24.7% 
IRK procurement costs 1,200,355 11.4% 
Vehicle running costs 522,204 4.9% 
Voucher production 255,275 2.4% 
Promotion activities 1,645,608 15.6% 
Training of health workers 627,224 5.9% 
Office running costs 347,077 3.3% 
Overheads 151,182 1.4% 
Sub total 7,358,432 69.7% 
   
User and ANC staff costs 
  
ITN user contribution 797,802 7.6% 
Direct travel costs 118,134 1.1% 
ANC clinic staff costs 64,786 0.6% 
Sub total 980,722 9.3% 
   
Total 10,559,367 100% 
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Figure 8: Breakdown of provider financial costs 
 
 
 
 
Cost per voucher used and per treated net year 
As at July 31st 2006 2,424,987 vouchers had been sent to District Medical Offices for 
distribution to pregnant women. Of these 1,157,885 vouchers had been utilized by 
pregnant women and the vouchers returned to MEDA. Based on data from the 
household survey and from MEDA's own calculations from vouchers returned 
compared with matching stubs (counterfoils), NMCP estimates that returned 
vouchers represent around 83% of all vouchers actually utilized by women at that 
point. Therefore the actual number of voucher nets delivered to pregnant women 
using the TNVS was at least 1,395,042 at the end of July 2006. This figure 
represents the baseline output figure for all the cost-effectiveness estimates. On this 
basis the financial cost (including user top up) per voucher used, and therefore ITN 
delivered, is $8.49 and the economic cost is $7.57. A total of 1,600,000 insecticide 
re-treatment kits were also distributed by the programme during the same time 
period. The household survey found that 69% of mothers who received a re-
treatment kit actually used it to retreat their nets and the baseline analysis is adjusted 
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on this basis. If the impact of delivered voucher nets and re-treatment kits (adjusted 
for lower retreatment rates) are added together it is calculated this led to a total of 
2,499,042 treated net years and a cost per treated net year of $4.23. 
It is estimated that start up costs comprise around 8% of the total costs (see Table 
15). If these costs are removed the economic cost per ITN delivered is estimated to 
be $6.93. The cost per treated net year is $3.87. The majority of start up costs 
represents training activities, some of which will need to be repeated at a future point 
in the scheme to ensure that skills and knowledge of health workers are maintained. 
Table 15: Economic costs – ‘start up’ versus ongoing costs 
 
 
US$ % 
   
'Start up' costs 
  
Formative research 27,121 0.3% 
NMCP planning and pre launch activities 235,014 2% 
Training of health workers 627,224 6% 
Sub total 889,359 8% 
   
Capital costs 
  
Office furniture and equipment 18,652 0% 
Vehicles 21,394 0% 
ITN costs (voucher subsidy) 2,153,047 20% 
Sub total 2,193,093 21% 
   
Recurrent costs 
  
Staff 2,374,494 22% 
IRK procurement costs 1,200,355 11% 
Vehicle running costs 522,204 5% 
Voucher production 255,275 2% 
Promotion activities 1,645,608 16% 
Office running costs 347,077 3% 
Overheads 151,182 1% 
Sub total 6,496,194 62% 
   
User and ANC staff costs 
  
ITN user contribution 797,802 8% 
Direct travel costs 118,134 1% 
ANC clinic staff costs 64,786 1% 
Sub total 980,722 9% 
   
GRAND TOTAL 10,599,367 100% 
TOTAL COST MINUS START UP 9,670,009 
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Cost per malaria case and death averted 
The programme resulted in a total of 2,499,042 treated net years and the mean 
number of children protected per voucher net is 0.88. If it is assumed that 1,000 
treated ITNs will avert 5.5 child deaths per year (Lengeler 2004), it is estimated that 
the programme averted 12,039 child deaths at an economic cost of $873 per child 
death averted. For averted malaria cases, the incidence of malaria outpatient 
attendances in children under 5 is reported as 723 per 1,000 per year (NMCP 
unpublished data). If it is assumed that ITNs lead to a 50% reduction in malaria 
incidence (Lengeler 2004), it is expected that 794,995 malaria cases could be 
averted each year at a cost of $13 per malaria case averted. 
 
Sensitivity analysis 
Sensitivity analysis was used to see if any of the results were sensitive to changes in 
uncertain parameters including: choice of discount rate; lifetime of vehicles; 
exchange rates; retail price of nets and proportion of nets retreated. On the 
effectiveness side the analysis varied the life time of ITNs, insecticide effectiveness, 
and utilization of ITNs amongst children. The main results from the sensitivity 
analysis are summarized in Table 16. 
 
Table 16: Sensitivity analysis of selected parameters 
 
Variable Baseline 
values New value Output indicators (baseline result) 
   
Cost 
per 
voucher 
used 
($7.57) 
Cost 
per 
treated 
net 
year 
($4.23) 
Cost 
per 
malaria 
case 
averted 
($13) 
Cost 
per 
death 
averted 
($873) 
User top up 
price 
TZS 1019 
($0.83) 
30% price 
reduction $7.40 $4.13 $13 $857 
  
200% price 
increase $8.14 $4.54 $14 $943 
ITN Life 
expectancy 3 years 2 years $8.59 $4.79 $15 $995 
Mean number 
of children per 
net 
0.88 0.5 $7.57 $4.23 $23 $1536 
Insecticide re-
treatment rates 69% 50% $7.57 $4.81 $19. $999 
ITN definition Treated within last 12 months 
Treated within 
last 6 months $7.57 $8.45 $27 $1754 
Long lasting 
nets   $8.09 $2.70 $8.48 $560 
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On the cost side, changing the discount rate, useful life of vehicles, exchange rates 
and staff time administering the scheme had a negligible impact on overall economic 
costs and hence cost per ITN delivered. The average top up price charged was Tsh 
1019 ($0.8). The sensitivity analysis examined the impact of increasing or lowering 
the top up amount by 30% and found that it had only limited impact on the cost per 
ITN delivered. However this assumes that the relationship between voucher 
redemption and price remains constant, which is unlikely. Examining the 
responsiveness (or price elasticity) of demand to changes in price is beyond the 
scope of this paper but will be the subject of future work using data from the 
household and retail surveys. 
Varying parameters on operational and effectiveness variables had a bigger impact 
on results. The base case analysis assumes that 69% of re-treatment kits distributed 
are actually used to retreat nets. If this figure is reduced to 50%, the cost per treated 
net year increases from $4.23 to $4.81, the cost per case averted increases from $13 
to $19 and the cost per death averted increases from $873 to $999. If the useful life 
of an ITN is assumed to be two rather than three years, the cost per ITN delivered 
increases to $8.59, the cost per treated net year is $4.79 and the cost per death 
averted is $995. If the mean number of children protected per voucher net falls from 
0.88 to 0.5 the cost per malaria case averted increases from $13 to $23 and the cost 
per death averted increases from $873 to $1536. 
Table 16 also shows the estimated economic cost per malaria case and death 
averted if all manufacturers switch to long lasting nets with three years life 
expectancy and a cost of $5. Aside from cost per ITN delivered, all cost per output 
ratios are substantially lower than with ordinary nets reflecting the greater 
effectiveness of long lasting nets versus the relatively high cost of procuring re-
treatment kits and lower re-treatment rates associated with ordinary nets. 
4.5 Discussion and Conclusion 
A total provider financial cost of $10.6 million for the delivery of 1.3 million voucher 
nets represents around 5% of the Ministry of Health's total budget. The average 
economic cost of the voucher scheme, including the user top-up, was found to be 
$7.57 per ITN delivered and $873 per death averted. An analysis of a free distribution 
of long lasting nets with a measles immunisation campaign in Togo reported a cost of 
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$5.95 per net distributed, $4.40 per malaria case averted and $856 per death averted 
(Mueller et al., 2008). In Malawi, a study of social marketing programme which 
delivered heavily subsidized nets through health facilities reported a figure of 
approximately $3 per net delivered (Stevens et al., 2005). In line with other 
evaluations the costs presented here represent an economic cost (Goodman et al., 
1999; Hanson & Goodman 2004). Importantly, we have attempted to capture as fully 
as possible all costs associated with running a national scale ITN distribution 
programme, including all training and logistical activities. This analysis differs from 
many others in that it captures the full costs incurred including time and travel costs 
of users to collect the nets as well as the top up prices charged by retailers. While the 
results presented here are somewhat higher than that reported in Togo and Malawi 
they are well within the benchmarks set by other malaria prevention studies. A review 
of all ITN cost effectiveness studies for the Disease Control Priorities Project found 
that the cost per death averted varied from $254 to $3,437 (Breman et al., 2006; 
Mulligan et al., 2005). The only other evaluation of a social marketing and voucher 
project, although on a smaller scale, reported a cost per death averted of $1,603 
(Hanson et al., 2003). 
Given the absence of pre- and post-incidence data on malaria, the calculations of 
effectiveness presented here are based on national averages and are indicative only. 
These estimates rely on the assumption that coverage and utilization remain at the 
same rate over the two years. The estimate of ITNs effectiveness is conservative 
since it only included effects for children under five and did not include any beneficial 
effects on the mother or other family members. As the TNVS is a targeted 
programme it is expected that a high proportion of nets will be used to protect infants 
and varying the usage rate of ITNs among children has a strong impact on its cost-
effectiveness. 
This analysis did not estimate the wider effects of using the retail sector as a 
mechanism for delivering nets. Evidence from the TNVS retail survey indicates that 
nets are now very widely available even in rural areas (Stephen et al., 2006). It is not 
possible to judge at this stage the extent to which this is a result of the voucher 
scheme alone. However, together with the social marketing activities of SMARTNET, 
the existence of a public subsidy for ITNs is thought likely to draw more retailers to 
the ITN market as well encourage existing retailers to remain. This has the potential 
 4. Costs and effects of the Tanzanian national voucher scheme 80 
for wider economic benefits to wholesalers, retailers and ultimately consumers (in the 
form of lower prices) from an expanding market. 
Cost-effectiveness analysis cannot address directly issues of sustainability or equity, 
but both are important to any discussion of how to scale up coverage, especially to 
the most vulnerable groups. A voucher system in the context of wider social 
marketing activities can promote sustainability objectives by providing a long-term 
system for distributing nets. But charging top up prices threatens equity objectives if 
the poorest groups cannot afford to pay. Delivery systems for ITNs have been 
debated for several years, but the evidence base on cost-effectiveness of alternative 
delivery systems is still largely drawn from small scale projects and relatively short 
follow-up periods, and does not yet reflect what would happen in large scale national 
programmes over time. More information is also needed on how to use existing 
market channels to distribute nets, free or otherwise. Continued monitoring and 
evaluation has a role to play in establishing the extent to which these distribution 
channels are sustainable and how they can supplement campaigns. Webster and 
colleagues note that free distribution or delivery of ITNs through integration with other 
campaigns (eg immunization) provides a fast catch-up solution to scaling up 
coverage (Webster et al., 2007). But where no other system is in place to keep-up 
this coverage, ownership is transient. The TNVS is designed to keep-up coverage, 
but to properly compare the effectiveness and cost-effectiveness of these different 
systems, they should be monitored over a period of at least three to five years 
(Webster et al., 2007). 
No-one can predict how the donor environment will change over the next five years, 
and there is no guarantee of long term commitment by donors for free net 
distribution. Even if that commitment is forthcoming, many believe exploring a mix of 
strategies of delivery which take account of the local context provides the best basis 
for scaling up (Muller & Jahn 2003; Stevens et al., 2005). In Tanzania it is recognized 
that neither the public sector nor the commercial sector alone can achieve and 
sustain the level of coverage required to meet the Abuja targets. Despite the success 
of free distribution systems for achieving rapid scale up of coverage, the WHO 
recognizes the importance of commercial channels in some settings (WHO 2007). 
Thus in Tanzania there has been a mixed approach to delivering ITNs: combining 
social marketing techniques with the targeting of vulnerable groups with subsidies 
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(Magesa et al., 2005). The results presented here suggest that the TNVS, a key part 
of that strategy, is a cost-effective method of delivering subsidized ITNs to targeted 
groups. 
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5.1 Abstract 
 
Background 
Insecticide-treated nets (ITNs) are known to be a cost-effective method for preventing 
malaria.  Extensive debate has, however, surrounded the choice of distribution 
methods at the country level.  Unfortunately, little information on the costs and cost-
effectiveness of large scale ITN programmes is available to underpin this debate. 
 
Methods 
This study used a standardized methodology, as part of a larger comparative study, 
to collect cost data and project cost-effectiveness information from a large 
programme providing commercial sector promotion with an emphasis on 
sustainability for ITN delivery in Senegal.   
 
Results 
Base case analysis results indicated that the average annual cost of ITN delivery 
(2005 USD 8.05) was comparable with past ITN delivery studies at different scales.  
Costs to the provider (2005 USD 3.62) were much lower and compared favorably to 
costs examined in other countries, mainly because a large portion of financing for the 
intervention was provided by purchasers of nets.  The intervention’s cost-
effectiveness is in an attractive range for sub-Saharan Africa: cost per DALY averted: 
USD 89-67.  As a significant portion of all nets sold were long-lasting insecticidal nets 
(LLINs), the cost-effectiveness estimates presented here are conservative.  
Sensitivity analysis suggested that the cost per DALY averted could fall near USD 20 
in a full LLIN scenario.  Costs were largely driven by relatively high net purchase 
costs at the retail level and may fall with increasing scale.   
 
Conclusions 
Commercial sector subsidies appear to be a cost-effective method for the distribution 
of significant numbers of ITNs with the potential benefit of added financial 
sustainability, but do not appear to deliver enough ITNs to reach international targets. 
Commercial distribution of ITNs has the potential to serve as an important 
complementary role in larger ITN distribution systems, and could play an important 
role in providing a source of ITNs to those not targeted by subsidized or free 
distribution over the short term, and a source of resupply for all over the long term.  
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5.2 Introduction 
 
Senegal is the western most country in Africa and lies at the upper edge of climactic 
suitability for malaria transmission. Nevertheless, essentially the entire population 
lives in areas regarded as endemic for malaria (www.mara.org.za). Transmission is 
generally seasonal and varies in timing and intensity, depending on the climactic 
region of the country.  The Programme National de Lutte contre le Paludisme (PNLP) 
has developed a national strategic plan with the target of reducing the morbidity and 
mortality burden of malaria to below 50% of 2000 levels by the year 2010 (PNLP 
Senegal 2008).   
 
Insecticide treated (bed) nets (ITNs) are a pillar of the international plan for malaria 
control (RBM 2005)) and are considered an important arm of the National Malaria 
Control strategy (PNLP Senegal 2008).  Several approaches have and are being 
used for ITN delivery in Senegal, including subsidized sale by non-governmental 
organizations (NGOs) and community based organizations (CBOs).  One strategy 
aimed at long term sustainability has been based on the continued development of 
the commercial market for ITNs as part of the USAID-supported NetMark project.   
 
NetMark is a large multi-country project operated by the Academy for Educational 
Development (AED) (NetMark 2008). Its mandate is to increase demand for and 
expand the availability of ITNs with a market-based approach of shared risk and 
investment. NetMark is based on the premise that as demand for ITNs grows within a 
competitive market, consumers will benefit from improvements in the quality of nets, 
lower prices, and wider availability. The project also subscribes to the idea that 
though the commercial sector is more sustainable in the long run, coordination with 
other stakeholders and the use of public subsidies is important and appropriate.  In 
recent years different subsidy mechanisms have been introduced and expanded in 
Senegal to complement the commercial market approach.  
 
NetMark Senegal was launched in 2002, but formal commercial activities began in 
2003.  The programme has several partners in Senegal including, Bayer 
CropScience AG (local distributor: Senphyto), Siamdutch Mosquito Netting Co. Ltd. 
(local distributor: Palunet and now called Tana Netting) and Vestergaard Frandsen 
Group (local distributor: Negitra).  Since the present study was completed, NetMark 
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Senegal has expanded to include BASF and Sumitomo as well.  For demand creation 
activities the programme works with both international manufacturers and local 
distributors. Local as well as international advertisers develop, create and 
disseminate locally relevant promotional materials and activities, including provision 
of matching funds for local distributor advertising and promotion campaigns.  
Additionally, NetMark coordinates activities with the Ministry of Health and the PNLP. 
During the period under review, the Netmark programme included a small-scale 
targeted subsidy programme, which has since expanded to cover five regions.    
 
In much of West Africa a commercial sector for bednets and a culture of use of nets 
for sleeping existed long before international ITN interventions. In the past many or 
most of these nets were locally tailored nets made from a variety of materials (Aikins 
et al., 1993; Aikins et al., 1994, D’Alessandro et al., 1994).  In Senegal some 
imported nets were also sold, but these represented only a part of the total market.  
According to the NetMark baseline survey in the year 2000, a majority of nets in net-
owning households were obtained from informal commercial sources, and 
approximately 19% of all nets in net-owning households were reported to be tailor-
made (NetMark 2001). Only about 14% of all the nets were obtained from non-
commercial sources such as projects or clinics (NetMark 2001). The high cost of nets 
was stated most commonly as the reason for not owning a net and was more 
commonly stated among the lower SES quintiles (NetMark 2001, NetMark 2001b). 
Few commercially available nets were treated with insecticide before the start of the 
NetMark Senegal project, and prices for untreated nets, based on market sampling 
and reports from net distributors, ranged from 8 to 16 USD (D. McGuire personal 
communication; NetMark 2000).  Tax and tariff barriers to net and ITN market 
expansion were high with import duties on nets and individual finished insecticide re-
treatment kits (IRKs) set over 40%, plus an additional 20% Value Added Tax 
(NetMark 2000). Later, NetMark was a major actor in the policy change to lift taxes 
and tariffs on imported ITNs in Senegal.      
 
The 2000 UNICEF MICS round II survey showed very low levels (below 2%) of ITN 
usage among under-five children (Table 17). It also showed that nationwide only 
approximately 15% of under-five children slept under an untreated net (Government 
du Senegal & UNICEF 2000). The 2000 NetMark baseline survey showed similar 
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rates of coverage for any net in under-five children (17.7%) but a very low level of 
use for insecticide-treated nets. Household net possession was approximately 34% 
(NetMark 2001). In addition, the survey showed that the distribution of nets and ITNs 
was at least equitable, with indicators showing higher ownership and usage of both 
nets and ITNs in rural areas and lower socioeconomic groups, though these 
differences were not always significant. However, comparisons between NetMark 
surveys and nationally representative surveys such as UNICEF’s MICS or ORC 
Macro’s DHS surveys must be made with care. NetMark surveys are designed to 
focus on specific areas and target groups and to reveal market information and are 
therefore not necessarily nationally representative. 
 
Table 17: Net ownership and usage in Senegal according to some recent surveys.  
 
 2000 MICS 2000 NetMark 2004 NetMark 2005 DHS 
 
Any net ITN Any 
net ITN 
Any 
net ITN 
Any 
Net ITN 
Children under nets 
last night         All     15.2% 1.6% 17.7% 4.6% 35% 23.9% 13.9% 7.1% 
                         Urban 13.3% 1.5%  3.9%  25.1% 13.7% 7.3% 
                         Rural 16.3% 1.7%  5.0%  23.3% 14.0% 7.0% 
 
Pregnant women under 
nets last night 
                         All   
   5%  31% 14.4% 8.5% 
                         Urban 
      14.8% 9.9% 
                         Rural 
      14.1% 7.8% 
 
Household possession 
                        All   33.6% 8.2% 56.1% 38.7% 38.0% 20.2% 
                        Urban 
  28.8% 7.3% 53.3% 40.3% 31.7% 18.0% 
                        Rural 
  36.8% 8.8% 58.0% 37.3% 43.9% 22.2% 
MICS= UNICEF multiple indicator cluster survey.  DHS=Demographic and health Survey. 
ITN=Insecticide-Treated Net. 
 
Past experience indicates that subsidizing the commercial sector may be one 
possible avenue for delivery of ITNs in Africa (Schellenberg et al., 2001; Magesa et 
al., 2005; Webster et al., 2005).  So far there has been no analysis of the cost of this 
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approach on a large scale in sub-Saharan Africa.  Recently, the various approaches 
to ITN delivery have been the subject of a fierce debate, with some arguing that mass 
distribution of fully-subsidized ITNs provides the only way to rapidly achieve 
international health targets, while others arguing that commercial distribution systems 
offer an important and more reliable distribution mechanism (Lengeler et al., 2007).  
Only recently has information begun to be available for programmes operating on a 
large scale in other countries (Stevens et al., 2005; Mueller et al., 2008; Mulligan et 
al., 2008; Yukich et al., 2008).  At present, there seem to be a strong consensus that 
multiple approaches are required in each country, with some strategies more suited 
to a rapid “catch-up” and other better suited to maintain sustainably high coverage 
(Lengeler & deSavigny 2007).  
 
This work is carried out in the frame of a large multi-center assessment designed to 
produce estimates of cost and cost-effectiveness for the main ITN distribution 
strategies being considered in sub-Saharan Africa (Yukich et al., 2008). The 
information presented here aims to illuminate the debate about the best strategies for 
ITN distribution and further highlight the role commercial sector promotion can play in 
an integrated strategy.    
 
5.3 Methods 
 
Time frame and perspective 
The present study captured costs from the beginning of US fiscal year 2000 through 
the end of US fiscal year 2005, thus covering both the start-up and running costs of 
the programme.  
 
In general, we have used the provider perspective for cost analysis. We have, 
however, included the direct user costs of net purchase, because these are felt to be 
important to the usage and uptake of the intervention. Furthermore, in a programme 
using commercial sector delivery mechanisms, price changes may be important 
indicators of market development and expansion as well as returns to scale in the 
expansion of the delivery systems.  Attempts have been made to follow existing 
guidelines for the cost evaluation of ITN programmes, as well as to use 
methodologies comparable to past studies in order to maximize comparability 
(Creese & Parker 1994; Stevens et al., 2005; Kolaczinski & Hanson 2006).  
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Additionally, this study was one part of a larger comparative study, so types of costs 
included, assumptions used in the base analysis as well as types of sensitivity 
analysis conducted were standardized across each study site (The full report of the 
multi-center study is available electronically (Yukich et al., 2007) and published in 
summary (Yukich et al., 2008)). 
 
Types of costs included 
NetMark programmes generally require few personnel and little capital in-country, 
therefore a significant amount of personnel and other costs are incurred in regional or 
national headquarters. An attempt was made to identify all of the central staff and 
overhead costs attributable to the country programme and include them in the 
analysis. However, since NetMark activities are distributed over no fewer than seven 
countries we expect to have missed some costs, although these likely to have been 
small.   
 
Additionally, as the NetMark programme was focused almost entirely on the 
distribution of ITNs through the commercial sector in 2005, no costs related to the 
use of public resources were captured. At the time these costs were small and refer 
only to the targeted-subsidies scheme using vouchers, which operated in only a 
limited number of locations. Costs included are detailed in Table 18. 
 
Table 18: Costs included in the Senegal analysis.  
 
Capital  Formative research 
Brand creation/initial market research 
Setup meetings/conferences at all levels 
Initial training  
Buildings 
Vehicles 
Equipment and furniture 
ITNs 
Recurrent Insecticide 
Personnel 
Fuel/maintenance of vehicles 
Office/warehouse rental 
Advertising and promotion 
Supplies/overheads 
Management cost 
Basic evaluation and monitoring (excluding specific research cost) 
 
 
Cost collection 
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Costs were collected by a review of the financial records of the NetMark Senegal 
project. Additional cost information was collected through review of other program 
records, including store check and survey data, activity reports, interviews with 
stakeholders, and reviews of commercial partner documentation. Interviews with 
stakeholders and site visits were also conducted to estimate levels of activity which 
were not reflected in the financial records. 
 
 
Cost classification and adjustments 
Costs have been divided into capital and recurrent costs based on the lifetime of the 
goods being purchased. Capital costs have been discounted in the economic 
analysis using lifetimes and discount rates determined through stakeholder 
interviews, expert information, and past literature. Varying discount rates and 
lifetimes were examined in the sensitivity analysis. Both financial and economic 
analyses were conducted, in order to show (1) what the actual expenses of running a 
programme would be, as well as (2) the level of all resources used. In the financial 
analysis, capital costs have not been discounted and are instead incurred in full at 
the time of purchase. 
 
Costs were collected in CFA francs (XOF) or USD.  XOF were converted to USD 
using the official yearly average exchange rate.  All costs have been adjusted for 
inflation to 2005 USD prices using the US GDP deflator index produced by the US 
Bureau for Economic Analysis (US BEA). 
 
Outputs 
Two main output measures were used: (1) number of nets sold and (2) number of re-
treatments sold. Both figures were aggregated from sales data reported by formal 
partners of NetMark. Additionally, sales to institutional purchasers, such as NGOs or 
the Programme National de Lutte contre le Paludisme (PNLP) who in turn sold 
subsidized nets, and retail purchasers were disaggregated.     
 
The two output indicators above were used to calculate a third combined output 
measure: treated net years (TNY), which blends the results of both outputs by 
assuming that either a re-treatment or a new ITN provides 1 year of full protection for 
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any individual using that net. This combined indicator is useful because it allows the 
inclusion of re-treatments of existing nets as part of the outcome measure, while the 
calculation of the cost per ITN delivered does not. Though some nets in each year 
were LLINs (approximately 40% of all partner sales), all nets have been treated as 
conventional nets for the calculation of outputs in the base scenario of this analysis. 
The number of TNYs delivered through an LLIN would be theoretically higher — 
approximately 3-5 years per net — and the inclusion of the extended benefits of 
using these nets would be expected to significantly lower the cost per TNY or the 
cost per health impact. Hence we also calculated the outputs using the assumption 
that all nets delivered were LLINs in the sensitivity analysis 
 
Base scenario 
In this analysis, the base case scenario relied on the following set of assumptions. A 
discount rate of 3% has been applied to both DALYs (see below) and to economic 
capital costs. Shared costs have been attributed to the interventions based on the 
actual value of the indicator chosen to allocate them. Nets have been assumed to 
last for 3 years and, as noted above, treated nets and re-treatments were assumed to 
provide 1 year of protection each. Fifty percent of the nets delivered were assumed to 
be used by under five children and only one child was assumed to sleep under each 
of these nets.  This assumption was made for the purpose of comparison with four 
similar studies in Togo, Eritrea, Malawi and Tanzania (Yukich et al., 2008).   
 
The cost of nets was calculated using two different methods. For net sales which 
were purely commercial, net costs have been calculated based on mean net prices 
drawn from NetMark survey data: XOF 4164 in 2000 and XOF 2756 in 2004 
(NetMark 2001c; NetMark 2005). For sales which were made to institutions such as 
the PNLP, NGOs, or CBOs, net costs were determined based on the sum of the 
average distributor sale price of a net at the time of research plus the margin at the 
facility or NGO level, as determined by stakeholder interviews.  In the base analysis 
all ITN and IRK sales from formal NetMark partners, whether purely retail or 
institutional, were treated as attributable to the programme. This assumption has 
been varied in the sensitivity analysis.  
 
Net and Insecticide Prices 
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Retail ITN prices varied both with net size and brand.  Distributor answers and 
NetMark store check data indicated that retail prices ranged from XOF 2,800 
(USD 5.60) to XOF 6,350 (USD 12.70) in 2005, reflecting both a wide variety of net 
sizes, shapes and types including the LLIN Permanet.  NetMark’s surveys also 
provided respondent-supplied information on the cost of nets. The median reported 
prices were XOF 4000 (USD 5.70) in 2000 and XOF 3000 (USD 6.00) in 2004. 
Average prices from the surveys may be affected by the shift in market shares from 
commercial nets only to an increased percentage of non-commercial nets in 2004. 
Though overall commercial sales of nets increased between 2000 and 2004, the 
market as a whole grew strongly as well, and non-commercial sources including 
clinics or NGOs - that may deliver highly subsidized nets for XOF 1000 (USD 2.00 
approximately) - represented the majority of nets in households by the time of the 
2004 survey (NetMark 2001c; NetMark 2005).  For the present study we based our 
prices in the base scenario on the results of the two NetMark surveys and project the 
costs for intervening years linearly.   
 
Impact estimates & Cost-effectiveness calculations 
We applied the estimates of impact for ITNs based on data from the Cochrane review 
of ITNs (i.e. 5.5 child deaths averted per 1,000 child-years of use) (Lengeler 2004).  
 
Disability-adjusted life years (DALYs) averted, discounted at 3%, were calculated 
based on years of life lost due to malaria-specific child mortality. Our calculations 
excluded: (1) DALYs due to disability, and (2) DALYs lost in persons over five years 
of age because no reliable data were available to quantify these effects.  In highly 
endemic areas the burden of malaria is largely dominated by mortality in children 
under five years (DCPP 2006). In addition, quantitative data on the effects of ITNs 
are very limited for older children and adults (Breman et al., 2006; Lalloo et al., 2006). 
In areas of low malaria transmission or epidemic-prone areas, the burden of disease 
is more evenly spread over the different age groups and our assumptions do not 
hold. All child deaths were treated as infant deaths and assigned a value of 33 
DALYs lost for each death (WHO-DALY 2006). Again, this is a conservative choice 
since estimating based on deaths among children between one and four years of age 
would have yielded a higher number of DALYs averted.  
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In a final analysis, the cost per TNY (for ITNs) were combined with the impact 
estimates to produce cost-effectiveness ratios.   
 
Additional details on the methods are available in an unpublished  report available on 
the Roll Back Malaria Partnership website: (Yukich et al., 2007). 
 
 
5.4 Results and Discussion 
 
By the end of fiscal year 2005, the NetMark Senegal programme had contributed to 
the delivery of approximately 750,000 ITNs and nearly 250,000 IRKs. In attaining this 
output, the programme incurred an estimated economic cost of USD 6 million or a 
total estimated financial cost of USD 7.7 million (including user charges). Table 19 
shows the cost structure of the NetMark project through the end of fiscal year 2005. 
Figure 9 represents the percentages of key cost components. As in previous 
analyses, the cost of commodities represented the major portion of the economic 
costs. Nets and insecticide comprised approximately 64% of the economic costs. The 
next most important share was advertising and promotion which represented almost 
one-quarter of the total economic costs. This result is unsurprising, considering that 
one main focus of the NetMark approach is demand creation. Staff costs are also 
important, representing approximately 7% of the total costs. Vehicles and fuel 
maintenance costs were small here but this may not reflect limited use of these 
resources, but rather the fact that these costs have been captured in the commercial 
sector through the retail prices of the nets themselves. 
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Table 19: Cost composition of the Senegal ITN programme (2005 USD). 
 
 Economic Financial 
Line item Total cost Contribution Total cost Contribution 
     
Recurrent 
    
   Insecticide 462,458 8% 462,458 6% 
   Staff 482,970 8% 503,857 7% 
   Fuel maintenance/travel 183,096 3% 202,977 3% 
   Advertising and promotion 1,439,203 24% 1,544,742 20% 
   Overhead 59,190 1% 63,528 1% 
   Rent and other 376,752 6% 402,729 5% 
Subtotal recurrent 3,003,670 50% 3,180,292 41% 
     
Capital 
    
   Start-up costs 145,023 2% 0 0% 
   Vehicles 6,678 0% 21,035 0% 
   Equipment 8,481 0% 36,669 0% 
   Nets 2,835,042 47% 4,471,147 58% 
Subtotal capital 2,995,225 50% 4,528,852 59% 
     
Grand total 5,998,894 100% 7,709,143 100% 
 
In the financial analysis the majority of funding (61%) came from donor sources, 
while 39%, came from user charges. Though the programme is largely commercial 
sector driven, the reason that users' charges are not equal in magnitude to the total 
net costs is that a significant portion of net sales have gone to institutional subsidized 
outlets, including NGOs and the Government of Senegal. 
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Figure 9: Costs of the program by cost category 
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Table 20 shows the results of the analysis in the base scenario. The overall 
economic cost of the programme was USD 8.05 per ITN delivered. When the cost of 
nets sold through retail and institutional channels was excluded from the analysis, the 
economic cost was USD 3.62 per ITN, which is a proxy for the economic cost of the 
NetMark system. However, it is not a complete reflection of the total cost of delivery 
of an ITN, because some of the distribution costs of the commercial sector partners 
were captured in the retail prices of the nets. Costs per TNY are significantly lower 
than costs per ITN distributed because of the sales of a substantial number of 
insecticide re-treatment kits (IRK), which provide one full year of protection at a 
fraction of the commodity cost of a net. 
 
Table 20: Average financial and economic costs of the Senegal Programme, per ITN 
and per TNY distributed (2005 USD).   
 
 
Including net and 
insecticide costs 
Excluding net and 
insecticide costs 
Per  ITN distributed   
Financial  10.34 3.72 
Economic  8.05 3.62 
 
  
Per treated net-year   
Financial  7.00 2.52 
Economic  6.05 2.45 
 
Table 21 shows the costs of the NetMark Senegal project disaggregated into fiscal-
year units. Some scale efficiency savings are apparently being realized: as ITN 
distribution numbers expanded through to 2005, costs per unit fell. Additionally, net 
costs have reportedly fallen by approximately 25% to 33% in local currency over the 
course of the programme (NetMark 2005).  Changes in price may be due to the 
delayed results of tax and tariff policy change, exchange rate variation, increasing 
competition, reduced commodity costs due to an expanding international market for 
ITNs and economies of scale within Senegal or a combination of these factors. 
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Table 21: Annual costs of ITN and TNY distribution including net in Senegal (2005 
USD).  
 
 2002 2003 2004 2005 Total 
Financial (ITN) 8.55 12.44 11.28 9.22 10.34 
Economic (ITN) 5.08 10.58 10.55 6.93 8.05 
Financial (TNY) 8.40 11.80 9.47 5.80 7.77 
Economic (TNY) 4.99 10.03 8.86 4.36 6.05 
ITNs 109,750 125,359 159,841 350,559 745,509 
Re-treatments 2,000 6,840 30,511 206,983 246,344 
TNYs 129,750 132,199 190,352 557,542 991,843 
Financial and economic costs shown are total annual costs of program with annual numbers of ITNs or 
TNYs delivered as denominator.  
 
 
There is no evidence for economies of scale in the TNY results, since the year with 
the highest annual delivery of TNYs also had the highest annual cost.  Though some 
evidence for economies of scale is present the difficulty of disentangling distribution 
costs from procurement costs in the retail sector prevents us from examining the 
evidence in more detail.  Costs were lower in the final year of data collection, when 
the number of ITNs delivered was also highest, this may be an indication of further 
improvements in cost-effectiveness in the future.   
 
Cost-effectiveness calculations 
Cost-effectiveness calculations begin with the base scenario cost analysis and are 
derived using either cost per ITN or cost per TNY, as noted in Table 21.  While the 
TNY numbers are likely to be more representative of full program impact, previous 
evaluations of ITN programmes have often reported cost per ITN delivered.  Thus 
calculating the effectiveness based only on protection from nets may aid with 
comparisons to other studies.  Table 22 shows the predicted health impacts of the 
intervention in a base scenario analysis. Using the total TNY measure of protection, 
significantly more deaths and DALYs are averted by the intervention due to the 
inclusion of protection through re-treatment delivery. Consequently, when only ITNs 
are included in the calculation, health impacts are lower. The amount of protection 
provided varies over the period studied, due to a large fluctuation in the number of re-
treatments delivered, which occurred despite the fact that actual numbers of ITNs 
delivered in each year increased through 2005.  Our estimates indicated that over the 
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four year period of analysis the programme could have averted more than two 
thousand child deaths. 
 
Table 22: Projected annual health impacts of the NetMark Senegal programme. 
  
Year 2002 2003 2004 2005 Total 
Deaths averted (ITN) 302 345 440 964 2,050 
Deaths averted (TNY) 307 364 523 1,533 2,728 
DALYs averted (ITN) 9,960 11,376 14,506 31,813 67,655 
DALYs averted (TNY) 10,141 11,997 17,274 50,597 90,010 
 
Table 23 illustrates the effect of the above protection on cost-effectiveness ratios. 
Overall, cost per death averted and per DALY averted were generally low in terms of 
WHO criteria for low income countries (Ad Hoc Committee 1996). TNYs yield 
significantly lower costs per death averted and DALY averted due to the large 
number of re-treatments provided by the programme.  
 
Table 23: Estimated cost-effectiveness of the NetMark Senegal programme (2005 
USD). 
 
 Using cost per ITN Using cost per TNY 
Deaths averted 2,050 2,728 
DALYs averted 67,655 90,010 
Cost per death averted 2,926 2,199 
Cost per DALY averted 89 67 
 
 
There are reasons to regard the figures here as only rough estimates. One major 
reason is that the sensitivity analysis, discussed below, shows that net prices in the 
commercial sector had a major influence on the cost-to-output ratio. Unfortunately, 
the evidence base for the costs of ITNs in Senegal was limited. In this study, costs 
were estimated using information from store check records held by NetMark, the 
2004 NetMark mid-term evaluation survey, and interviews with distributors (NetMark 
2005). Store check records are not representative of the entire country and are likely 
to be biased towards urban areas, where prices may be lower. Interviews with 
distributors revealed only the suggested retail prices for nets but yielded no 
confirmed information as to what prices are actually charged in retail settings. 
Household survey results can also be distorted both by recall problems and 
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confounding due to project subsidized nets.  The observed prices in the commercial 
sector were high compared to other African settings. These have already gone down 
since 2005 (D. McGuire, personal communication).  Additionally, Senegal has a high 
GNI (Gross National Income) per capita compared to many sub-Saharan countries, 
and though it still qualifies as a low-income country by World Bank standards, the 
price level is expected to be higher than in other African settings.     
 
 
Sensitivity analysis 
The sensitivity analysis (Table 24 and Table 25) indicated high variability in the 
results. The variability appeared to be most heavily dependant on the costs of the 
nets used in the analysis as well as the attribution of sales to NetMark activities. 
Interestingly, a significantly lower price of nets due to competition could be a prime 
indicator of the success of the project, as well as potentially providing a positive 
feedback loop leading to increased sales.  Evidence cited earlier indicated that retail 
prices have indeed fallen over the duration of the programme and after 2005. 
Additionally, attribution of sales dramatically affected the programme, as it effectively 
reduced the scale of the programme without a proportional reduction in provider 
costs.  Results are similar in the TNY analysis, with the additional finding that the 
length of protection offered by an ITN or a re-treatment has a strong impact on the 
cost-output ratio increasing the cost per TNY to USD 24.19 if only 3 months of 
protection is assumed per ITN or re-treatment kit.   
 
Table 24: Sensitivity analysis: cost per ITN and TNY distributed in Senegal (2005 
USD). 
 
Parameter Values Assumed Range (ITN) Range (TNY) 
Discount rate 1–10% 7.89–8.61 5.93–6.47 
Cost of nets 2.00–12.00 5.58–12.26 4.19–9.21 
Lifetime of nets 1 year–5 years 10.42–6.77 7.83–5.09 
Cost of IRK 0.20–2.00 7.49–8.09 5.63–6.08 
Net sales attributed  30–50–100% 17.95–12.29–8.05 8.54–7.40-6.05 
LLIN use  Base – 3 years, USD 5 –  5 years, USD 7 8.05–7.58–7.36  6.05–2.64–1.67 
Length of protection provided 
by ITN or re-treatment 
3 months–6 months–        
1 year N/A 
24.19–12.10–
6.05 
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The results of sensitivity analysis of the cost per death and per DALY averted are 
shown in Table 25. The same factors which are important to calculation of cost to 
output ratios also influenced the cost per death and DALY averted.  Further, the 
assumptions regarding (1) the length of protection provided by an ITNs and re-
treatments, or (2) assumptions about the usage of nets by children had a dramatic 
impact on the results. As it is difficult to make the link between a net delivered or sold 
and a net being used by a child, we have made assumptions which appear to be 
plausible. Usage rates have also been varied in the sensitivity analysis to include 
expected wastage rates.   
 
Table 25: Sensitivity analysis: cost per death and disability adjusted life year (DALY) 
averted in Senegal (2005 USD).    
 
Parameter Values Assumed 
Range 
(Death) (ITN)  
Range 
(Death) 
(TNY) 
Range 
(DALY) 
(ITN) 
Range 
(DALY) 
(TNY) 
Discount rate 1–10% 2,869–3,132 2,156 – 2,354 87–95 65–71 
Cost of nets 2.00–12.00 2,029–4,457 1,525–3,350 61–135 46–102 
Lifetime of nets 1 year – 5 years 3,790–2,461 2,848–1,850 115–75 86–56 
Cost of IRK 0.20–2.00 2,725–2.942 2,048–2,221 83–89 62–67 
Net sales 
attributed  30–50–100% 
6,527–4,469-
2,926 
3,106–2,691-
2,119 198–135-89 94–82-67 
Length of 
protection 
provided  
3 months–6 
months–1 year 
11,704–
5,852–2,926 
8,797–4,399–
2,199 355–177–89 267–133–67 
Usage of nets 25–50–100% 5,852–2,926–1,463 
4,399–2,199–
1,100 177–89–44 133–67–33 
Children under 
net 1–2 2,926–1,463 2,199–1,100 89–44 67–33 
LLIN use (TNY)  
Base – 3 years, 
USD 5 – 5 
years, USD 7 
2,199–960–606 67–29–18 
 
One other important consideration is that NetMark was the most prominent provider 
of generic ITN promotion in Senegal, and thus may have had beneficial effects on the 
uptake of other ITN interventions.  Such added benefits are impossible to quantify in 
this analysis, as estimation of the magnitude of this effect which might be attributable 
to the NetMark program is not possible with the available data. 
    
Removal of taxes and tariffs 
The NetMark project was a major driver for the policy decision to remove taxes and 
tariffs on nets and insecticide in Senegal.  While it was not possible to determine 
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specific outcomes of the policy change and thus to include them in the in the cost-
effectiveness calculations, it is clear that the removal of these tariffs likely had 
favorable effects on the prices of nets and insecticide.  Following the methodology of 
Simon et al. (Simon et al., 2002) we have attempted to estimate the potential effects 
of tax and tariff removal in Senegal on ITN and re-treatment sales.   
 
Equation 1: Effects of removal of taxes and tariffs on ITN retail prices  
 
)1]()1([)( tTwr rMrpTP +++=  
 
Where Pr(T) is the final retail price offered to consumers, and pw is the c.i.f. price, rT is 
the duty rate, M is the retail margin which is equal to (pw )*30%, and rt is the V.A.T. 
rate. 
 
Using Equation 1 we can show what prices would have been assuming that current 
prices arose in a situation where the Pr(T) is equal to those prices at the beginning of  
the study and both tax and tariff rates are zero.  We can then back-calculate the c.i.f 
(cost, insurance and freight) price and re-calculate what the retail prices would have 
been with taxes and tariffs present.  Assuming (1) the average prices of nets and 
insecticide used in this study, (2) that all nets were retail sales, and (3) a retail margin 
of 30% over c.i.f. prices, taxes and tariffs as they existed in the year 2000 (duty 47% 
on finished insecticide re-treatment kits and 42% on nets, plus VAT of 20% 
applicable to both) might have increased the cost of ITNs to USD 10.34 from USD 
6.07 and for finished re-treatments from USD 1.88 to USD 3.32.   
 
Price changes and demand (sales) of nets are related by the price elasticity of 
demand which is commonly defined according to the following equation (2). 
 
Equation 2: Point price elasticity of demand 
 
P
P
Q
Q
Ed ∆
∆
=  
 
Where Ed is equal to the point price elasticity of demand, Q is equal to the quantity 
demanded at the starting price and P is equal to the starting price. 
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If purchase quantities had remained the same regardless of price (perfect price 
inelasticity of demand (Ed = 0)) the financial costs of the programme might have 
increased by approximately 3.5 million USD.  However, the price elasticity of demand 
for ITNs and re-treatments is certainly non-zero, meaning that changes in price will 
result in some change in demand (or purchases) for ITNs and re-treatments.  Few 
studies have estimated the price elasticity of ITNs and these have found divergent 
values (Onwujekwe et al., 2004; Cropper et al., 2000).  One study which modeled the 
effects of tax and tariff removal from ITNs and re-treatments used values ranging 
from -0.5 to -1.5 (Simon et al., 2002).  Using these same values and methodology 
here, the calculated changes in ITN price (41%) and re-treatment price (43%) could 
have increased the demand for ITNs or re-treatments by 21% to 62%, meaning 
approximately 160,000 to 460,000 excess ITN sales and 50,000 to 150,000 excess 
re-treatment sales.  Thus under a highly elastic scenario the price effects of this 
policy change might have been responsible for more than half of all partner net sales.  
While this scenario is only illustrative, it is indicative of the importance and difficulty of 
considering impacts of programs that fall outside the rubric of traditional cost-
effectiveness analysis.        
   
 
LLIN Scenarios 
When all nets delivered in the programme are assumed to be LLIN with a three year 
lifetime and a nominal cost of USD 5.00, the cost-effectiveness of the programme 
improves, with cost per DALY falling from USD 89 to 67 in the base analysis to USD 
46 to 29 (the second number in each pair includes the benefits of re-treatments 
delivered).  Further improvement in cost-effectiveness is seen if the nets are 
assumed to last five years and cost USD 7.00.  The implications of these findings are 
that in the context of Senegal it appears that delivering LLIN at prices available on 
the world market could improve the cost-effectiveness of the programme, and in this 
scenario the cost-effectiveness of the programme might fall to levels deemed highly 
attractive for low income countries (Ad Hoc Committee 1996).  
 
5.5 Conclusions  
 
Based on the results of this study, it appears possible to deliver nets through an 
integrated commercial approach at acceptable cost levels. In relation to other models 
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for ITN delivery examined in the framework of the larger comparative study 
mentioned previously, total costs here were high. However, unlike most other 
programmes a large proportion of costs in the NetMark approach were borne by the 
users of the nets.  When only the provider costs of each intervention were compared, 
NetMark‘s costs compared favorably with other programs (Yukich et al., 2008).   
 
In addition, the main driver of high costs in the NetMark program was the high retail 
costs of the nets.  Fortunately, these prices are subject to change and did show a 
downward trend over the period of the study. However, the changes in net or ITN 
usage nationwide have been slow and it is now clear that a commercial approach 
alone can not lead to the required 80% usage levels set by international targets.  In 
several other settings, including Tanzania, Kenya, and Malawi commercial ITNs or 
socially marketed ITNs have contributed significantly to the overall net crop in the 
country, without playing a leading role (Noor et al., 2007; Khatib et al., 2008).   
 
One additional advantage of the commercial approach that is not often discussed in 
the literature and cannot be valued accurately is that the stimulation of the 
commercial sector increased the stockpiles of ITNs available within the country and 
regionally.  In events such as malaria epidemics ITNs could be purchased directly 
from distributors and moved into areas much more rapidly than would have been 
possible if an international tender had been required.  Also, commercial nets provide 
a source of nets independent of any government sourcing, giving effectively another 
option for people living in endemic areas to protect themselves if they wish to do so 
(Lengeler et al., 2007).  
 
Interestingly, while commercial sector approaches are commonly expected to 
produce inequitable results, all surveys in Senegal seem to indicate that net 
possession and usage is very similar across urban and rural settings and the most 
recent data indicate that households with lower socioeconomic status had higher 
ownership of recently treated nets (Schellenberg 2001; NetMark 2001c; NetMark 
2005; CRDH & Measure DHS+ 2005).  This high level of equity when compared to 
even some non-commercial approaches may, however, be due more to cultural 
patterns of net usage and possession than to factors inherent in the net delivery 
system.  It is also possible that other campaigns and NGO activities which have 
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occurred in Senegal contributed to the relatively equitable ownership and usage 
levels. 
   
Finally, commercial sector distribution carries additional benefits in the sense that 
profitable commercial sector activities are more likely to continue in the absence of 
donor funding and are thus more financially sustainable than other types of directly 
subsidized delivery.  The level of funding provided here by the net users seems to 
indicate this as well, though donor input was still high.  Unfortunately, the large 
volumes of ITNs needed to drive coverage levels to meet international targets were 
not reached in Senegal during the time frame of this study.  It is also likely that the 
relatively small volumes of ITNs meant that retail prices were unlikely to fall as 
dramatically as was hoped. It is now clear from the Senegal, Kenyan and Tanzanian 
experiences that a purely commercial sector approach to net delivery seems will not 
lead to the fulfillment of international targets, but that such strategies can represent a 
valuable complement when combined appropriately with other approaches. In the 
case of Senegal, this approach provides an important policy option for the 
maintenance of net gains and it should be further supported. 
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6.1 Abstract                                    
 
Background 
Five large insecticide-treated net (ITN) programmes and two indoor residual spraying 
(IRS) programmes were compared using a standardized costing methodology.  
 
Methods 
Costs were measured locally or derived from existing studies and focused on the 
provider perspective, but included the direct costs of net purchases by users, and are 
reported in 2005 USD. Effectiveness was estimated by combining programme 
outputs with standard impact indicators.   
 
Findings 
Conventional ITNs: The cost per treated net-year of protection ranged from USD 
1.21 in Eritrea to USD 6.05 in Senegal. The cost per child death averted ranged from 
USD 438 to USD 2,199 when targeting to children was successful.    
Long-lasting insecticidal nets (LLIN) of five years duration:  The cost per treated-
net year of protection ranged from USD 1.38 in Eritrea to USD 1.90 in Togo.  The 
cost per child death averted ranged from USD 502 to USD 692. 
IRS:  The costs per person-year of protection for all ages were USD 3.27 in KwaZulu 
Natal and USD 3.90 in Mozambique.  If only children under five years of age were 
included in the denominator the cost per person-year of protection was higher: USD 
23.96 and USD 21.63.  As a result, the cost per child death averted was higher than 
for ITNs: USD 3,933-4,357.  
 
Conclusions 
Both ITNs and IRS are highly cost-effective vector control strategies. Integrated ITN 
free distribution campaigns appeared to be the most efficient way to rapidly increase 
ITN coverage. Other approaches were as or more cost-effective, and appeared better 
suited to “keep-up” coverage levels.  ITNs are more cost-effective than IRS for highly 
endemic settings, especially if high ITN coverage can be achieved with some 
demographic targeting.  
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6.2 Background 
 
Prevention of malaria in highly endemic countries relies largely on vector control 
through one of two main methods: insecticide treated (mosquito) nets (ITNs) and 
indoor residual (house) spraying (IRS). Both methods are known to be highly 
effective and current evidence suggests they are very similar in their impact 
(Lengeler & Sharp 2003). Given the increasing availability of resources for malaria 
control, the Roll Back Malaria Partnership (RBM) has set the ambitious target for 
2010 of 80% protection of high-risk groups by a "locally appropriate" vector control 
measure (RBM 2005).  While few countries were near this objective in 2007, 
substantial progress has been made. Inevitably, this has been accompanied by 
vigorous debate as to the best way forward with regard to the different 
implementation models for ITNs, as well as the relative merits of ITNs versus IRS 
(Curtis & Mnzava 2001; Lengeler 2001; Curtis et al., 2003; Lines et al., 2003; 
Teklehaimanot et al., 2007; Lengeler & deSavigny 2007). While the implementation 
of IRS is typically through vertical programmes, available options for ITN 
implementation are more diverse.  
 
Besides feasibility, sustainability and health impact, cost is obviously an important 
factor in the choice between different strategic options. Unfortunately, little is known 
on comparative costs and operational requirements for the delivery of ITNs and IRS.   
Direct comparisons in single settings in sub-Saharan Africa (SSA) have shown 
conflicting results on cost per person protected using either control method (Curtis et 
al., 1998; Goodman et al., 2001; Guyatt et al., 2002). A comprehensive modelling 
study has been conducted covering ITNs and IRS (Goodman et al., 1999) and the 
authors found overlapping cost-effectiveness ranges for the two interventions. For 
ITNs, four studies have examined large-scale programmes using field data in The 
Gambia, Malawi, Tanzania and Togo (Aikins et al., 1998; Stevens et al., 2005; 
Mulligan et al., 2008; Mueller et al., 2008).  However, each of these studies focused 
on only one strategy and methodological differences make direct comparisons 
difficult (Kolaczinski & Hanson 2006). With the scale up of ITN activities in several 
SSA countries it has become possible to collect and analyse such information for a 
range of settings. This was undertaken for ITNs in five sub-Saharan countries, and 
for IRS in two countries.  The present work allows, for the first time, a direct cost-
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effectiveness comparison between different ITN strategies and IRS implementation 
on a large scale. Hence, this work provides a solid evidence base for a discussion of 
malaria vector control strategies in the most highly malarious areas of the world.  
 
6.3 Methods 
 
Programme selection  
The ITN programmes were deliberately chosen to represent the major existing 
distribution strategies operating at large or fully national scale in sub-Saharan Africa.  
At the beginning of this research, few large-scale ITN programmes utilizing similar 
distribution systems existed, thus the choice of a representative country for each 
strategy was limited. The main exception was subsidized commercial distribution, 
which was implemented in several countries. Senegal was chosen for this category 
mainly to increase representation of West African countries.  The strategies were 
defined using terminology derived from Webster et al.(Webster et al., 2007): (1) free 
ITN delivery through public sector health services and at the community level – 
Eritrea (Macintrye et al., 2006; Nyarango et al., 2006); (2) free public sector ITN 
delivery through integrated vaccination campaigns – Togo (US CDC 2005); (3) highly 
subsidized mixed public-private sector ITN delivery through routine services – Malawi 
(Chavasse et al., 2001); (4) partially subsidized private retail sector promotion – 
Senegal (AED 2005); (5) partially subsidized private retail sector promotion with a 
partially subsidized, mixed public-private, routine services voucher scheme – 
Tanzania (Magesa et al., 2005). Table 26 presents programme details with regard to 
size, time frame, total economic costs and the latest available coverage figures.  
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Table 26: Main characteristics of the ITN and IRS programmes that were reviewed.  
 
 
Population 
covered 
(millions) 
Period Total 
num. 
of nets 
(mill) 
Total 
num. 
of re-
treat. 
(mill) 
Total 
economic 
cost 
(Mio USD) 
Net coverage in 
children under five 
years 
 
  Any net              ITN 
ITN Programmes 
Eritrea 2.9 2001-
05 
0.9 2 3.7 Nav 59 
Togo 5.3 2004 0.9 0 6.5 Nav 54 
Malawi 12.2 1999-
05 
4.7 0.5 15.7 38 36 
Senegal 10.0 2000-
05 
0.75 0.25 6.2 14 7 
Tanzania 35.7 2002-
05 
6.4 7.8 30.5 41 28 
IRS Programmes 
KwaZulu-
Natal 
0.6 1997-
99 
0.3 structures 2.2 High High 
Mozambi
que 
0.8 1999-
01 
0.15 structures 1.0 >95% 
structures 
>95% 
structures 
Figure legend: Nav=not available. ITN=insecticide-treated net. 
 
The ITN programmes also adopted different strategies for the provision of re-
treatments for existing nets: Eritrea - free re-treatment through community level 
campaigns, Malawi - commercial sector cost recovery sales in urban areas, Senegal 
- partially subsidized private retail sector promotion, and Tanzania - cost recovery 
private retail sector sale and free delivery to pregnant women at antenatal care visits.  
Unfortunately, empirical cost evidence was only available for a single country where 
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long-lasting insecticidal nets (LLINs) were introduced, doing away with the need for 
re-treatment (Togo). 
  
The two IRS programmes were chosen because they were large African programmes 
and cost data were available for both. They represented: (1) a programme funded 
locally (KwaZulu-Natal, South Africa) and (2) an international intervention funded by 
donors and a public-private partnership (Lubombo Spatial Development Initiative - 
LSDI, Southern Mozambique).  
 
The full programme descriptions are available elsewhere (Yukich et al., 2007). 
 
Costs 
The data on costs were either collected retrospectively for the purpose of the study 
from financial and operational records (Eritrea, Tanzania, Senegal, Malawi), or taken 
from raw data sets or published studies which could be adapted to this framework 
(KwaZulu-Natal, Mozambique, Malawi, Togo).  The collection of cost data covered 
different periods between 1996-2005 (Table 26). 
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Where possible, the ingredients approach was used: inputs were identified, valued, 
and classified into activity categories. Where this approach was not possible, either 
because the information was deemed too sensitive (typically for salaries) or was not 
available in adequate detail, aggregated expenditures were used. All costs were 
converted to United States Dollars (USD) based on official yearly average exchange 
rates for the period during which the costs were incurred (excepting Togo where the 
exchange rate for the month when most expenditure occurred was used). All costs 
were adjusted for inflation to 2005 prices using the US gross domestic product 
deflator (US BEA). Some costs were estimated using the WHO Choosing 
Interventions which are Cost-Effective (WHO-CHOICE) unit cost and activity 
database, specifically those for public sector inputs in Tanzania (WHO-CHOICE).  No 
adjustments for purchasing power have been made, and in some cases this may 
result in problems of comparability across countries due to differences in country 
specific price levels. 
 
Where possible, both financial and economic costs were collected in order to both 
estimate the financing requirements for programmes and to examine their efficiency.  
Financial costs represent purely monetary flows, while economic costs represent the 
value (or opportunity cost) of all resources necessary to implement a given 
intervention. Only economic costs are presented here as they are considered the 
appropriate tool for comparisons of programme efficiency.  Financial costs are 
available elsewhere (Yukich et al., 2007). 
 
A modified provider perspective was used; travel or time costs to users, or other 
household-level costs or cost savings have not been included. However, the direct 
costs of net purchases incurred by users have been included where the nets were 
partially subsidized or sold at full cost.  Double counting was avoided by excluding 
the provider costs which were offset by these user fees.  Details on included costs 
are presented in Table 27.  
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Table 27: Types of costs included in the analysis of the ITN and IRS programmes.  
 
 ITN Programmes IRS Programmes 
Capital  cost Buildings 
Vehicles 
ITNs (retail cost & subsidies) 1 
Other equipment 
Start-up costs2 
Buildings 
Vehicles 
Sprayers 
Other equipment 
Recurrent cost Insecticide (when separable from 
nets) 
Personnel 
Fuel/maintenance 
Management cost/training & 
meetings 
Office/warehouse rental 
Supplies/overheads 
Recurrent building costs 
Advertising and promotion3 
Basic evaluation and monitoring 
(excluding specific research costs) 
Insecticide 
Personnel 
Fuel/maintenance 
Management cost/training & 
meetings 
Office/warehouse rental 
Supplies/overheads 
Recurrent building costs 
Basic evaluation and 
monitoring (excluding specific 
research costs) 
Figure legend: 1Procurement costs in Eritrea and Togo, subsidies plus user payments in Senegal, 
Tanzania, and Malawi.  
2Economic costs which arose before outputs of those programmes occurred; these costs apply in 
Tanzania, Senegal and Malawi; they accounted for fewer than 3% of total economic costs in all cases. 
3Information, education and communication, health promotion, direct or indirect advertising and 
promotion subsidies or other similar activities. 
 
Costing scenarios 
The base case costing scenarios relied on the following set of assumptions:  a 
discount rate of 3% was applied to capital costs; nets were assumed to last for 
three years (physical lifetime), but the effect of initial treatment as well as of 
subsequent re-treatments were assumed to provide only one year of protection 
(protective lifetime) (WHO 2007); fifty percent of the nets delivered were assumed to 
be used by children under five years of age and only one child was assumed to sleep 
under each of these nets on a given night. These are believed to be conservative 
assumptions (Macintyre et al., 2006; Baume & Marin 2007). The cost of nets was 
based on the cost, insurance and freight (c.i.f.) price of the nets or on the full retail 
price paid by users plus any subsidies (direct or via vouchers) as estimated by survey 
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data (Senegal and Tanzania) or key informant interviews and project records 
(Senegal and Malawi). For IRS, it was assumed that the given number of annual 
spraying rounds (one or two) protected an entire household for one year, with perfect 
post-spraying compliance (no re-plastering of walls). Reported coverage by IRS was 
always very high, over 95% at the time of data collection in Mozambique, though high 
levels of re-plastering have been reported in some IRS interventions (Table 1) 
(Conteh et al., 2004; Mnzava et al., 1998).   
 
Several alternative scenarios were also calculated.  One involved the delivery of 
conventional ITNs in Togo, where only long-lasting insecticidal nets (LLINs) were 
actually distributed.  The other programmes distributed a majority of conventional 
nets and therefore the costs and outputs in Togo were recalculated assuming a net 
cost of only USD 3.00 instead of the USD 4.33 paid per LLIN (Mueller et al., 2008; 
RBM 2004). Other alternative scenarios estimated the potential impact of LLIN use 
on the cost-effectiveness of the programmes. These scenarios were estimated in two 
ways.  The first approach was simply to change the net parameters, including 
physical lifetime (three or five years), protective lifetime (three or five years) and cost 
(USD 5.00 to USD 7.00) to values believed to be representative of available LLINs, 
while not changing the properties, costs or benefits associated with re-treatments 
(Mnzava et al., 1998; RBM 2004; Tami et al., 2004; N’Guessan et al., 2001).  The 
second approach used the same changes for the nets but removed the benefits and 
commodity costs associated with re-treatments.  While it might be reasonable to 
expect that re-treatments will not be delivered in a LLIN programme, this dual 
approach was required due to difficulty in separating management and other costs 
associated with re-treatment. Thus, comparing the two approaches helped us to 
identify biases in the comparison between programmes due to different re-treatment 
approaches as well as to better quantify the potential benefits from a shift to LLINs, 
which would probably result in the discontinuation of most re-treatment activities.  
One way sensitivity analysis was conducted on all cost estimates.   
 
Outputs 
Two main output measures were used for ITN programmes: (1) number of nets 
delivered, and (2) number of re-treatments performed. These measures were used to 
calculate a third combined output measure: treated net years of protection (TNY), 
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assuming that either a re-treatment or a new conventional ITN provided one potential 
year of protection for anyone sleeping under the net.  For IRS programmes two 
related outputs have been measured: (1) number of persons of any age protected, 
and (2) number of under-five children protected. Both calculations were made by 
applying the reported coverage rates to the total population of the sprayed areas - 
based on census information adjusted for population growth (WHO 2006; POP-Div 
UN 2004).  
 
Outcomes  
In order to combine cost data with public health impact, two outcomes were 
considered.  First, the impact of ITNs and IRS on child mortality was estimated. 
Country-specific estimates were not available but robust impact estimates are 
available for ITNs from a Cochrane review (Lengeler 2004): ITN use in a high 
endemicity and high coverage situation averts 5.5 child deaths per 1,000 child-years. 
For IRS, however, unbiased impact estimates are scarce and have not been 
systematically reviewed. This is a recognized problem and a Cochrane review is 
currently investigating this issue (Pluess et al., in press).  In the absence of a better 
data set for IRS, and because the impact of ITNs and IRS was found to be similar in 
the five available randomized comparisons (Lengeler & Sharp 2003; Curtis & Mnzava 
2000), the same estimate of impact for both ITNs and IRS (i.e. 5.5 child deaths 
averted per 1,000 child-years of use) was applied.  
 
Secondly, disability-adjusted life years (DALYs) averted, discounted at 3%, were 
calculated based on years of life lost due to malaria-specific child mortality. These 
calculations exclude: (1) DALYs due to disability, and (2) DALYs lost in persons over 
five years of age.  In highly endemic areas the burden of malaria is largely dominated 
by mortality in children under five years (Breman et al., 2006). In addition, 
quantitative data on the effects of the two interventions are very limited for older 
children and adults (Breman et al., 2006; Lalloo et al., 2006). In areas of low malaria 
transmission or epidemic-prone areas, the burden of disease is more evenly spread 
over the different age groups and these assumptions do not hold. All child deaths 
were treated as infant deaths and assigned a value of 33 DALYs lost for each death 
(WHO-DALY). This is also a conservative choice as estimates based on deaths 
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distributed across children from one and four years of age would have yielded a 
higher number of DALYs averted.  
 
Cost-effectiveness calculations 
In a final analysis, the cost per TNY (for ITNs) and per child protected (for IRS) were 
combined with the impact estimates to produce comparable cost-effectiveness ratios 
for both interventions.  For calculation of impact estimates for ITNs, the number of 
treated net years (TNYs) delivered was adjusted for net wastage and usage among 
children by assuming that only 50% of delivered nets (or re-treatments) would be 
used by under five children and that only one child would sleep under each of these 
nets.  These assumptions are examined in the sensitivity analysis.  
 
The full set of country-specific operational and costing results is available in an 
unpublished report (Yukich et al., 2007); selected results only are presented here.  
 
 
6.4 Results  
 
Tanzania and Malawi were the largest programmes and also the most expensive 
ones, with a total economic cost of 30.5 and 15.7 million dollars for the periods under 
review (Table 26).  All the ITN programmes were larger in terms of population 
protected than the two IRS programmes.  When the scale of the largest annual ITN 
delivery is compared to the size of the population at risk for the particular country 
(MARA/ARMA), Togo and Malawi had the highest ITN to population ratios (1:6) and 
(1:8), respectively, while Senegal had the lowest (1:30).  According to the most 
recent data available for each country, Eritrea had the highest reported ITN usage 
rate among children under five years of age, while Senegal had the lowest.  Both IRS 
programmes reported very high coverage rates in the targeted areas. 
 
Economic costs for conventional ITNs  
Annualized economic costs per conventional ITN distributed varied from USD 3.23 in 
Togo (or USD 2.75 if the net price is set to USD 3.00 instead of USD 4.33 - see 
methods) to USD 8.05 in Senegal (Table 28). Costs per treated net year (TNY) were 
lower in some cases due to the inclusion of re-treatment of existing nets, which 
offered additional years of full protection with low commodity costs (approximately 
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USD 0.30. Both measures (cost per ITN and per TNY) include the cost of re-
treatments. Hence, the costs per TNY delivered by conventional ITN programmes 
ranged from USD 1.21 in Eritrea to USD 6.05 in Senegal.  It is important to note that 
higher costs in Senegal were driven to a large extent by higher net costs in the retail 
sector.   
 
Table 28: Average annual economic costs for ITN and IRS programmes.  
 
ITN 
programmes 
Average annual 
cost per ITN 
distributed 
 Average 
annual cost 
per TNY 
Cost per death 
averted** 
Cost per DALY 
averted**  
Eritrea 3.98 1.21 438 / 1,449 13 / 44  
Togo 3.23 3.23 1,174 36 
Togo* 2.75 2.75 998 30 
Malawi 3.36 3.04 1,105 /1,222  33 / 37 
Senegal 8.05 6.05 2,199 / 2,926  67 / 89 
Tanzania 4.80 2.17 788 / 1,745  24 / 53 
 
IRS 
programmes 
Cost per person 
protected (whole 
population) 
Cost per 
under-five 
child protected 
Cost per death 
averted 
Cost per DALY 
averted 
KwaZulu-Natal 3.27 23.96 4,357 132 
Mozambique 3.90 21.63 3,933 119 
*Assuming an average net cost of USD 3 instead of USD 4.33 (the actual cost incurred for LLINs by 
the campaign). 
**In paired numbers the left value includes protection from re-treatment kits 
 
There were important differences in the composition of costs for each programme. 
The percentage of the total cost born by the programme providers ranged widely:  
Togo 100%, Eritrea 83%, Malawi 69%, Tanzania and Senegal 45%. When a pure 
provider perspective is taken by removing all costs paid directly by users of nets, the 
annualized costs to the provider per net distributed were fairly similar between sites 
(range USD 2.75-3.63; for detailed results see (Yukich et al., 2007)).   
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Additional calculations for the year during which the programme delivered the largest 
number of nets were not substantially different from the cost data presented in Table 
28 (Yukich et al., 2007).  However, the programmes varied greatly in scale (200,000 
to approximately three million ITNs per year) and this is likely to contribute to the 
observed differences in unit costs. 
 
Economic costs for IRS 
In both IRS programmes cost data were only available for one or two years of 
operations, after the start of the programmes. As a result, it was not possible to 
measure start-up costs.  The annualized costs per person protected for IRS were 
USD 3.27 in KwaZulu Natal and USD 3.90 in Mozambique (Table 28). However, 
when only children under five years were included in the denominator for IRS (see 
methods section) the cost per under five child protected by IRS was substantially 
higher: USD 23.96 per child protected in KwaZulu Natal and USD 21.63 in 
Mozambique.  
    
Sensitivity analysis: one way results 
Sensitivity analysis was carried out on the main assumptions and parameters used to 
calculate cost to output and cost-effectiveness ratios.  Discount rate, physical lifetime 
of nets and costs of insecticide or re-treatment kits all had relatively small effects on 
the results, however, other parameters were more important, and fit into two groups: 
(1) those relating to net properties (cost or protective lifetime) and (2) those related to 
net usage.  For programmes involving retail net sales the attribution of commercial 
sales to programme activities also played an important role. All results were in the 
expected direction (Yukich et al., 2007).  
 
For the IRS programmes the discount rate also had relatively little effect on the 
results of the analysis, as did a change in the population growth rate.  Several 
parameters had larger effects on the results, especially the compliance of the 
population with spraying. Additionally, the cost of adding or removing one of the 
annual spray rounds or of switching types of insecticides had large effects on the 
cost-effectiveness of the programmes.  Longer transmission seasons or shorter-lived 
insecticides would require additional spray rounds.  The same applies if, for political 
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or resistance reasons, a shorter-acting insecticide were used; more spray rounds 
imply a higher cost (and potentially higher refusal rates).  
 
Sensitivity analysis: LLIN cost scenarios 
 
Table 29 shows the annualized economic cost per unit delivered for long-lasting 
insecticidal nets (LLINs) with three years duration and a cost of USD 5.00. In most 
settings, annualized costs per net distributed were higher than for conventional nets 
because of the higher initial purchase price. Senegal was the exception because the 
commodity costs observed in the programme were much higher than in other 
programmes.  In Togo, the costs changed little because the programme only 
delivered such LLINs. The annualized delivery costs ranged from USD 3.47 in Togo 
to USD 7.75 in Eritrea. The cost per TNY was lower than for conventional nets in 
most cases, ranging from USD 1.46 in Eritrea to USD 2.64 in Senegal (when re-
treatments were dropped: USD 2.04 in Malawi to USD 4.14 in Senegal).   
 
Table 29: Average annual economic costs for ITN (3-year LLIN) programmes. 
   
ITN 
programme 
Average 
annual cost 
per LLIN 
distributed* 
Average 
annual cost 
per TNY* 
Cost per 
death 
averted*  
Cost per 
DALY 
averted*  
Eritrea 7.75 / 7.28 1.46 / 2.43 531 / 882 16 / 27 
Togo 3.47 2.37 862 26 
Malawi 5.18 / 4.50 2.19 / 2.04 798 / 743 24 / 23 
Senegal 7.58 2.64 / 4.14 960 / 1,503 29 / 46 
Tanzania 6.04 / 5.36 1.83 / 2.39 664 / 870 20 / 26 
* In paired numbers the left value includes protection from re-treatment kits while the right value 
results from removing both protection and commodity costs related to re-treatment kits (see main text 
for details). 
Assumes all nets are conventional ITNs. 2005 USD.  TNY = treated net-year. DALY = disability-
adjusted life year. 
 
The annualized cost per delivered 5-year LLIN costing USD 7.00 generally fell 
compared to the three-year scenario, though the differences were not large (Table 
30). They ranged from USD 3.23 in Togo to USD 10.08 in Eritrea (when re-
treatments are dropped: USD 3.23 in Togo to USD 9.60 in Eritrea).  The cost per 
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TNY was also lower than for conventional nets or for three-year LLINs, ranging from 
USD 1.38 in Eritrea to USD 1.90 in Togo (when re-treatments are dropped: USD 1.69 
in Malawi to USD 3.25 in Senegal).   
 
Table 30: Average annual economic costs for ITN (5-year LLIN) programmes.  
 
ITN 
programme 
Average 
annual cost 
per LLIN 
distributed* 
Average 
annual cost 
per TNY* 
Cost per 
death 
averted*  
Cost per 
DALY 
averted*  
Eritrea 10.08 / 9.60 1.38 / 1.92 502 / 698 15 / 21 
Togo 3.23 1.90 692 21 
Malawi 5.05 / 4.36 1.79 / 1.69 651 / 616 20 / 19 
Senegal 7.36 / 6.96 1.67 / 3.25 606 / 1,181 18 / 36 
Tanzania 5.74 / 5.06 1.62 / 2.28  588 / 828 18 / 25 
* In paired numbers the left value includes protection from re-treatment kits while the right value 
results from removing both protection and commodity costs related to re-treatment kits (see main text 
for details). 
Assumes all nets are long-lasting insecticidal nets (LLIN) with 5 years duration and a cost of USD 7. 
2005 USD. TNY = treated net-year. DALY = disability-adjusted life year. 
 
Cost-effectiveness of ITNs, LLINs and IRS for child mortality prevention 
The results for targeted conventional nets are shown in Table 28, the cost per death 
averted ranged from USD 438 to USD 2,199. The cost per DALY averted was below 
USD 100 in all cases. Under scenarios with targeted LLINs with three-year physical 
and protective lifetimes (Table 29), the range of cost per death and DALY averted 
was lower than in conventional ITN scenarios, although when re-treatment benefits 
and commodity costs were excluded Tanzania and Eritrea did not show cost-
effectiveness improvements.  For targeted LLINs with five-year physical and 
protective lifetimes (Table 30), the cost per death averted in all cases showed cost-
effectiveness improvements when compared to the three-year LLIN scenarios.  
 
For IRS, the cost per death averted ranged from USD 3,933 in Mozambique to USD 
4,357 in KwaZulu-Natal (Table 28).  The cost per DALY averted ranged from USD 
119 to USD 132. 
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LLINs, when targeted to high-risk groups in highly endemic areas appear more cost-
effective than conventional nets and also more cost-effective than IRS delivered 
population-wide.  Interestingly, the only circumstances in which LLINs did not clearly 
improve the cost-effectiveness of treated net programmes were in Eritrea and 
Tanzania (Figure 10). In Eritrea the initial commodity costs for nets were substantially 
lower than in other settings and in both countries the numbers of re-treatments 
delivered compared to nets delivered was high.   
 
Figure 10: Cost-effectiveness results of shifting to long-lasting insecticidal nets 
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Cost-effectiveness results of shifting to three-year (USD 5) or five-year (USD 7) long-
lasting insecticidal nets (LLINs) relative to conventional ITN estimates. LLIN CE 
estimates do not include protection from re-treatment kits but may include some costs 
associated with their distribution (see main text). 
 
 
 
Sensitivity analysis: usage of nets by children 
 
A major difference between ITNs and IRS is that the latter intervention cannot be 
targeted to high-risk demographic groups (pregnant women and small children), 
since IRS has to be applied to a large proportion of all houses in a geographic area 
to be effective.  This has implications for total cost and also cost-effectiveness, which 
was explored in a sensitivity analysis.  In the base analysis, only one child per net 
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was allowed and it was assumed that only 50% of nets were used to protect children.  
In sensitivity analysis this usage parameter had an important effect on the cost-
effectiveness of every ITN programme because it altered the number of child years of 
protection provided without changing the costs.  At lower usage levels (below 20-
30%), the cost-effectiveness of net programmes (especially with conventional nets) 
resembled that of IRS programmes (Yukich et al., 2007).   
 
An important element that is not considered here for lack of reliable empirical 
evidence is how coverage of the intervention relates to its health impact.  So far, few 
large-scale vector control programmes have been evaluated reliably with regard to 
health impact. However, it is well described that with ITN coverage above 50% there 
is a substantial community effect (Hawley et al., 2003; Killeen et al., 2007), while 
impact is reduced at lower coverage levels. Since all programmes aim at a high 
coverage rate (60-80%) and since all reliable impact data has been gathered under 
this level of coverage (Lengeler 2004), it seemed best to consider only one set of 
impact values.   
 
6.5 Discussion          
  
Main findings 
These results confirm previous work showing that vector control for malaria in sub-
Saharan Africa is extremely cost-effective, as even with conservative assumptions 
the cost per death averted was typically below USD 1,000 for LLINs.  Clearly, the 
move from conventional ITNs to LLINs needs to be effected as soon as possible. In 
this review, all major types of programmes were covered, with the exception of  
programmes distributing free LLINs to the whole population (and not only special risk 
groups such as children) - as promoted recently by WHO (WHO 2007). No such 
programmes had taken place at the time of this work and, therefore, no data could be 
collected on this strategy.  Although the implications of such a large change in the 
scale of ITN activities are difficult to quantify at present, it should be possible to 
estimate the cost of such an approach on the basis of this data.  
 
In all programmes under review the cost per treated net-year was surprisingly close 
in the LLIN scenarios, indicating that programme managers do have real options. 
However, cost-effectiveness is only one criterion for comparing strategies and 
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decision makers must also consider other important aspects including:  (1) the value 
of continuous promotion (such as found in social marketing programmes) versus a 
more intermittent approach; (2) the potential of a strategy to strengthen clinics / 
health facilities and improve uptake of antenatal care or immunization services; (3) 
the total cost of the strategy in relation to available resources; (4) the equity 
implications of each strategy; (5) which stakeholders and sectors bear the burden of 
a given strategy; (6) the opportunity cost in relation to other available health 
interventions.  
 
It appears that the most cost-effective means of preventing child deaths from malaria 
is through successfully targeting LLINs to under-five children, while still achieving a 
relatively high coverage in the rest of the population. If nets were to only protect 
children little community effect would be realized as children represent less than 20% 
of the population in sub-Saharan Africa (Killeen et al., 2007). Under any scenario 
these findings suggest that LLINs are more cost-effective in high endemicity settings 
compared to IRS. In areas of year round transmission, especially those with limited 
physical and human infrastructure, LLINs are also likely to be more feasible than IRS.  
By contrast, IRS is competitive with ITNs and may be the better option in areas 
where few spray rounds are required due to either short transmission seasons, the 
use of inexpensive but long lasting insecticides (such as DDT), or in epidemic prone 
areas and other situations where good geographic and temporal targeting is possible 
(Worrall et al., 2007).  
 
Economies of scale and scope need to be considered, as they may have significant 
effects on the unit cost per ITN by creating efficiencies within the supply chain or by 
improving demand through the integration of ITN delivery or promotion with a wider 
range of desirable products or services.  In this study, the effects were found to be 
complex and not clearly present in all reviewed programmes. In Malawi this effect is 
well documented and the cost per unit in the 5th year of operation fell to 
approximately 30% of the first year (Stevens et al., 2005). To some extent, 
differences in scope and scale may also confound these comparisons given the large 
differences in the operational scale of each programme as well as relative to the 
context in which they operate.   
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Limitations in the comparability of vector control programmes 
In making inter-country comparisons, uncontrollable differences in infrastructure, 
society, culture, and other variables can induce bias.  This study presents selected 
case studies believed to be representative of different ITN and IRS programmes and 
delivery approaches in sub-Saharan Africa.  However, there may be significant 
variations in the performance and costs of implementation of these strategies in other 
settings.  Also, in comparing cost information other limitations inevitably arise 
because of the nature and timing of large scale implementation. For example, it was 
not possible to compare data sets corresponding to the exact same time period, 
either temporally or in the history of the programme, nor was it possible to completely 
control for differences in the scale of programmes. Similarly, it was not possible to 
control perfectly for variations in price level, although all five ITN countries fit the 
World Bank definition of a low-income country (GNI per capita below USD 905 in 
2006).  New country-specific impact data at varying levels of coverage and over the 
long-term could improve the impact predictions, although ultimately all malaria vector 
control programmes will aim towards a high coverage of LLINs and hence these 
differences might not ultimately be marked.  Additionally, only the economic costs of 
programmes are presented here and though this can give guidance in and towards 
the selection of strategies, decisions must be made in each setting, in the light of 
both ecological and epidemiological factors as well as local health systems and 
resources. 
 
Health system effects 
Prevention of malaria can lead to a drastic reduction in the number of patients in 
health facilities, reducing pressure on over-stretched health facilities and thus benefit 
the whole health system. The provision of free or low-cost nets at health facilities 
(through vouchers or as a direct donation) may also be an enticement to pregnant 
women and mothers to use preventive services. In Malawi a portion of income 
received from the sale of highly subsidized nets is retained at the facility level and 
may act as an incentive for staff. On the other hand, comprehensive vector control 
programmes can burden weak health systems with new activities and lead to 
additional problems.   
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ITN programmes with their range of strategic options and possible interactions with 
non-health sectors appeared more flexible in their demands on the health system 
than the IRS programmes examined - though some recent IRS programmes, in Bioko 
Island, Uganda, and Zanzibar have shown that this burden may be shifted to NGOs 
or commercial organizations (PMI).  In any case, vector control scale-up requires a 
capacity expansion in the preventive health care delivery sector. All of the ITN case 
studies examined here depended to some extent on public sector involvement 
(though levels of public input were highly variable).  Table 31 attempts to summarize 
qualitatively the demands of the seven vector control programmes on three sectors 
(public, commercial, non-governmental) based on the results of interviews, document 
reviews and costing. In the case of the two programmes with a high commercial 
sector involvement (Tanzania and Senegal), reliance on this sector comes with profit 
incentives for the actors involved. 
 
Table 31: Level of involvement of public, private and non-governmental (NGO) 
sectors in vector control programmes.  
 
Programme Public sector  Commercial 
sector 
NGO sector 
Eritrea ♦♦♦  ♦ 
Togo ♦♦  ♦♦♦ 
Malawi ♦♦ ♦♦ ♦♦ 
Senegal ♦ ♦♦♦ ♦♦ 
Tanzania ♦♦ ♦♦♦ ♦♦ 
    
KwaZulu-Natal ♦♦♦   
Mozambique ♦♦♦ ♦ ♦ 
Higher numbers of diamonds indicate more demands on that sector relative to other 
programmes; a larger total number of diamonds for each given programme does not 
necessarily indicate a more demanding intervention. 
 
 
IRS programmes require a high level of expertise in entomology and management, 
which might put overwhelming demands to public systems in the face of the generally 
low availability of trained personnel in many endemic settings. However, a 
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programme can also help to develop local capacity in these areas. The South African 
example has demonstrated the many ways in which vector control programmes can 
contribute not only to the reduction of disease but also to the development of local 
capacity and the training of technicians and scientists. 
 
Coverage and timing 
Major differences were seen in both the levels of coverage achieved in the various 
ITN programmes, as well as in the duration of time that was required to achieve 
these coverage levels, or alternatively the time over which they were able to maintain 
coverage levels.  The coverage levels achieved generally correlated with the price 
charged to users for ITNs: those programmes which delivered nets to users freely 
achieving the highest measured coverage levels and those with user charges 
reporting lower coverage and usage.  The time to achieve increases in coverage was 
also generally much faster in programmes without user charges, but only one 
programme, Eritrea’s, allowed for the examination of the long term implications of 
maintaining coverage with no user charges.  While coverage in Eritrea has been 
successfully maintained for several years without user charges the overall cost per 
ITN was higher than in several other programmes.  The free ITN programmes 
appeared to be highly effective at achieving higher coverage more quickly than those 
with user charges, while maintaining lower or competitive cost-effectiveness.    
        
“Catch-up” versus “keep-up” 
Currently, there is a consensus for ITNs that both “catch-up” (to rapidly increase ITN 
coverage) and “keep-up” (to maintain high ITN coverage) strategies are required in 
each country (RBM 2005; Lengeler et al., 2007). Integrated vaccination/ITN 
campaigns such as those carried out in Togo (studied here), Mozambique, Niger and 
other settings have achieved good coverage rates (50-60%) within a short period of 
time (US CDC 2005; Grabowsky et al., 2005). Such campaigns can therefore be 
seen as serving the initial need for “catch-up” in ITN usage levels.  However, there is 
also a strong need for “keep-up” programmes to maintain high net usage levels, 
especially in newly pregnant women and newborns.  Three of the ITN programmes 
reviewed tended to represent “keep-up” strategies (Malawi, Senegal, Tanzania) while 
one (Eritrea) mixed both.  Recent work in Ghana (Grabowsky et al., 2005; 
Grabowsky et al., 2007) and on the Kenyan ITN programme (Noor et al., 2007) have 
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highlighted the complementarity of both “catch up” and “keep-up” approaches in 
achieving high ITN coverage and impressive health impact. Further information and 
effort will be required to determine which methods can be the most effective and 
cost-effective to “keep-up” coverage over time.    
 
Financing 
None of the ITN programmes appear to be independently financially sustainable.  
Even the largely commercial systems, such as the SMARTNET programme in 
Tanzania or the NetMark programme in Senegal, had substantial donor input and 
would be unlikely to continue operating at the same scale without continuing donor 
funding.  However, all the programmes under review appeared to be operationally 
feasible and sustainable in the presence of continued funding.  Additionally, in terms 
of financing, particular attention should be paid to pure provider costs which are more 
reflective of the inputs of programmes, donors or health ministries because they 
exclude costs which are borne specifically by users.  These costs were similar across 
the ITN programmes examined here (Yukich et al., 2007). 
 
6.6 Conclusions 
 
These findings confirm that large-scale delivery of ITNs and IRS in sub-Saharan 
Africa is feasible and highly cost-effective using a range of strategies. Delivery of 
LLINs through campaigns provides a highly cost-effective and achievable method for 
rapidly improving ITN coverage. However, many other options exist for ITN 
programming, some well suited to maintain coverage levels after campaigns. IRS, or 
a combination of ITNs and IRS, remain attractive and viable options in some settings. 
Given that sustainable high-level funding appears to be available in the long-term 
through new global financing mechanisms, every malaria endemic country should 
aim to upscale their vector control programmes as rapidly and sustainably as 
possible.    
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7.1 Abstract 
 
Background 
The switch to expensive artemisinin combination therapy (ACT) in a time of 
decreasing malaria transmission rates calls for more rational use of anti-malarial 
drugs in African health facilities.  Rapid Diagnostic Tests (RDTs) provide one way to 
rationalize anti-malarial use by introduction of reliable and simple laboratory 
diagnosis.  The economic effects and desirability of these tests appear to be highly 
situation dependant. 
 
Methods  
We recruited 257 patients in 6 primary health care facilities (4 with RDTs and 2 
controls) and conducted in-charge interviews and records reviews during a trial of 
routine RDT roll out in Dar Es Salaam, Tanzania.  Using these tools we collected 
data on patient-specific expenditure and patient-specific provider costs. 
 
Results 
RDTs significantly lowered patient expenditure on drugs (savings: USD 0.37; 
p=0.001) as well as provider drug costs (savings: USD 0.44; p=0.014). However, 
RDT introduction did not significantly reduce patients’ overall expenditures (USD 1.08 
(0.82 – 1.41) vs. USD 1.36 (1.01 – 1.79)) and may have increased total provider 
costs (USD 3.62 (3.39 – 3.87) vs. USD 2.31 (1.97 – 2.68)).  Clinician’s compliance 
with test results was higher in clinics with RDTs than in clinics with routine 
microscopy (95% in RDT clinics vs. 83% in control facilities; p=0.001). 
 
Conclusions 
RDTs reduce drug costs in this low-transmission setting but may not reduce them by 
a large enough amount to offset the cost of the tests themselves.  Nevertheless, the 
test also brought additional benefits including shortened clinic visits, improved 
provider compliance with lab results and ultimately better case management. 
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7.2 Background 
 
Malaria is largely diagnosed in African public health facilities on clinical grounds 
alone, and fever cases are routinely treated without laboratory confirmation (World 
Malaria Report 2008). Malaria microscopy, when available, is often of poor quality 
(Mundy et al., 2000). However, with the high costs of the new generation artemisinin 
combination therapy (ACT), as well as concerns about the development of drug 
resistance due to drug overuse, many donors and health system managers are 
searching for ways to improve the rational use of drugs for malaria treatment.   
Additionally, intense malaria control activities and rapid urbanization in many 
endemic areas have led to falling incidences rates of clinical malaria. As a 
consequence, the malaria-attributable rates in fever episodes have been falling 
(D’Acremont et al., 2009), further increasing the need for improved diagnostic 
strategies.   
 
The modern generation of HRP2 antigen based rapid diagnostic tests (RDTs) have 
been shown in trials to have high sensitivity and specificity for the diagnosis of P. 
falciparum infection among clinical patients in Africa in some settings (Bell et al., 
2006, Reyburn et al., 2007; Abeku et al., 2008).  Given the poor standard of 
microscopy in endemic areas, RDTs are likely to produce more accurate diagnostic 
results, even though expert microscopy should still be regarded as the gold standard 
for research purposes (Mundy et al., 2000; Reyburn et al., 2007; Abeku et al., 2008).   
 
There are potential drawbacks to their use for routine malaria daigosis including the 
persistence of the target antigen in the blood stream for up to several weeks after an 
infection has been treated, hence they cannot be used to estimate treatment success 
(Mayxay et al., 2001; Iqbal et al., 2004; Swarthout et al., 2007).  Additionally, such 
tests cannot determine parasite load and the specificity of such tests may vary 
according to the setting (Bell et al., 2006; Abeku et al., 2008). 
     
While more accurate laboratory diagnosis may help to rationalize anti-malarial drug 
use at health facilities in Africa (Reyburn et al., 2007; Hume et al., 2008), there is also 
a clear possibility that any cost-savings made from the reduction of anti-malarial 
prescriptions may be outweighed by increases in prescription of antibiotics or other 
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drugs to treat test-negative patients.  Additionally, RDTs add cost to case 
management which is not proportional to throughput, and which could outweigh cost-
savings from reduced anti-malarial consumption (Lubell et al., 2007).  The effects of 
diagnostic changes will also depend on the adherence of clinicians to the diagnostic 
result, the frequency with which they request a test, as well as on the prevalence of 
parasitaemia among the clinical population (Zurovac et al., 2006; Lubell et al., 
2008b). 
 
There is a sizable body of literature which has examined the implications of improving 
malaria diagnostic methods, including both empirical and modeling studies.  The 
results of the empirical studies have shown that there is a possibility to reduce 
average cost per patient and household costs through improved malaria diagnosis, 
and that such interventions could be highly cost-effective (Jonkman et al., 1995; 
Hume et al., 2008; Lubell et al., 2008b; Zikusooka et al., 2008).  
 
Modeling studies have helped to confirm and highlight the myriad factors which could 
influence both the cost-effectiveness and the overall cost-saving potential of 
improved diagnosis.  The main factors which influence the desirability of one testing 
strategy over another relate to the proportion of febrile cases which are parasite 
positive, the sensitivity and specificity of the new method and its alternatives, the 
costs of the tests, as well as the cost of the drug regimens prescribed to parasite 
positive and parasite negative patients (Shillcutt et al., 2008; Jonkman et al., 1995; 
Lubell et al., 2007a; Lubell et al., 2007b; Lubell et al., 2008a; Lubell et al., 2008b; 
Hume et al., 2008; Zikusooka et al., 2008).  
 
Since the potential for improvements in outcomes and cost savings appear to be 
highly situation dependant it is necessary to evaluate the decision to shift to rapid 
diagnostic test locally and at specific levels of the health care system. While models 
can be used to explore decision making (Lubell et al., 2008a) there is still a strong 
rationale to assess alternatives empirically in representative settings.  This paper 
describes a study of the economic implications of the implementation of RDT 
diagnosis with RDTs in a low-endemicity urban African setting in Dar es Salaam, in 
the United Republic of Tanzania.  
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7.3 Methods 
Study area 
 
Dar es Salaam is the economic capital of the United Republic of Tanzania. It is a 
large urban area (population approximately 3 million) with highly heterogeneous land 
use, including commercial districts, industrial districts, residential districts, urban 
slums, and areas with high levels of urban agriculture (Dongus et al., 2009). As a 
result there is a high variability in the number of Anopheline breeding sites and hence 
adult mosquito densities.  As of 2009 it is considered a low but stable malaria 
transmission area: EIR ≈ 1.3 with low parasitaemia prevalence (less than 10% in the 
general population) (Geissbuhler et al., 2009).  All of the health facilities included in 
the costing exercise are located in densely populated low-income areas, though one 
facility’s catchment area (Kawe dispensary) also includes some peri-urban and 
higher income areas. 
 
Twelve public health facilities were selected for inclusion in a trial of RDT rollout 
(d’Acremont et al., in preparation).  Of these, six primary health care facilities were 
included in the costing exercise.  Four primary care facilities (three dispensaries and 
one health center) were experimental facilities in which RDTs replaced routine 
microscopy for the diagnosis of malaria. Two primary care health facilities, both 
dispensaries, remained as controls with only routine microscopy.   
Collection of patient and facility costs and resource use 
 
Costing was conducted both from the patient and provider perspectives.  A larger 
survey examining the effects of RDT introduction on health worker practices and 
patient response was used as a platform for collecting patient-specific and facility 
costs (D’Acremont et al. in preparation).  Within the six selected facilities the inclusion 
criteria were the following: (1) first consultation for the present complaint (not a 
follow-up visit), (2) absence of severe disease, and (3) main complain not trauma 
related.  Eligible patients or caretakers of young patients were included if they gave 
oral informed consent. Their consultation was then passively observed by a survey 
worker with clinical training.  These patients or caretakers were then questioned 
during an exit interview, which included questions relating to their perceptions of the 
clinical and laboratory consultation, as well as episode-related expenditures and any 
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previous treatment seeking and related expenditures.  The questionnaire also probed 
travel time and costs, time spent accessing the facility and missed work or lost 
income due both to the attendance at the facility and/or any time taken to care for the 
patient at home. 
 
All patients or caretakers who participated in the exit interview (and therefore had 
costing questions) were requested to return to the same health facility one week later 
for a follow-up interview. They were also provided with a small incentive to cover 
transportation costs. At this follow up, all patients or caretakers were administered a 
second questionnaire which solicited information on their current health status and 
any treatment seeking activity or expenditure during the intervening week, as well as 
lost income and time taken to care for the patient at home. They were also asked 
about the previous consultation and any associated expenditures, mainly as a check 
on consistency, as well as to potentially garner information about informal payments.  
If in-person follow-up was not possible we attempted a shortened follow-up interview 
via mobile telephone. All follow-up patients who reported at a health facility were 
tested with an HRP2 based RDT in order to check for missed infections, as well as to 
identify false negatives or positives in the control facilities given the persistence of the 
HRP2 antigen in treated patients.  In patients who tested positive by RDT during 
follow-up it was ascertained whether they had received appropriate first line 
treatment, and whether their condition had improved. If this was not the case we 
ensured that they were subsequently treated at the health facility.   
 
In order to assess treatment costs to the provider a health facility survey was 
conducted in the six facilities participating in the cost study to identify per patient 
resource use at the facility level.  In-charge interviews and a health facility level data 
survey instrument were used to collect information on the number of outpatients and 
malaria cases seen at the facility over the past three years, as well as numbers of 
blood slides and RDT tests performed.  Additionally, they collected information on 
numbers and grades of staff and estimated effort dedicated to outpatients.  We also 
collected additional information used to calculate overhead and patient visit costs, 
including the facilitiy’s spending on electricity, water, other overhead costs, and the 
numbers of capital items in the facility – including microscopes and other clinical 
equipment.  We also utilized facility records to collect information on the use of 
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consumables including laboratory books, giemsa stain, blood slides, lancets, syringes 
and other items.  
 
Valuation of Resource use 
 
Costs of resource inputs were determined for the provider costs on the basis of (1) 
the Tanzania pharmaceutical and supply price list for 2008, and (2) interviews with 
the appropriate financial managers of the Dar Es Salaam City Medical Office of 
Health.  Information on drug prices was obtained from the International Drug Price 
Indicator Guide database published by Management Sciences for Health (MSH) or 
from a WHO-AFRO database of indicator drug prices (MSH, 2009; WHO-AFRO, 
2008).  Patient costs were valued according to patients reported expenditures and 
lost income. 
 
Costs for the initial implementation of RDTs, including training and quarterly 
supervisory visits were calculated based on reported expenditure and activities, 
excluding specific research costs.  Costs were reported in the local currency (TSH), 
U.S. Dollars (USD), or Swiss Francs (CHF).  All costs were converted to USD using 
official exchange rates for the year in which the cost occurred and adjusted into a 
common year (2008) using the U.S. GDP deflator (US BEA, 2009).  Capital costs 
were discounted and annualized using a 3% discount rate and assumed lifetimes for 
equipment based on expert opinion and past literature.  All costs attributable to RDT 
implementation were then divided by the estimated total number of RDT tests 
performed in the nine experimental health facilities (328,000 – 435,000) over the 
entire duration of the project (approximately two years) to calculate an average 
implementation cost per test.  The number of tests was estimated in two ways: the 
first and lower number was the number of RDTs performed according to facility 
records, and the second and larger number referred to the number of RDTs delivered 
to the facilities according to project records.  This range had little effect on the cost of 
implementation per test (excluding the cost of the test itself).       
 
Statistical analysis 
We tested the differences in patient expenditure and provider costs using two 
different statistical tests.  We first applied the Kruskal-Wallis test for equality of 
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populations.  We used this test because, as is typical of expenditure data, the 
distribution of both patient specific provider costs and patients expenditures was 
highly non-normal, due both to a significant right skew and a large zero-mass.  Thus 
performing significance testing with a non-parametric method was necessary.   
 
Additionally, we used non-parametric bootstrapping to estimate confidence intervals 
for each expenditure value. This approach was adopted due to the fact that 
alternative non-parametric methods do not compare arithmetic mean costs and 
transformation of the data to a log scale would result in comparison of geometric 
means, and further transformation did not result in a normal expenditure distribution.  
Methodological studies and reviews have suggested this methodology to 
appropriately deal with the need to compare arithmetic means and generate 
confidence intervals on such data (Barber & Thompson 1998; Nixon et al., 2009)     
 
Total time for patient visits to the health facility was normally distributed and thus 
amenable to standard parametric tests.  Data was entered in EpiInfo 3.4.1 (US CDC), 
and analyzed in STATA 9.2 (Stata Corporation, College Station, TX).   
 
 
7.4 Results 
 
General results 
 
339 patients were recruited at each of the six selected facilities for exit interviews.  
257 patients were successfully administered an exit interview.  The final rate of 
follow-up (for patients participating in the full costing study) was 84%, and is 
illustrated in  
 
.  
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Figure 11: Losses to follow-up during the study 
 
        
 
 
 
 
Patients who were lost to follow-up were not significantly different on several 
measures of demographic information from those who were successfully re-
interviewed (Tables 32a and 32b).  No significant differences were found for age 
distributions, sex, methods of travel to and from the health facilities or the occupation 
of the patients’ head of household. Additionally, we found no significant differences 
on the same set of measures between facilities which offered RDTs and those 
facilities which did not offer RDTs (Tables 32a and 32b).      
 
Patients with observed 
consultation 
(N=339) 
Patients given exit interview  
(N=257) 
 
In person follow-up  
(N=180) 
 
Refused exit interview 
(N=82) 
Did not return for follow up 
(N=77) 
Telephone follow-up 
(N=35) 
 
 
Lost to follow-up 
(N=42) 
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Table 32a: Comparability of control and experimental populations, and those lost to 
follow-up  
 
 
 
N Estimate 
95% 
confidence 
interval 
p-value 
Proportion of patients age five years and older 
Control facility 80 52.5 41.6 – 63.4 
RDT facility 177 47.5 40.1 – 54.8 0.45* 
Lost to follow up 42 59.5 44.7 – 74.4 
Not lost to follow up 215 47.0 40.3 – 53.6 0.14* 
Proportion of patients who were female 
Control facility 80 55.0 44.1 – 65.9 
RDT facility 177 54.8 47.4 – 62.1 0.98* 
Lost to follow up 42 54.8 39.7 – 69.8 
Not lost to follow up 215 54.9 48.2 -61.5 0.99* 
*p-values are based on Pearson’s χ2 test with d.f.(1)  
 
 
Table 32b: Comparability of control and experimental populations, and those lost to 
follow-up 
  
Patients method of travel to health facility 
(proportion) 
 
Lost to 
follow 
up 
(N=42) 
Not lost 
to follow 
up 
(N=212) 
RDT 
facility  
 
(N=176) 
Control 
facility 
 
(N=80) 
Walking 66.7 60.4 61.5 61.3 
Mini-bus 33.3 35.9 35.1 36.3 
Other 0.0 3.8 2.5 3.5 
p-value 0.501** 0.967** 
**p-values based on Fischer’s Exact Test 
 
Of the 257 patients who were administered exit interviews 177 were interviewed at 
experimental facilities (with RDTs) and 80 were patients at control facilities (no 
RDTs).  Within the RDT facilities, patients were significantly less likely than in control 
facilities to receive results for a laboratory test for malaria (84% vs. 95%; p=0.014 
Fischer’s exact), a difference that was also significant in patients five years and older 
(86% in RDT facilities vs. 98% in control facilities; p=0.04) but not for children under 
five years (82% in RDT facilities vs. 92% in control facilities; p=0.13).  Patients in 
RDT facilities were also significantly less likely to test positive for malaria parasites 
(14% vs. 42%; p<0.001).   While in both control and RDT facilities large fractions of 
all patients received laboratory diagnosis, clinicians in the RDT facilities appeared to 
be more parsimonious in their use of tests, at least among adults. 
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Unexpectedly, adults were significantly more likely than children under five years to 
test positive for malaria in control facilities, but not in RDT facilities (55% vs. 26% in 
control facilities; p=0.01 and 15% vs. 12% in RDT facilities; p=0.54).  These results 
clearly suggest a problem with microscopic examination, and indeed the low quality 
of routine microscopy was confirmed in more detailed studies in the same facilities 
(Kahama et al., in preparation).   
 
Patients within RDT facilities were significantly less likely to receive the first line anti-
malarial drug ALU (Artemether-Lumefantrine) compared to patients in control 
facilities. This was seen when the analysis was restricted to patients who left the 
facility with any drug prescription as well as among all patients observed: 11% vs. 
51% p<0.001 (with any prescription); 10% vs. 48% p<0.001 (all patients). This 
difference remained highly significant regardless of the age of the patient.    
 
Patients in RDT facilities were also more likely to receive ALU in correct 
correspondence with the results of their diagnosis.  When only patients with a 
laboratory diagnosis were examined, those in RDT clinics received ALU in 
correspondence with the laboratory diagnosis 95% of the time vs. 82% in control 
facilities (p=0.002). A related study has shown that most positive blood slide results 
in these facilities are false positives (Kahama et al., in preparation).  Thus high 
clinician compliance with microscopy results in control facilites leads to overuse of 
anti-malarial drugs. When patients with only clinical diagnosis were included the 
results were similar: 95% in RDT facilities vs. 83% in control facilities (p=0.001).   
This difference remained significant when examined only for children under five years 
(97% in RDT facilities vs. 83% in control facilities; p<0.01), and nearly significant for 
patients age five and older (92% in RDT facilities vs. 80% in control facilities; 
p=0.07).  Patients under the age of five years appeared no more likely to be correctly 
prescribed ALU than those over five years of age (93% under five vs. 88% five and 
older; p=0.19).  Differences remained statistically insignificant when restricted within 
either RDT facilities or within control facilities (details not shown).         
 
The diagnostic results on the full study sample are described in more detail by 
D’Acremont et al. (in preparation) and Kahama et al. (in preparation). 
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Implementation costs of RDT programme (provider) 
 
Cost data on implementation was collected over a 14 month period.  During this 14 
month period approximately 435,400 RDTs were issued to implementing facilities and 
usage data indicated that approximately 330,000 RDTs for malaria had been 
performed.  Due to the high volume of tests (approximately 400,000), the cost of 
implementation training and support for RDT roll-out was relatively low when 
considered per test.  The total cost of the RDT intervention over this period (not 
including the test kits themselves) was estimated to be $16,946 in 2008 USD, or 
$1,883 USD per implementing facility.  Thus we estimated that the cost of 
implementation per RDT test (excluding the test kits themselves) was between 0.04 
USD and 0.05 USD. The test kits themselves were estimated to cost USD 0.66 each.  
When calculating the cost per patient in RDT clinics we include the cost of RDT 
implementation.      
 
The bulk of the expenses went to staff salaries for the implementation of the RDT 
rollout (72%) and for training and quality control at the implementing facilities (22%). 
The only other substantial line item cost was transport, which accounted for 3% of the 
total cost of implementation. 
 
Patient perspective – direct costs (expenditure) 
 
Patient costs consist of two main parts: direct costs due to expenditure on medicines, 
transport, diagnostics and other health services, and indirect costs, such as lost 
productivity or the opportunity cost due to time spent seeking care.  We attempted to 
measure both.   
 
Patient expenditures were directly reported by patients. Table 33 shows arithmetic 
mean expenditure per patient in RDT or control facilities arising before and during the 
first consultation, as well as after the first consultation for the subset of patients with 
follow-up.  Expenditures have been subdivided into several categories, and are 
reported here in Tanzanian Shillings and USD. 
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Table 33: Patient expenditures. HF=Health Facility, Totals are different than sum of 
means because of varying sample sizes for each group  
 
Mean cost per 
patient Type of Expenditure  N TSH USD 
Standard 
Deviation  
(TSH) 
Significance+ 
RDT 177 89 0.07 639 Care pre-HF Control 80 46 0.04 304 0.554 
RDT 177 466 0.38 1064 Drugs at HF Control 80 914 0.75 1413 0.001 
RDT 124 80 0.07 122 Out-patient charges Control 55 105 0.09 126 0.319 
RDT 121 245 0.20 418 Lab fee at HF Control 55 256 0.21 430 0.938 
RDT 125 286 0.23 1017 Post visit  Control 55 71 0.07 452 0.633 
RDT 177 365 0.30 905 Travel Control 80 274 0.22 811 0.801 
RDT 121 1320 1.08 2057 Total Control 55 1660 1.36 1832 0.044 
+significance results are based on Kruskal-Wallis tests 
 
Table 33 shows that significant differences in reported expenditure were found 
between patients at RDT clinics and those at control clinics. Patients’ mean total 
expenditures were lower in RDT clinics (USD 1.08) compared to control clinics (USD 
1.36), and were significantly different using the Kruskal-Wallis test for equality of 
populations.  Patients mean expenditure on drugs was 0.47 USD lower in RDT clinics 
than in control clinics.   
 
Table 34 shows bootstrapped means and bias corrected confidence intervals for 
each of the parameters shown in Table 33 above.  Each estimate is based on 10,000 
re-samples of the observed data.  
 
Arithmetic mean patient expenditures, when reduced into smaller component parts, 
failed to show significant differences in all but the line item expenditure for drugs at 
the first health facility visit, which was highly significantly different in RDT clinics 
(using the Kruskal-Walis test: TSH 466 (USD 0.38) vs 914 (USD 0.75); p=0.001). 
Bootstrapped confidence intervals showed, however, that the difference was only 
close to significance.   
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Table 34: Results of non-parametric bootstrap for confidence interval estimation of 
patient expenditures.  Totals are different than sum of means because of varying 
sample sizes for each group  
 
 
Mean cost per 
patient 
95% Bias Corrected C.I.  
 
Type of Expenditure 
 
2008 USD TSH 
RDT 0.07 0.02 – 0.18 Expenditure for care pre-HF  Control 0.04 0.01 – 0.12 
RDT 0.38 0.27 – 0.53 Drug expenditure at HF Control 0.75 0.53 – 1.03  
RDT 0.07 0.05 – 0.08 Out-patient charges Control 0.09 0.06 – 0.12 
RDT 0.20 0.15 – 0.27 Lab fee at HF Control 0.21 0.13 – 0.32 
RDT 0.23 0.10 – 0.42 Post visit expenditure Control 0.07 0.00 – 0.22 
RDT 0.30 0.19 – 0.41 Travel expenditure Control 0.22 0.15 – 0.31 
RDT 1.08 0.82 – 1.41 Total expenditure Control 1.36 1.01 – 1.79 
   
 
 
The similarity of expenditure across the two types of facilities helped to support our 
assumption that the populations of patients in control and RDT facilities were similar 
since the cost of transportation and actions taken before attending the health facility 
would not be expected to be significantly different between the two groups.  Further, 
it supports the argument that effects on patient expenditures were largely limited to 
those on drug purchases. 
 
Expenditures on drugs at the health facility accounted for the largest single 
component of patient expenditure, followed by laboratory fees and travel costs. 
 
Patient Perspective – indirect costs 
Additionally, patients incured indirect costs through lost income, reduced productivity, 
and the opportunity cost of lost time due to attending the facility either as patients or 
as caretakers of patients.  One hundred-six (41%) patients or caretakers reported 
missing work to attend the health facility; of that group, 85% reported lost income as 
a result. Neither result was significantly different at the 10% level between RDT and 
control facilities: p=0.17; d.f.(1) and p=0.78; d.f.(1).  Among those reporting lost 
income, mean lost income was reported as 7234 TSH (5.92 USD) a figure which was 
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not significantly different between control and RDT groups (Kruskal-Wallis p=0.135).  
This figure is significantly larger than patients’ expenditures on all other categories. 
For patients who lose income to attend the facility, the opportunity cost of facility 
attendance is far larger than the direct costs of health care and such large 
opportunity costs might prevent significant numbers of people from accessing care.  
 
Total time per visit, including transportation time was measured by adding estimates 
of time at which the patients or caretakers left their home or work place to attend the 
facility to the time they spent at the health facility (determined by the time of the start 
of their exit interview), with an additional time factor added for their estimated time to 
return home.  In control clinics mean time per visit was estimated to be 4.7 hours 
while in RDT clinics it was estimated at only 4.0 hours (t=2.8703; p=0.005).    Being a 
patient in an RDT clinic in our sample was associated with approximately 42 minutes 
shorter total visit time.  Though a certain amount of this variation can be attributed to 
slightly shorter travel times to RDT facilities (mean travel time 44 minutes) compared 
to control facilities (35 minutes; p=0.049) resulting in a mean difference of 
approximately 9 minutes of travel in each direction, or 18 minutes total.  Reduced 
waiting times and total visit times might help to reduce the opportunity costs of facility 
attendance and thus could improve access to care, though the reductions seen here 
are small (~10%) in relation to total visit time.     
 
Provider perspective 
In this analysis we focus on gross provider economic costs and not net costs, which 
would account for the collection of user fees by health facilities.  We measured 
resource use at each of the six facilities through a questionnaire administered to the 
in-charge of health facility, as well as the collection of routine data on facility use, 
numbers of outpatients treated, numbers of malaria test performed, and records of 
consumable used.  Additionally, we conducted data collection at the central offices of 
the City Medical Office of Health to estimate the costs of construction of health 
facilities and other costs which we could not obtain directly from the health facilities 
themselves, including salary ranges for various grades of health workers.  The 
following table (Table 35) lists the costs which were included in the analysis.   
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Table 35: Costs included in provider perspective analysis   
 
Recurrent Costs 
    Clinical staff salaries 
    Lab technician salaries 
    Support staff salaries 
    Consumables 
    Drug costs 
    Diagnostics 
    Electricity  
    Water 
    Communication 
 
Capital Costs 
    Building and furnishings 
    Microscopes 
    Other equipment 
 
All costs were related to their allocation to outpatient services (as opposed to 
maternal and child health services) and then related to the number of out-patients 
seen at the facility during the period under which their consumption could be 
measured (between 2005 and 2008).  Because some resource usage could not be 
measured at each facility due to missing records (26% of requested records were 
missing) these costs have been estimated using the mean values per patient from 
the facilities where information could be collected.  Prices of drugs have been 
adjusted to account for transport costs and wastage according to the following 
assumptions.  Drugs costs were inflated 20% over actual costs to adjust for wastage, 
then an additional 10% for local transport, and finally an additional 10% for 
international transport where CIF (Commodity insurance and freight) prices were not 
available.    
 
Table 36 shows the results of the provider perspective analysis for the RDT and 
control facilities and illustrative results when the analysis was limited only to patients 
who had laboratory diagnosis (either by blood slide or RDT).  The table shows the 
results of non-parametric tests for each of three sub-divisions of total provider costs.  
They are analyzed either within control or experimental facilities or for patients with 
laboratory diagnosis, by type of laboratory diagnosis.  “Drug costs” represent the cost 
to the provider of all drugs and prescription provided to a given patient.  “Marginal 
costs” include drug costs and RDT costs and thus represent the cost of treating a 
patient excluding the facility costs for staff, overhead consumables and capital 
 7. RDT costing working paper 142 
equipment.  “Facility cost” is the cost of the commodities whose usage is measured 
at the facility level but not linked to specific patients (overhead, staff costs, equipment 
and general consumables, excluding drug costs), thus there are only six observations 
corresponding to the number of facilities in our study.  Significant differences were 
found for all costs except facility cost, though the latter result is compromised by the 
extremely small sample size. 
 
Table 36: Provider costs per patient.  Totals are approximately marginal cost (which 
includes the drug cost) plus facility cost, but vary due to differences between 
facilities. 
 
Type of cost  
(per patient) Group N Arithmetic mean 
Standard 
Deviation Significance 
   
TSH USD TSH 
 
Drug cost  RDT facility 177 1554 1.27 1796 
 Control facility 80 2083 1.71 1950 0.014
+
 
Facility cost RDT facility 4 1926 1.58 904 
 Control facility 2 720 0.59 424 0.161
*
 
Marginal cost RDT facility 177 2504 2.05 1783 
 Control facility 80 2083 1.71 1950 0.017
+
 
RDT facility 177 4421 3.62 2009 Total cost 
(facility cost 
+marginal cost) Control facility 80 2818 2.31 1986 
<0.001+ 
+Kruskal-Wallis based p-values 
*t-test based p-values 
 
When patients who received RDT results were compared to patients whoreceived 
blood slide results, drug costs were significantly lower for patients with RDT results 
(USD 1.13 vs. USD 1.73; p=0.002).  However, provider costs were higher for patients 
who received RDT results, both for marginal cost (including the RDT cost) and total 
cost: USD 2.14 vs. USD 1.73; p=0.003 for marginal cost and USD 3.71 vs. USD 2.33; 
p<0.001 for total cost. 
 
Again we were confronted with results which were highly non-normally distributed, 
including in some cases a large zero mass and in all cases a significantly right-
skewed distribution. Hence we estimated confidence intervals using non-parametric 
re-sampling (bootstrapping) with 10,000 re-samples for each outcome, excepting 
facility cost (Table 37). 
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Table 37: Results of non-parametric bootstrap for confidence interval estimation of 
provider economic costs. Cost values in 2008 USD. 
 
  All Ages Under Five Over Five 
Type of cost  
(per patient) Group 
Mean 
cost 
95% bias 
corrected 
C.I. 
Mean 
cost 
95% bias 
corrected 
C.I. 
Mean 
cost 
95% bias 
corrected 
C.I. 
Drug cost RDT facility 1.27 1.06 – 1.50 1.17 0.88 – 1.51 1.38 1.12 – 1.69 
 
Control 
facility 1.71 1.36 – 2.06 1.05 0.71 – 1.55 2.29 1.82 – 2.79 
Marginal cost RDT facility 2.05 1.85 – 2.27 1.94 1.64 – 2.27 2.18 1.91 – 2.48 
 
Control 
facility 1.71 1.37 – 2.08 1.05 0.71 – 1.53 2.29 1.82 – 2.81 
Total cost RDT facility 3.62 3.39 – 3.87  3.56 3.23 – 3.92 3.69 3.37 – 4.05 
 
Control 
facility 2818 1.97 – 2.68 1.68 1.33 – 2.22 2.87 2.38 – 3.39 
 
Bootstrapped confidence intervals generally confirm the results of the Kruskal-Wallis 
tests. However important differences do exist between the two results.  The 
confidence intervals for drug costs between RDT and control facilities show a large 
overlap when analyzed for all age groups.  However, when the sample is stratified by 
over and under five years of age a significant difference exists for patients five years 
of age and older.  This may be the result of a combination of high rates of ALU 
prescription in control facilities and the higher cost of this drug for adults in relation to 
other adult drugs.   Marginal costs (including RDTs) were significantly different in 
RDT facilities compared to the control facilities using the non-parametric Kruskal-
Wallis test.  Bootstrapped confidence intervals, however, show overlap for mean 
marginal cost to the facility, though this overlap is small.  When this result 
disaggregated by age group we see that costs for under five children are significantly 
higher and there is no significant overlap in the bias corrected confidence interval.  
The addition of the costs of the RDT diagnostic push the cost for under five patients 
significantly higher in RDT facilities and bring the marginal costs of older patients into 
a similar range as those in control facilities.  Once facility costs are included, the total 
cost of treating a patient including all provider costs is significantly higher in RDT 
facilities than in control facilities.         
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Summary of all results 
In all the results indicate that in the presence of RDTs drug cost savings are likely to 
accrue to patients, and may also accrue to the providers, especially for adults.  
However, whether these savings translate into overall cost savings is more in doubt.   
 
For patients, it appears likely that there is some reduced overall spending when 
RDTs are availiable.  However, the savings is small (USD 0.37) and it represents 
only a small component of the total economic costs to patients.  
 
For providers the drug cost savings is of a similar order (USD 0.44) as a result of 
RDT introduction.  Unfortunately, these savings appear to be too small to offset the 
entire cost of RDT introduction and use.  In fact, it appears that RDTs may increase 
the cost of treatment per patient in public facilities, despite reducing anti-malarial drug 
usage and creating drug cost savings for the health system.  Additionally, the cost 
savings arise largely from reduced anti-malarial usage among adults who are most 
likely to be charged a user fee for drugs.  Hence, the resulting reduction in user fee 
revenue due to reduced patient drug expenditure will reduce the financial incentives 
for RDT implementation.   
 
7.5 Discussion 
 
This study was conducted under routine conditions in health facilities and sampled 
patients were taken from six different health facilities.  While randomization was not 
possible for logistical and political reasons, care was taken to select the facilities that 
were as comparable as possible.  As there is likely to be a tendency towards similar 
prescribing practices within facilities, the results should be adjusted for clustering 
within health facilities (Rowe et al., 2002).  Unfortunately, because of the small 
sample size and small number of health facilities included in the study, we were 
unable to formally account for this in most of the statistical analysis.  Nevertheless we 
believe that these results are likely to be robust, although the extent to which they are 
generalizable depends on how representative these facilities are of typical Tanzanian 
facilities or more widely of other sub-Saharan African health systems.   
 
These results are of course sensitive to the relative prices of malaria drugs and 
antibiotics (ALU: USD 0.41 to USD 1.60 depending on dosage; Antibiotics USD 0.20 
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to USD 3.50 depending on drug, dosage and formulation) as well as any other drugs 
used to treat test positive and test negative patients.  It is possible that given 
changes in drug prices our results could change.  One of the most expensive drugs 
commonly in use among this type of patients is artemisinin combination therapy for 
malaria.  Much of the drug cost savings seen in this study, both to the patients and to 
providers is due to reduced anti-malarial usage in RDT facilities.  Hence, a reduction 
in the price of anti-malarial drugs may erase the drug cost savings seen here.  
Currently a global subsidy scheme for antimalarials is at an advanced stage 
(Gelband & Seiter, 2007) and a virtually free drug at country level might prove to be a 
disincentive to testing for malaria.   
 
It has been postulated in several studies that RDTs could produce cost savings to 
health facilities in low transmission settings (Shillcut et al., 2008; Zikusooka et al., 
2008).  Here we show based on empirical data from six health facilities in Dar Es 
Salaam that indeed significant drug cost savings and reductions in anti-malarial drug 
usage appear to be achievable in such settings.  In addition, clinicians’ compliance 
with test results was significantly better when RDTs were in use, and this is likely to 
have contributed to the drug cost savings seen here (Lubell et al., 2008b).  Increased 
compliance by providers may be a result of intense training or their perception of the 
increased accuracy of RDTs compared to their routine laboratory diagnostic methods 
(D’acremont et al., in preparation).   
 
However, despite demonstrable drug cost savings we did not see overall cost 
savings due to the use of RDTs and in fact provider costs appeared to significantly 
increase in the presence of RDTs.  Though some of this increase is likely due to 
higher fixed costs within the set of facilities selected for this study, the drug cost 
savings that we observed (USD 0.44) were not likely to be large enough to offset the 
cost of the RDTs themselves when a high percentage (84%) of the patients at the 
facility have the test administered.  Further, reduced patient expenditure on drugs 
leads to falling revenue from user fees, which might make the intervention appear 
less attractive at the facility level.  
 
Unfortunately, in the context of this study it was not possible to measure differences 
in health outcomes between the groups of patients, nor to asses whether patients 
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were truly malaria infected using expert microscopy or polymerase chain reaction 
(PCR) methods. Thus, it was not possible to asses the cost-effectiveness of the 
intervention, either per health outcome or per additional correct diagnosis.  An in-
depth analysis of case management practices will determine if RDTs improved 
compliance with standard treatment guidelines and improved case management 
(d’Acremont et al., in preparation). That information could also be used to calculate a 
cost per additional correct treatment, as has been done in previous diagnostic costing 
studies (Reyburn et al., 2007; Lubell et al., 2007b).  
 
An additional benefit is that with a more reliable laboratory test it becomes more 
realistic to monitor malaria trends on the basis of routine data.  Though it is unclear 
what monetary value such a benefit would have for the health system, improved 
knowledge of malaria incidence rates could lead to efficiencies in other health care 
domains.  Distribution of malaria prevention and treatment resources could potentially 
be more efficiently allocated to high incidence areas.  Alternatively, more accurate 
measures of malaria incidence could enhance the responsiveness of health systems 
to malaria epidemics (Abeku et al., 2004).    
 
Finally, reduction of irrational anti-malarial use is important to limit the development of 
resistance to ACTs (Wongsrichanalai et al., 2007).   
 
 
7.6 Conclusions 
 
Our results show significant savings on drug expenditure to patients and on drug 
costs to providers in the presence of RDTs.  However, the savings are outweighed by 
other fees and charges and lost income for patients, or the cost for RDTs and higher 
facility costs for providers.   
 
Clinicians’ compliance with test results was higher when RDTs were in use, showing 
that they trusted this new technology.  It is also likely that the use of such tests 
accrues significant other benefits, including improved case management, more 
rational anti-malarial use, and reductions in development of resistance to ACTs.  
While valuation of such benefits is outside of the scope of this work they are highly 
important from a public health perspective. 
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8. Discussion 
 
8.1 General Discussion on the costing of vector control programmes 
 
The main purpose of this thesis was to collect high quality cost data on large scale 
vector control operations in sub-Saharan Africa and to apply a standard methodology 
both to the collection and analysis of these data.  Because so much of the previously 
available information on this topic suffered from lack of comparability (Kolaczinksy 
and Hanson 2006), standardization we introduced has improved the quality of 
information available to decision makers in Africa and globally. For the first time, 
consistent costing information on large-scale vector control programmes has become 
available.   
 
Generally our findings show that ITN programs appear to be more cost effective for 
highly endemic areas of sub-Saharan Africa.  In some situations, however, the results 
are less conclusive. These include areas of low-endemicity and areas prone to 
epidemic malaria transmission.  The shift from conventional nets to LLINs should be 
rapidly made in all programs which have yet to do so, as our results clearly show that 
this would substantially improve the cost-effectiveness of ITN programs.  
Nevertheless, re-treatments to existing nets can be delivered at lower costs than 
entirely new nets and re-treatment of already existing nets is an efficient way to 
provide protection during the transition to LLINs.  As mass-distribution campaigns are 
increasingly the distribution method of choice, LLIN distribution can be effectively 
mandated by international donors and ministries of health.  Our results also highlight 
the need for more research on the economic implications of switching from a model 
of ITN distribution targeted towards children, to a full population coverage model.    
 
As scale is important in the functioning of any economic production system (including 
the delivery of ITNs or IRS) we chose to examine only programs which were 
operating on national or very large scales, the types of programs that decision 
makers are likely to consider.  While all the programs we examined were large 
relative to previous costing attempts, their scale still incorporated substantial variance 
- as much as three fold in the number of persons protected per year.  The programs 
we examined also varied significantly in their operational goals and targets, and 
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correspondingly in their operational strategies.  All these factors, which are inherent 
in a case study approach, can contribute to difficulties in interpreting results. The 
following sections discuss methodological and interpretive problems with data of this 
type, potential steps for remedying some of these problems, as well as extending the 
LLIN estimates to better reflect the current global policymaking environment.  
 
8.2 Methodological problems with uniform methods of cost collection 
 
A uniform method of cost collection was aimed for so as to minimize variability in the 
results of the study.  Despite our best attempts, however, there were several specific 
issues which varied from setting to setting.  Because this study incorporated the 
collection of retrospective data the quality of data sources was inevitably variable.  
Differences arose either because the information was not collected in the first place, 
was poorly (or not) preserved, or was simply recorded in incompatible manners.   
By way of example, vehicle costs were largely recorded as cost of temporary rental in 
Eritrea and available as aggregate data, while in Malawi almost all of the vehicle time 
used was derived from vehicles in a shared pool for which purchase prices or 
replacement costs could be accurately measured, but vehicle use data had to be 
estimated based on proxy indicators.   
 
Another frequent difficulty was the estimation of personnel costs, as salary 
information is generally considered sensitive and some institutions were reluctant to 
release files with specific costs of employment.  In some cases it was possible to get 
salary ranges for employees of specific grades and use these to estimate the costs of 
personnel, in others only the number of persons employed related to a program and 
their general level of responsibility was available. In such situation their level of effort 
was estimated based on a proxy indicator or an interview and their cost of 
employment based on WHO-CHOICE data (World Health Organization, 2006).   
 
In all cases solutions were available which fit existing guidelines for the economic 
analysis of programs (Phillips et al., 1993; Creese & Parker, 1994; Drummond et al., 
2005; Kolaczinski & Hanson, 2006), but in many cases completely uniform standards 
for retrospective data collection were difficult to maintain. Fortunately, in both types of 
vector control intervention studied here the major cost centers were those related to 
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either ITNs/LLINs or to insecticide and these costs were also the most amenable to 
uniform methods of data collection.   
 
With ITNs the greatest variability arose from the issue of when and where program 
outputs and costs were measured.  In order to measure the denominator it was 
necessary to address questions such as: are ITNs considered delivered when they 
reach a user, or when they reach a district health facility or a primary health care 
facility?  Alternatively, how are commercial sector sales measured and how are they 
attributed to social marketing or public-private partnership effort? For IRS the primary 
question was: how does operational coverage relate to actual coverage? One must 
consider the possibility of inadequate insecticide dosing or reporting by spraymen, 
and leakage of insecticide outside of the spraying program.  Any of these issues can 
confound cross-country measurement.  For cost of commodities in both interventions 
the question of which accounting method is most appropriate, either LIFO (Last In 
First Out) or FIFO (First in First Out) or an average cost method (used here) and how 
to account for delivery of slightly different types of commodity become important. 
 
Further, one very important issue is price level since it is well established that 
purchasing power varies greatly across different country settings (World Bank Group, 
2009).  While the magnitude of such variations appears to be greatest when low-
income countries are compared with high-income countries, there is still considerable 
variation within the low-income countries of sub-Saharan Africa, and even across 
various components of the same economy (World Bank Group, 2009).  
 
Unfortunately, the methodological prescriptions for dealing with such variation are a 
source of considerable debate (Rogoff, 1996). The use of Purchasing Power Parity 
(PPP) adjustments across countries to establish uniform opportunity costs for non-
traded goods is a standard method of adjusting for price level differences between 
countries.  This, however, presents the problem of defining what is and is not a 
traded good; while the issue of misclassification bias in such circumstances is 
probably relatively small it still must be considered (Rogoff, 1996; Hutton & 
Baltussen, 2005).  More problematic is that the basis for such adjustments are 
baskets of goods designed to represent the full scope of the economy of a country 
and are unlikely to be reflective of the basket of goods actually used by a vector 
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control program (Hutton et al., 2005).  The construction and maintenance over time of 
a properly sampled basket of goods for estimating price level variations is not trivial 
and indeed is generally beyond the scope of the economic analysis of a health care 
intervention.  Even the international institutions which maintain global baskets of 
goods do not update these annually and price levels, although they tend to fluctuate 
less than nominal exchange rates, are not constant. Furthermore, even when 
updated these measures present a moving base line which may be shifted by 
changes entirely unrelated to costs in the sector of interest (Rogoff, 2006; World 
Bank Group, 2009).              
 
8.3 Methodological issues related to program outputs 
 
Generally, each program was evaluated economically with regard to either the 
number of ITNs/LLINs delivered or the number of total persons who slept in a 
sprayed dwelling.  Both of these measures incorporated uncertainty on several 
levels. For ITNs this uncertainty largely revolves around two issues: (1) the accuracy 
of the reported numbers of ITNs/LLINs delivered, and (2) by whom are those nets 
used?  For IRS there are two main problems which arise: (1) how does the 
operational definition of coverage relate to actual coverage, and (2) how are 
population estimates derived?   
 
A “delivered” ITN can be measured at many separate stages in the process of actual 
ITN delivery.  The measurement point has a potential to bias the results of a study in 
one direction or another.  In systems which use commercial sector delivery without 
direct user subsidies another methodological issue arises, the attribution of net sales 
to program activities since it is certain that not all market sales are likely to be 
attributable to a program’s promotional.  
 
Further, it is quite clear from extensive anecdotal evidence that some fraction of ITNs 
are used for alternative purposes, such as the commonly touted fishing nets and 
bridal veils - this type of alternative use is commonly called wastage (Minakawa et al., 
2008).  Unfortunately, empirical estimates of the size and scale of this phenomenon 
are very limited. While there is currently an ample amount of evidence available 
relating to net possession and usage, relatively little attention has been paid to either 
understanding the “demographics” of the net and ITN “populations” in large scale 
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operational settings or to estimating the main factors which determine the size of the 
gap between net possession and usage (Macintyre et al., 2006). 
   
For IRS the factors relating operational coverage to actual coverage are also many 
and complicated.  Spraying of houses requires a high level of training of spraymen to 
produce a uniform and appropriately dosed coating of insecticide on walls of varying 
sizes and materials.  When operational definitions are used to define spray coverage 
it is clear that some houses or structures defined as sprayed will be in fact 
inadequately dosed with insecticide either because of low application rates or the 
failure to spray all of the appropriate rooms or surfaces.  Furthermore, without high 
quality supervision, structures may be reported sprayed which are in fact missed all 
together.  Neither is IRS exempt from behavioral and demand-side factors which can 
influence effective spray coverage.  Householders may refuse entry to spray teams 
or be absent and lock buildings or homes preventing access, and they may re-paint 
or re-plaster walls even after allowing their homes to be sprayed (Mnzava et al., 
1998).  Little quantitative information is available on these phenomena but what is 
available indicates that large fractions of the population may engage in refusal or re-
plastering in some situations (Mnzava et al., 1998).   
    
8.4 Methodological concerns with the estimation of health outcomes   
 
The estimation of health outcomes or impact presents further problems for inter-
country comparisons.  These methodological issues come on several fronts.  One 
main issue is the lack of current and reliable efficacy estimates for IRS.  A recent 
Cochrane review on this topic showed that despite the identification of over one 
hundred thirty studies on the health impact of IRS only six fit the inclusion criteria for 
a rigorous systematic review, and none of these studies estimated the impact of the 
intervention on mortality in children (Pluess et al. in press).  As a surrogate, 
comparative evidence between ITNs and IRS shows that when both strategies are 
employed at high coverage there seem to be little difference in the entomological and 
health impact (Curtis & Mnzava, 2001; Lengeler & Sharp, 2003; Pluess et al., in 
press).   
   
The main problem for health impact estimation in specific settings relates to (1) the 
difficulty to get representative coverage measures, and (2) a lack of empirical 
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evidence on how impact of the interventions vary with coverage levels.  Both 
interventions can provide some level of personal protection from malaria transmission 
(under some circumstances for IRS) as well as community protection based on a 
mass killing of vectors.  The community effects, however, vary with effective 
coverage and quantification of the relative importance of these effects at varying 
levels of coverage with each intervention is difficult, despite some recent advances 
through modeling (Killeen et al., 2007).  The estimates of impact used here are based 
on high levels of coverage, and thus may not accurately reflect health impact if high 
coverage is not achieved, as was the case for example in Senegal.   
 
What follows is one example of how uncertainty in making the link between known 
efficacy and field effectiveness can be complicated by factors relating to the uptake 
and use of the intervention (Figure 12).  The following figure shows a threshold 
analysis between the cost-effectiveness for ITNs and IRS, where the number of years 
of child protection derived from each net is varied.  Hypothetical confidence intervals 
are shown based on an assumption that the true cost effectiveness at each point is 
somewhere between the highest measured CE + 20 USD per DALY and the lowest 
measured CE for that intervention – 20 USD per DALY (approximately the cost 
difference which would arise from choosing either the highest or lowest end of the 
95% confidence interval from the Cochrane review of ITNs).  Under these conditions 
it is clear that though the point estimates of average CE show that ITNs are favored 
at around one child year of protection for every five nets delivered, if uncertainty is 
incorporated this might increase to one child year of protection for every 1.5 to 2 nets. 
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Figure 12: Threshold analysis of child usage of nets with theoretical confidence 
bounds. See text for explanation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
8.5 Average cost-effectiveness and the one number effect 
 
Much evidence on the cost-effectiveness of interventions has typically been based on 
trial data and focused on the use of average cost-effectiveness, as is largely this 
case in this study.  This simplification, though it adds to the appearance of clarity, 
may also mask important areas of variation in the cost-effectiveness of health 
interventions and implications for decision making (Hanson, 2004; Johns & 
Baltussen, 2004).  From the studies of ITN programs undertaken here it is clear that 
the scale and scope of interventions, as well as the timing of measurement can have 
clear impacts on the measures of cost reported, and thus on the cost-effectiveness 
estimates.   
 
For instance, in Malawi, the average annual cost per ITN distributed fell by more than 
50% over the course of the program’s evolution.  Which part of this cost curve is the 
most relevant for decision makers contemplating a similar strategy in another setting?  
The average cost, which is the easiest number to consider and reference, 
incorporates higher costs at lower scales which might not be replicated in another 
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setting, where a program began immediately on a large scale. Thus, it might be more 
appropriate to consider only the cost of delivery at a scale close to that which could 
be achieved in a similar program.  However, it is not entirely clear from the limited 
evidence available whether similar effects would be replicated by all programs or 
whether specific operational or context specific factors may have contributed to this 
phenomenon.   
 
Additionally, even the average cost of delivery at full scale may be different than the 
marginal cost of delivering an additional net through a given system, thus giving 
decision-makers incorrect information on how to make further decisions once a given 
strategy is already in place.  Figure 13 graphically illustrates the relationship between 
average and marginal costs as the scale of a production system changes, using data 
from Malawi. The figure shows the relationship between the annual average and 
marginal costs ITN distribution in Malawi.  Point estimates of cost and cost 
effectiveness may be misleading due to these types of relationships.  
 
Health intervention effectiveness in terms of absolute burden may also vary with 
scale, with an additional net or house sprayed in an already high coverage area likely 
to avert fewer deaths and infections than a net or house sprayed in a low coverage 
situation.  Further, a population which is covered first by any intervention is usually 
the easiest and least costly to cover.  For these reasons it is likely to be more costly 
to go from 70% coverage to 80% coverage with an intervention than to go from 20% 
coverage to 30% coverage, though the absolute increase in population protected is 
the same (Johns et al., 2004).  
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Figure 13: Average and marginal costs of delivering ITNs in Malawi. MC=marginal 
cost curve (shows the average annual cost of delivering the additional ITNs in each 
year as the program expanded). AC=average annual cost of delivering all ITNs in a 
given year. 
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8.6 Estimating the cost per person protected under a full coverage scenario 
 
On the basis of this work we are interested in describing the economic cost of a full 
population coverage LLIN program, which is now the model recommended by WHO 
(WHO 2007).  Given known distribution or delivery costs, the cost per person year of 
protection (PYP) with LLINs depends on three factors: (1) how many nets are 
wasted, (2) how many nets are used, and (3) by whom. We do assume here that the 
population under nets will be representative of the entire population.   
 
For IRS, full protection is taken to mean 95% of the population of a sprayed area is 
protected. The IRS programs in our work represent one round of pyrethroid spraying 
in KwaZulu-Natal and two rounds of carbamate spraying in Mozambique, and both 
are assumed to provide one full year of protection.  
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Under this scenario we understand that the cost per PYP is indicative of cost per 
child year of protection (CYP). Based on our results we can then generate costs per 
PYP according to the following relationship (Equation 3): 
 
Equation 3: Cost per person year of protection under full coverage 
 
( ) usagenumpernetwastage
CostTNYCostPYP
∗∗−
=
1
 
 
Where CostPYP is the cost per person year of protection, CostTNY is the cost per 
treated net year of protection, wastage is the wastage rate, numpernet is the average 
number of persons sleeping under each used net, and usage is the rate at which all 
nets which remain in households are used. 
 
Assume that 10% of nets will simply vanish – e.g. become fishing nets or bridal veils 
Also assume that each TNY protects one person for one year (a very conservative 
estimate), or alternatively that a net protects two people but that only half of the nets 
are used or they are all used but only half of the time. Table 38 illustrates the results 
derived from our data. 
 
Table 38: Scenario analysis, full population coverage with no scale effects 
 
 3 year LLIN @ 5 USD 5 year LLIN @ 7 USD 
 
LLIN Cost per PYP Cost per PYP 
      Eritrea 2.70 2.13 
      Togo 2.63 2.11 
      Malawi 2.27 1.88 
      Senegal 4.60 3.61 
      Tanzania 2.66 2.58 
 
IRS 
  
      KwaZulu-Natal 3.27 3.27 
      Mozambique 3.90 3.90 
 
The cost per PYP using LLINs appears to be lower in all cases except Senegal when 
compared to IRS. Of course, the margin is much lower with regard to CYP compared 
to when successful LLIN demographic targeting scenarios are considered.  This 
scenario analysis assumes that the average cost of delivery per LLIN would not 
decrease when programs shift to full population coverage, which is unlikely but there 
are no data on this at present. 
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8.7 Parasitological diagnosis with RDTs and costing methodology 
 
Results from our Rapid Diagnostic Test (RDT) costing study showed that significant 
drug costs could be saved by shifting from routine microscopy and clinical diagnosis 
of malaria to parasitological diagnosis using RDTs.  However, overall case 
management cost were not reduced and the implications of our findings are therefore 
important in practice. This result is in contrast to some studies which have estimated 
the potential for cost savings from RDT use in low transmission areas (Shillcut et al., 
2008; Lubell et al., 2008) However, neither of these studies projected certainty of cost 
savings and both suggested that savings would be dependant on clinicians’ 
compliance with the test result.  Though in our study compliance with test results was 
high we still did not observe cost savings.  A recent study in Zanzibar also showed 
that cost savings may not accrue with RDTs despite improved case management in 
that setting (Msellem et al., 2009).  RDTs have been shown to improve case 
management, rationalize drug use and could theoretically help to slow the spread of 
drug resistance (Bell et al., 2006).  All these factors could contribute to them being a 
good investment despite higher costs and studies have estimated that they would be 
cost effective in large areas of sub-Saharan Africa (Shillcut et al., 2008; Lubell et al., 
2008).   
 
Our study was small, both in terms of numbers of patients recruited and, more 
importantly, in the number of facilities surveyed.  Further, our study was conducted at 
the primary health care level in a relatively low transmission area.  Generalizability 
may be compromised both due to heterogeneity within the limited number of facilities 
as well as by the issue of whether these facilities are representative outside Dar Es 
Salaam.  In order to deal with both sources of variability it would be appropriate to 
extend the study to a larger number of facilities, as well as to account for 
heterogeneity with multi-level statistical methods which adjust for clustering within 
facilities. At least our results apply to the primary care level, which is by far seeing 
most patients in malaria-endemic areas.  
 
Low transmission areas are characterized by lower malaria attributable fractions of 
fever cases, and thus more potential for reductions in anti-malarial drug use through 
improved diagnostic accuracy. Hence, it is important to note that despite this 
 8. Discussion 158 
favorable situation, the overall case management cost tends to be higher following 
RDT use.  On this basis it is reasonable to assume that case management costs 
would further increase in higher endemicity areas, where the proportion of fever 
cases requiring antimalarial treatment is higher.  
 
The results of the present study are also dependant on the assumed drug prices. In 
the context of a global ACT subsidy which would significantly reduce the cost of 
antimalarials, the actual drug cost savings to health systems may no longer be 
present.  Under such a scenario (which is increasingly developing at the global level), 
a shift to parasitological diagnosis with RDTs would inevitably increase the overall 
costs to the health system.   
 
 
8.8 Possible extensions to this research 
 
One possible avenue for an additional analysis of the vector control data we collected 
is to develop Monte Carlo (MC) simulation based estimates of the uncertainty 
associated with input and output measures.  This would allow for better quantification 
compared to one-way sensitivity analysis of the areas where the decision space may 
be more or less certain. While this approach would make some inferences more 
robust, it also faces the problem that where information on the variance or probability 
distributions of variables does not exist, or is itself poorly understood or un-quantified, 
the simulations may add little value (Drummond et al., 2005). 
   
More information could be garnered on costs by continuing to sample ITN and IRS 
programs in a variety of settings and operational conditions over time, and thus build 
a larger evidence base on the cost of delivery of these interventions. Additional data 
are available for at least two additional IRS programs in Bioko Island, Equatorial 
Guinea (Schwabe et al., 2007) and some PMI countries (Brantly and Worrall et al., 
2007) An urgent addition in terms of implementation model will be the costing of a 
universal LLIN coverage campaign, since this is now implemented or planned in a 
number of countries. With more data from country studies it might be possible to use 
econometric methods to examine the drivers of delivery costs and outcomes 
achieved in a more accurate and reproducible way.  However, based on the time and 
effort required to collect the primary data in this thesis this requires a substantial 
investment of time and effort. Efforts are currently underway via the Global Malaria 
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Program at the World Health Organization to collect this type of data in an increasing 
number of countries. 
 
Finally, mathematical models are becoming available which can robustly examine the 
health effects of vector control in varied eco-epidemiological settings, with varied 
levels of effort or success in terms of coverage,  usage and insecticide properties 
(Smith, 2007; Smith et al., 2008).  Our data will be used in this modeling effort and it 
is our hope that applying our cost data to models which better quantify the health 
impact in the study settings might yield improved estimates of the cost-effectiveness 
of vector control programs. Such efforts may provide improved aid to decision making 
in the context of uncertainty and with the long time horizons needed to properly 
advise malaria control programs throughout varied settings in sub-Saharan Africa. 
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9 Conclusions 
 
9.1 Implications of results 
 
Vector control with ITNs and IRS 
This thesis represents an extensive and unique collection of large scale cost data on 
malaria vector control operations in Africa.  It has the additional advantage that the 
data have been collected in a methodologically similar way and analyzed by one 
person according to a standard set of principles and with transparent assumptions.  
Thus, it provides a substantial amount of evidence which can be used to guide 
decision making in areas where interventions have yet to reach real scale.  The study 
yielded several interesting and important results: 
 
 In many situations LLINs appear more cost-effective than IRS; characteristics of 
such situations are:   
o The uptake of the intervention is good and averting mortality in children is 
the primary outcome of interest  
o The transmission season is long, and/or the presence of insecticide 
resistance precludes the use of the inexpensive and longer lasting classes 
of insecticide for IRS   
o Preferential usage of bednets by children 
 Large expansion of vector control and improved treatment with ACT may 
decrease the applicability of the base results 
 Our results have less relevance when elimination of all malaria transmission is the 
goal since maximization of control efforts might imply the need for using multiple 
approaches. 
 Operational requirements of the different strategies varied greatly, and this needs 
to be considered when choosing interventions. 
 The financial sustainability of any of the examined programs appears weak in the 
absence of international funding. 
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Introduction of RDTs for malaria diagnosis 
 Drug cost savings were apparent after RDT implementation, but despite this 
overall provider costs increased.  
 Clinicians were more compliant with the results of an RDT test than with routine 
microscopy, given adequate training. 
There may be substantial additional benefits of introducing RDTs, and these should 
be considered and measured.    
 
9.2 Recommendations to control programs 
 
 LLINs are generally the most cost-effective way forward for malaria vector 
control in sub-Saharan Africa 
 Conditions which favor ITNs/LLINs over IRS are: 
o The area is highly endemic with a long transmission season 
o Burden of disease is concentrated in under five children 
o Bednets will be used by the population, preferentially by children, and 
wastage is low 
 
 Decision makers should also consider the use of IRS, especially when 
o The transmission season is short 
o Longer lasting and inexpensive insecticides (such as DDT) are 
available and can be used 
o Pyrethroid resistance becomes an impediment to the use of LLINs 
o Operational capability for IRS is present or easily mobilized 
  
 ITN distributions should primarily consider the use of integrated campaigns for 
the “catch-up” phase and highly subsidized distribution approaches for “keep-
up” strategies 
 Maintenance of high and stable levels of donor funding for vector control of 
any type is critically important 
 
9.3 Steps forward 
 
The previous chapters have described the results of and methodological issues 
related to the studies contained in this thesis.  They raise certain questions as to 
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what could be done to either to improve the quality of the information available, or to 
use what exists to better quantify the level of uncertainty associated with imperfect 
information.  Several options for continuing this work are available: 
 
 Development of Monte Carlo (MC) simulation based estimates of the 
uncertainty associated with the measures within this thesis. 
 Continued sampling of ITN and IRS programs in a variety of settings and 
operational conditions over time (especially universal coverage with LLINs), 
combined with the use of econometric methods, to examine the drivers of 
delivery costs and outcomes achieved 
 Mathematical modeling of vector control and associated costs and effects 
 Diagnostic studies expanded both to a larger number of facilities and into 
different transmission and health system contexts.   
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